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ABSTRACT 
 
Equine endometritis is one of the most common and important reproductive 
conditions causing infertility in mares. After mating there is a normal, transient 
inflammation in response to sperm, seminal plasma and bacteria in the uterus, termed 
mating-induced endometritis (MIE). Mares are classified as susceptible to persistent 
mating-induced endometritis (PMIE) when they fail to clear the uterus from MIE 
within 36-48 hours post mating. PMIE creates an adverse uterine environment, 
resulting in subfertility due to inflammation and disruption of the endocrine 
maintenance of pregnancy. An equine endometrial explant system was previously 
established to measure uterine inflammation via Prostaglandin F2α as a biomarker. 
However, it was not determined if the transcriptome from explants was altered once 
in culture.  
The aim of this study was to characterise the genetic profiles of equine endometritis 
in vitro to better understand the transition from MIE to PMIE. The objectives were 1) 
to determine if the transcriptome of cultured endometrial explants collected from 
native pony mares represent the transcriptome of  the whole mare in the pre-
breeding, non-inflammatory state and thus, determine how the transcriptome of 
explants is modulated once in culture; 2) compare the transcriptome profiles from 
unchallenged cultured explants from the follicular, luteal and anoestrous phases to 
characterise the global uterine transcriptomic changes throughout the oestrous cycle 
and anoestrous; 3) determine the RNA-Sequencing (RNA-Seq) changes in cultured 
explants after challenge with E. coli lipopolysaccharide (LPS) to better understand 
transcriptome modulation during inflammation; 4) compare the transcriptome 
profiles of mares resistant and susceptible to PMIE before breeding.  
Endometrium was collected from mares sent to a commercial abattoir, during 
different stages of the oestrous cycle or anoestrous, and explants established as 
appropriate to address each objective. RNA-Seq was performed for all experiments 
and differentially expressed genes (DEGs) were investigated in terms of significantly 
enriched biological pathways. In vitro explants cultured for 24 hours demonstrated 
significant transcriptomic changes compared to the ex vivo 0 hours biopsies, but 
thereafter remained similar up to 48 hours in culture. DEGs related to inflammation 
differing between 0 and 24 hours were set as the baseline changes between the ex 
vivo biopsies and the in vitro explants. The gene expression of innate immunity 
genes was greatest during the follicular phase of the oestrous cycle, followed by the 
anoestrous period and lower during the luteal phase in accordance with the endocrine 
milieu. Cultured explants did not exhibit large scale gene expression changes in 
response to LPS challenge and it was not in agreement with other studies. In 
addition, the transcriptome of resistant and susceptible mares showed different 
expression profiles of immune genes even before breeding. 
The thesis investigated the use of an explant tissue culture system as a future model 
for studies of equine endometritis at the level of the transcriptome. Innate immune-
associated genes exhibited increased expression during the follicular phase compared 
to the luteal phase of the oestrous cycle and anoestrous period. Furthermore, four 
genes were suggested to have the potential of distinguishing mares likely to be 
resistant or susceptible to PMIE, which may be identified in practice at pre-breeding 
examination. 
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CHAPTER 1 
 
INTRODUCTION 
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Pregnancy rates in broodmares have remained low, between 50-65 % per cycle, for 
many years, notwithstanding extensive research into fertility problems (Ball et al., 
1986; Allen et al., 2007). Of the nearly 24,000 Thoroughbred (TB) mares sent to the 
stud in Great Britain and Northern Ireland in 2017, only 61 % produced a live foal 
(www.weatherbys.co.uk). The equine industry is a financially lucrative business 
worldwide, however persistence of uterine inflammation (endometritis) is one of the 
main causes of infertility in mares and the third most important clinical problem 
affecting adult horses according to equine practitioners in the USA (Traub-Dargatz et 
al., 1991; Watson, 2000). It has been reported that 15-40 % of a normal population of 
TB mares suffer from persistent endometritis, reducing pregnancy rates by 13 % 
(Pycock and Newcombe, 1996; Zent et al., 1998). 
Mating-induced endometritis, also known as MIE, is a normal physiological 
endometrial inflammation that occurs in response to a variety of stimuli such as 
spermatozoa, seminal plasma, debris and bacteria introduced in the uterine lumen 
during breeding (Troedsson, 1999; Watson, 2000; Katila, 2001). Mating-induced 
endometritis eliminates the excess of semen and bacteria from the uterine lumen after 
breeding, leaving the uterus in a sterile and non-inflamed condition to receive the 
embryo 5-6 days after fertilization through immune responses and mechanical 
clearance of fluid (Betteridge et al., 1982; Troedsson, 2006). Nonetheless, some 
mares fail to clear this transient normal inflammation, which then becomes 
persistent, known as persistent mating-induced endometritis or PMIE (Watson, 2000; 
Troedsson, 2006). Mares that clear their uteri from the normal transient MIE within 
36-48 hours after breeding are considered resistant to PMIE, while mares that fail to 
clear inflammation within this time are classified as susceptible to PMIE (Katila, 
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1995; Troedsson, 1999). Figure 1.1 demonstrates the major differences between MIE 
and PMIE.  
Figure 1.1 – Pathophysiology of Mating-induced endometritis (MIE) and Persistent mating-
induced endometritis (PMIE). 
 
Early identification of mares susceptible to PMIE is critical for appropriate breeding 
management. Research has demonstrated that cytokines contribute to the 
pathogenesis of persistent endometritis induced by semen and/or bacteria, focusing 
on the factors associated with resistance and susceptibility in mares (Fumuso et al., 
2003; Christoffersen et al., 2010; Christoffersen et al., 2012; Woodward and 
Troedsson, 2013). Nonetheless, the mechanisms linking the progression of MIE to 
PMIE are not well elucidated, and the endometrial global gene expression in resistant 
and susceptible mares before challenge is still unclear. Once the mechanisms 
underlying uterine inflammation are better understood at the transcriptomic and gene 
expression levels, identification of mares likely to be susceptible to PMIE at the pre-
breeding examination will lead to appropriate management and an increase in 
fertility.  
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It is known that the steroid hormone changes within the oestrous cycle affect the 
efficiency of the uterine immune response.  Depending on the stage of the oestrous 
cycle, the uterine environment faces challenges differently. During the luteal phase 
progesterone effects predominate over those of oestrogens in the uterus. Linked to 
these the proliferation of bacteria, accumulation of uterine fluid and accumulation of 
neutrophils is significantly greater when compared to the follicular phase of the 
oestrous cycle (Evans et al., 1986a; LeBlanc et al., 1994). However, there is a lack of 
knowledge regarding the change in global gene expression of the endometrium 
throughout the oestrous cycle and anoestrous period. Elucidating the changes in gene 
expression between phases will improve the understanding of the influence of 
hormones in resistance and susceptibility to PMIE.  
An endometrial explant culture system composed of epithelial and stromal cells and 
resident leukocytes has already been used in previous research, and it responds to 
inflammatory stimuli by secreting markers of inflammation such as prostaglandin F2α 
(PGF2α) synonymous to that of the whole animal (Nash et al., 2008; Nash et al., 
2010b; Nash et al., 2018). However, it has not been determined whether the 
transcriptome of cultured endometrial explants is altered once in culture. The use of 
abattoir-derived tissue negates the need to collect numerous uterine biopsies from 
living mares, and it also allows the entire surface of the endometrium to be used in 
laboratory experiments with different treatments. An in vitro system is needed to 
further study the equine endometrium and to better understand the global gene 
expression changes related to endometrial inflammation. Following successful 
analysis of the explant system at the transcriptomic level, this endometrial model 
presents a promising means by which PMIE may be explored further.  
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The aim of this thesis was to first investigate the use of an ex vivo endometrial 
explant tissue culture system at the level of gene expression as a baseline 
transcriptome for future studies, reducing the need for whole-animal research. 
Establishing an in culture model is important for studying the endometrial innate 
immune system as a baseline for future studies analysing equine endometritis. The 
second aim was to characterise the global gene expression in the equine 
endometrium and generate transcriptomic profiles of unchallenged endometrial 
cultured biopsies during the follicular and luteal phases of the oestrous phase, as well 
as during the anoestrous period. These findings will provide an innovative and 
significant insight into the understanding of physiological variation due to hormonal 
changes during the different phases of the oestrous cycle. The third aim of this thesis 
was to investigate the mechanisms underlying inflammation at different time points 
to understand the link between MIE and PMIE in mares. By using the explant tissue 
model, the innate immunity gene expression during challenge with Escherichia coli 
(E. coli) lipopolysaccharide (LPS) was characterized. The fourth and final aim was to 
determine the differences in global gene expression between resistant and susceptible 
mares before breeding. Identifying genes linked to both MIE and PMIE before the 
endometrium faces a challenge with semen and/or bacteria will improve the 
understanding of the delicate balance between resistance and susceptibility to PMIE 
in mares.  
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2.1 | Introduction 
The equine sector is of significant economic importance worldwide. It is worth 
approximately 73 billion pounds annually with around 7 million horses in the 
European Union (BETA, 2015). In Europe horses have historically been widely used 
in the military, industry, agriculture and for transportation. In modern times, horses 
perform sports activities and are extensively used for leisure. It is projected that 
horses will be no longer used for agricultural work. Instead, they will increasingly be 
used in sports and for recreation, due to the great popularity of such activities 
(Aurich and Aurich, 2006).  
Investments in equine-related research worldwide are closely related to the 
increasing growth and development of the equine industry. Due to constant progress 
in animal genetics producing high commercial value horses, the equine industry is a 
financially lucrative, global business (Coelho and Oliveira, 2008). To capitalise on 
this, equine reproductive management aims to achieve the highest percentage 
possible of mares producing live foals per mating. However, it is not guaranteed the 
mare will deliver a live foal as a consequence of mating. The costs associated with 
producing a foal are high, such as investment in the mare, mating costs, nutrition and 
management costs. A study looking at the financial value of mares and the impact of 
reproductive efficiency over time indicated that mares are long-term investments and 
for them to be financially viable they need to produce at least six foals over a 7 year 
period (Bosh et al., 2009). Therefore, mare fertility in the equine industry needs to be 
constantly optimised so that the aim of one foal per mare per mating per year is 
achieved in order to minimise costs. Understanding the mechanisms involved in low 
fertility rates is strategic to maximising breeding efficiency and, consequently, 
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profitability (Bosh et al., 2009). Reproductive efficiency, in the mare, is associated 
with a series of different events such as puberty, ovulation, oestrous cycles, age at 
first conception and first parturition, birth intervals, easy of parturition, the number 
of live foals delivered, and longevity (Gonçalves et al., 2009). Amongst these, one of 
the most important is the ability to conceive after mating. This is governed by 
amongst other things the ability of the uterus to accept a pregnancy and so can be 
adversely affected by conditions such as endometrial inflammation, known as 
endometritis. In order for the mechanism of endometritis to be understood, 
knowledge of the mare’s reproductive tract is required.  
2.2 | Female Reproductive System 
2.2.1 | Reproductive Anatomy 
Female reproductive anatomy is critical to the breeding value and success of the 
mare (Jones and Troxel, 2006). The mare’s reproductive tract lies horizontally with 
50 % in the abdominal and 50 % in pelvic cavity. It is composed of the perineum, 
vulva, vestibule, vagina, cervix, uterus, oviducts, and ovaries (Figure 2.1). 
Abnormalities and/or lack of function in any portion of the reproductive tract can be 
partly responsible for reproductive problems (Jones and Troxel, 2006; Dascanio, 
2011). 
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Figure 2.1 – Dorsal view of the mare’s reproductive tract. The left infundibulum is retracted to 
expose the ovulation fossa. The urethral orifice is shown by retraction of the transverse fold. 
Structures shown: bladder (b), broad ligament (bl), constrictor vestibuli and vulvae (cv), cervix (cx), 
glans clitoris (gc), infundibulum (inf), labia (l), left ovary (lo), left uterine horn (luh), ovarian artery 
(oa), oviduct (od), ovulation fossa (of), proper ligament of ovary (plo), transverse fold (tf), tubal 
membrane (tm), uterine artery (ua), uterine body (ub), urethral orifice (uo), ureter (ur), vagina (va), 
vestibule (ve), vaginal fornix (vf) and vestibular gland openings (vgo).  From Ginther (1992). 
 
The perineum and the labia of the vulva constitute the external genitalia. The 
perineum comprises the outer vulva, anus, caudal rectum, vestibule, and the body 
wall surrounding the urogenital tract outlet (Ley, 2004). The vulva is the exterior 
opening to the reproductive tract. It is composed by two labia, clitoris, and the 
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vestibule, and it is also part of the urinary system. The labia enclose the external 
opening of the vulva and prevent the entrance of air and contaminants into the 
vagina. The labia have a dorsal and ventral commissure; located at the junction near 
the anal sphincter and at the rounded confluence surrounding the clitoris, 
respectively. The clitoris is situated at the ventral commissure. The vulva should be 
upright, vertically orientated, dorsal to the pelvic floor and ventral to the rectum and 
anus (Jones and Troxel, 2006; Dascanio, 2011). A section of the vulva called 
vestibule connects the vagina to the vulvar lips. When mechanically separating the 
vulvar lips, the vestibule and the vestibulovaginal fold are exposed and this is known 
as the “Windsucker test”. No inrush of air into the vagina should occur, indicating a 
good seal by the vulvovaginal fold. If there is any inrush of air a condition called 
pneumovagina occurs where air and debris enter the tract, leading to inflammation 
(Dascanio, 2011). 
The vagina is an elastic muscular tube, with a mucous aglandular membrane that 
connects the vulvar vestibule to the cervix. The cranial vaginal walls and the vaginal 
portion of the cervix join together and form the vaginal fornix. Major stretching 
occurs during parturition allowing the passage of the foal (Ley, 2004). The vagina 
has acidic bacterial and spermicidal secretions. Consequently, it protects and cleans 
the reproductive tract. Sperm are deposited into the cervix and/or bottom of the 
uterus at mating in order to avoid the acidic spermicidal condition (Davies Morel, 
2015). 
The cervix is located between the uterus and the vagina. It is a tight, constricted 
thick-walled muscular sphincter and it is the final physical barrier defending the 
reproductive system against contamination and infection during the luteal phase of 
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the oestrous cycle and pregnancy. The cervix is a highly vascularized structure 
characterized by a folded muscular, collagenous connective tissue wall, which is 
lined by longitudinally folded columnar epithelium containing mucous-secreting 
cells. Its shape and colour vary and adapt to suit different patterns of reproduction 
depending on hormones. During parturition, it dilates to allow foal’s passage. During 
the follicular phase of the oestrous cycle it is pink and relaxed, lying on the vaginal 
floor and secreting mucus to lubricate the passage of the penis and to allow the entry 
of semen into the uterus. During the luteal phase of the oestrous cycle the cervix is 
white, toned, does not lie on the vaginal floor and its secretion is thick and minimal 
(Jones and Troxel, 2006; Davies Morel, 2015). 
The “Y” shaped uterus is divided into two uterine horns and the uterine body and it is 
located in the abdominal cavity, supported and suspended by the mesometrium. The 
uterine horns approach the fallopian tubes, and the uterine body joins the cervix. The 
uterus is divided into three different layers: the perimetrium, the myometrium, and 
the endometrium (Figure 2.2). The perimetrium is the outermost serosa layer, which 
is continuous with the broad ligaments. The myometrium is the middle muscular 
layer, composed of an outer longitudinal layer of smooth muscle, an inner circular 
layer of smooth muscle and a middle vascular layer. The myometrium is responsible 
for elasticity, expansion of the uterus and contractions during parturition. The 
endometrium is the inner layer of the uterus, characterized by longitudinal folds 
similar to the cervix. It is composed by an inner submucosa containing endometrial 
glands, ducts, stromal cells and connective tissue, and an outer layer of epithelial 
cells. Hormonal changes ruled by the oestrous cycle influence the appearance and 
activity of these epithelial cells and endometrial glands (Dascanio, 2011; Davies 
Morel, 2015). 
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Oviducts are also called Fallopian tubes or uterine tubes. Each mare has two 
oviducts, which are tortuous tubes continuous with the uterine horns that connect to 
the ovaries. The oviducts are thin structures of 20-30 cm long each when extended. 
They are divided into three parts from the ovary to the horn: infundibulum, ampulla, 
and isthmus. The oviducts are located in peritoneal folds, in the mesosalphinx part of 
the broad ligaments. The infundibulum has a slightly funnel-shaped form with hair-
like projections called fimbriae. The infundibulum covers the ovulation fossa in the 
ovary, the only site where ova are released. The fimbriae catch and guide the ova 
released into the oviduct. The ampulla is an expanded part of the oviducts, and where 
fertilization occurs. The isthmus is a narrow structure that connects the ampulla to 
the uterine horn. It has a thicker myometrial layer when compared to the other two 
structures to push the fertilized ova from the ampulla into the uterus by contractions. 
The uterotubal junction is the site where the lumen of the uterus and the lumen of the 
oviduct connect together (Ginther, 1992; Davies Morel, 2015). 
 
Figure 2.2 – Equine uterine wall diagram. The relative myometrium thickness is reduced in this 
diagram for illustrative purpose. Made by Kenney (1978), from Ginther (1992).  
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Ovaries in mares are kidney/bean-shaped with a noticeable depression, the ovulation 
fossa. Its size and texture vary according to the phase of the oestrous cycle. During 
the breeding season, the ovaries are fully functional, exhibiting many soft follicles 
filled with fluid. Different from other mammals, the supporting tissue called medulla 
is the outer part of the ovaries while the inner part is the cortex. The ovaries produce 
the female gametes and hormones, and the follicles and corpus luteum (CL) grow 
within the cortex. A thick layer known as tunica albuginea protects the whole surface 
of the ovary, except for the ovulation fossa through which ovulation can occur 
(Ginther, 1992; Davies Morel, 2015). 
2.2.2 | Reproductive Cycle of the Mare 
Within the breeding season, independent of mating, mares present multiple 
spontaneous oestrous cycles and because of this are termed seasonal polyoestrous 
spontaneous ovulators (Davies Morel, 2015). Mares are classified as seasonal 
breeders as their reproductive cycle and sexual activity occur during the spring, 
summer and autumn months when the length of the daylight is longer (Allen, 1977). 
The non-breeding season takes place during the winter months and it is known as 
anoestrus. The oestrous cycle of 21 days (± 3 days) is a period characterized by 
physiological and behavioural events controlled by specific hormones, which is 
divided into follicular (or oestrus) and luteal (or dioestrus) phases. The follicular 
phase lasts 4-6 days normally and it is when the follicles mature in the ovary and 
ovulate, oestrogen is secreted and consequently the mare is sexually receptive to the 
stallion (Ginther, 1992; Watson, 1998). Ovulation occurs normally in the last 24-48 
hours of the follicular phase and it is known as day 0 (Ginther, 1992; Watson, 1998). 
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The luteal phase lasts 15-16 days and the mare shows no sexual receptiveness to the 
stallion (Aurich, 2011; Davies Morel, 2015).  
The hypothalamic-pituitary-gonadal axis is the endocrine control of the oestrous 
cycle.  Artificial and/or natural light reduces the melatonin secretion by the pineal 
gland, removing inhibition of the hypothalamus and allowing gonadotropin releasing 
hormone (GnRH) to be released (Snyder et al., 1979; Sharp, 2011; Davies Morel, 
2015). It is released through pulsatile secretions and reaches the anterior pituitary via 
the hypophyseal portal vessels, stimulating the production and secretion of 
luteinising hormone (LH) and follicle stimulating hormone (FSH) into the general 
circulatory system (Irvine and Alexander, 1997; Elhay et al., 2007; Alexander and 
Irvine, 2011). GnRH may have a bigger effect on LH than it has on FSH, where they 
predominate at the follicular phase and mid- to late-luteal phase respectively (Watson 
et al., 2000; Ginther et al., 2004; Elhay et al., 2007). However, GnRH is also 
controlled by an LH, FSH, and oestrogen feedback system. Furthermore, sexual 
stimulation may increase GnRH concentration, and other situations such as stress, 
nutrition and body condition can affect the production of GnRH (Alexander and 
Irvine, 2011). During the anoestrous period, low frequency pulses of GnRH are 
associated with a basal production of LH from the pituitary gland, to inhibit 
ovulation (Snyder et al., 1979).  
FSH is responsible for stimulating follicle development, growth and maturation, and 
its secretion begins to increase slowly after ovulation. The FSH concentration rates 
during the oestrous cycle in mares are still unclear, and different concentration peaks 
have been reported (Alexander and Irvine, 2011; Davies Morel, 2015). Preliminary 
studies measured FSH concentrations in mare’s serum and indicated that FSH 
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concentration peaks occurred at 10-11 days intervals. The first peak usually appeared 
within 24 hours of ovulation, whereas the second one occurred mid cycle normally 
10 days before the next ovulation (Evans and Irvine, 1975).  It is now suggested by 
recent studies that during the luteal phase there is actually only one elongated FSH 
peak with elevated levels observed around ovulation, FSH episodic release slowing 
rising throughout the 21-day cycle. Inaccurately and non-continuous sampling of 
episodic hormone release may be the cause of previous errors when describing FSH 
concentration (Davies Morel, 2015).  
The developing follicles then secrete oestrogen into the blood stream. Oestrogen 
prepares the equine reproductive tract for pregnancy by acting on the oviducts, uterus 
and cervix. At this stage the cervix is characterized by a pink colour, it is relaxed, 
opened, oedematous and mucus producing, whereas the uterus is flaccid and 
oedematous. Oestrogens are also responsible for the behavioural signs of the 
follicular phase, when mares show sexual receptiveness to stallions. This includes 
standing to be mounted, seeking stallion’s attention, raising the tail, urination, clitoris 
exposure by everting the vulva, and absence of kicks or flatter ears (Watson, 1998; 
Jones and Troxel, 2006). 
When blood oestrogen reaches a certain level, the pituitary gland releases LH into 
the blood stream stimulated by high frequency pulses of GnRH from the 
hypothalamus. LH is the hormone responsible for oocyte maturation, ovulation, 
luteinizing the dominant follicle and transforming it into a CL. During the follicular 
phase, its secretion is tonic and pulsatile. LH concentration begins to increase days 
before the follicular phase starts and there is a prolonged peak shortly after ovulation. 
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In the middle of the luteal phase (between days 6 and 15) the concentration of LH is 
low (Ginther, 1992; Alexander and Irvine, 2011). 
Progesterone is the steroid hormone produced primarily by the CL to prepare the 
uterine environment for pregnancy. It inhibits the release of GnRH and hence LH 
and FSH and, therefore it suppresses follicular development and follicular phase 
behaviour. It also regulates the uterine and cervical tone and secretions in the tubular 
genitalia. Under the influence of progesterone, mares enter the luteal phase of the 
oestrous cycle. The principal function of progesterone is to maintain pregnancy by 
sustaining a uterine environment conducive to foetal development (Aurich, 2011; 
Vanderwall, 2011). Oxytocin is a neuropeptide secreted by the posterior pituitary and 
by the endometrium in order to stimulate smooth muscle contraction in the uterus. If 
the mare is not pregnant, the CL remains functional for around 12-14 days. Then, 
oxytocin stimulates the production of Prostaglandin F2α (PGF2α) by the endometrium, 
which induces the luteolysis of the CL, allowing the onset of another follicular phase 
and ovulation. Much higher concentrations of oxytocin also cause smooth muscle 
contraction within the uterus post coitum as a means to help eliminate debris 
deposited at mating and so ensure the uterus is fit to accept a pregnancy (Morresey, 
2011; Stout, 2011; Davies Morel, 2015). Understanding the oestrous cycle is 
important as breeding takes place during the follicular phase of the cycle. Therefore, 
this is the relevant time to study uterine inflammation. 
2.3 | Mare Infertility 
Fertility is the competence of a mare to deliver a live foal in the year following 
mating, and it may be expressed as the percentage of mares pregnant per mating/per 
oestrous cycle/at the end of the season or the percentage of mares producing live 
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offspring (Davies Morel, 2015). Infertility is characterised by a mare’s transitory 
failure/incompetence to conceive a foal. Sterility, on the other hand, is a permanent 
inability to reproduce, often associated with anatomy defects of the reproductive 
tract. Mares with good reproductive history but that are not pregnant at the end of a 
breeding season are classified as barren, regardless the reason underlying it 
(Troedsson and Ricketts, 2007; Davies Morel, 2015). In the UK, the percentage of 
mares delivering a live foal varies hugely from 40 % to 80 %, mainly due to different 
management procedures (Osborne, 1975; Sullivan and Pickett, 1975; Baker et al., 
1993). More recent studies carried out among well-managed Thoroughbred (TB) 
showed percentages between 78-83 % of mares producing a live foal after mating   
(Morris and Allen, 2002; Hemberg et al., 2004; Bosh et al., 2009). Furthermore, of 
the nearly 24,000 Thoroughbred mares sent to the stud in Great Britain and Northern 
Ireland in 2017, 39 % failed to produce a live foal (www.weatherbys.co.uk). 
Some pathogenic causes of low pregnancy rates and high levels of embryonic loss 
are related, even partially, with diminished uterine contractility, decreased uterine 
clearance of external/foreign material, including bacteria, high endometritis rates, 
large amounts of intrauterine inflammatory exudate, and  elevated spermicidal and 
embryocidal effects (Carnevale and Ginther, 1992; LeBlanc and Causey, 2009; 
Woodward et al., 2012).  
2.4 | Endometritis 
Endometritis is an inflammatory condition of the endometrium, mainly caused by 
opportunistic or sexually transmitted bacterial infections but may also be caused by 
fungi and yeasts (Watson, 1998; Albihn et al., 2003b; Hurtgen, 2006; Troedsson and 
Woodward, 2016). Different species of microorganisms can be found and linked to 
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fertility problems, as stud farm management and the breeding system used can 
influence this. Escherichia coli (E. coli), and Streptococcus zooepidemicus (S. 
zooepidemicus) are common pathogens cultured from the uterus of mares, but also 
the ones regularly isolated from mares with bacterial endometritis (Albihn et al., 
2003a; Frontoso et al., 2008; Rasmussen et al., 2015; Christoffersen and Troedsson, 
2017). Endometritis in mares is considered one of the most common pathogenic 
causes of infertility (Bennett, 1987; Card, 2005; Hurtgen, 2006; Liu and Troedsson, 
2008; Troedsson and Woodward, 2016). It creates an adverse and unfavourable 
uterine environment, resulting in early embryonic loss and abortion due to the 
difficulty of embryo survival and implantation. It is characterized by large amounts 
of fluid accumulation and occasionally mucus exuding the vulva, uterine increased 
blood flow and high leukocyte count (Troedsson, 2006; Davies Morel, 2015; 
Troedsson and Woodward, 2016). The uterus is often large and flaccid, and oedema 
and fluid retention may be evidenced by ultrasound scanning. In some instances, 
irritation to the uterine wall results in prostaglandin production which causes 
premature CL regression; therefore, the oestrous cycle may be shortened and 
pregnancy loss (Neely et al., 1979; Troedsson et al., 2001b). 
During natural mating and artificial insemination (AI), semen is deposited into the 
uterus. It carries spermatozoa, seminal components, debris, and bacteria, that 
contaminate the uterus causing a normal, transient uterine inflammation (Troedsson, 
1999; Watson, 2000; Katila, 2001; Troedsson et al., 2001a). This inflammation is 
required for uterine cleaning of bacteria and excess spermatozoa. This normal 
response is called mating-induced endometritis (MIE) and it is occasionally clinically 
noticeable as a vaginal discharge of purulent fluid during the first hours after 
breeding. Efficient reproductive management is important: no mare presenting this 
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normal inflammatory response must undergo treatments as these may affect embryo 
survival and may even bring more contamination (Troedsson, 2006; Christoffersen 
and Troedsson, 2017).  
After breeding only a small part of the ejaculated or inseminated sperm are 
transported from the uterus to the oviduct, within a period of 4 hours. This rapid 
transport of sperm coincides with increased myometrial contractions, which are also 
responsible for the elimination of non-viable sperm through the cervix. The 
myometrial contractions are not enough to eliminate the excess of spermatozoa from 
the uterus after breeding. Therefore, a combination of innate immune reactions 
characteristic of MIE and mechanical cleaning occur (Troedsson, 2006; Woodward 
and Troedsson, 2015). The uterus uses combined defence mechanisms to combat 
endometritis, which include physical clearance of bacteria and inflammatory 
products (Evans et al., 1986a; Evans et al., 1986b; Troedsson and Liu, 1991), 
phagocytosis (Liu et al., 1986) and local uterine antibody-mediated immunity 
(Williamson et al., 1983). 
About 10-15 % of broodmares present failure of uterine defence mechanisms, being 
unable to effectively eliminate antigens and/or inflammatory products from the 
uterus after breeding (Pycock and Newcombe, 1996; Zent et al., 1998). 
Consequently, the inflammation that was previously physiological becomes 
persistent known as persistent mating-induced endometritis (PMIE), bringing 
detrimental effects on uterine environment, and therefore on embryo survival and 
sperm motility (Troedsson, 1997, 2006; Woodward and Troedsson, 2015). Studies 
suggest that mares considered normal must be able to spontaneously clear the 
inflammation within a period of up to five days after breeding, which is the period of 
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time that the fertilized oocyte remains in the oviduct before descending into the 
uterine lumen (Betteridge et al., 1982; Troedsson, 1999, 2006). However, the 
inflammatory response in most mares disappears within a period of 36-48 hours after 
breeding and these mares are classified as resistant to PMIE. Mares are classified as 
susceptible to PMIE when they fail to clear the uterus from the normal transient 
inflammatory response within 48 hours post mating (Hughes and Loy, 1975; Katila, 
1995; Troedsson, 1999, 2006; Woodward and Troedsson, 2013).  
MIE and its persistence, PMIE, seem to be particular to the mare. Cows, for example, 
do not show persistent inflammation after mating, but do suffer from subclinical 
endometritis and persistent endometritis after parturition (Bretzlaff, 1987; Wagener 
et al., 2017). Postpartum endometritis impacts the fertility in dairy cows by 
increasing the days to conception as well as increasing the number of services and 
maintenance for conception, consequently increasing the risk of culling (LeBlanc et 
al., 2002; Ghanem et al., 2015). It has been shown that persistent endometritis after 
parturition is correlated with the presence of Trueperella pyogenes in the uterus of 
cows, which can prolong the luteal phase and decrease ovarian activity between 
weeks 3 and 5 post-partum (Ghanem et al., 2015). Since the pathophysiology of 
persistent mating-induced endometritis in mares and persistent post-partum 
endometritis in cows is different and associated with distinct bacteria, results from 
cows cannot be extrapolated to mares. For this reason, research on equine MIE and 
PMIE is required to better understand these conditions and improve the mare’s 
breeding management and efficiency.  
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2.5 | Persistent Mating-induced Endometritis 
The persistence of MIE can be facilitated by predisposing factors such as stress, 
impaired general health, and malconformation or abnormalities in the reproductive 
tract (Davies Morel, 2015; Woodward and Troedsson, 2015). Reduced closure of the 
vulvar lips (Hemberg et al., 2005) and pneumovagina (Caslick, 1937) may also 
predispose uterine infection, for example. Mares are more predisposed to retain 
uterine fluid as the uterus is more ventrally located in the abdomen, below the pelvic 
brim (LeBlanc et al., 1998). This is exacerbated by age; the uterus of young mares 
shows a greater ability to eliminate infectious organisms, while older mares and 
multiparous mares display lower defence response against harmful organisms 
(Hughes and Loy, 1975; Evans et al., 1986a; Ley, 2004). In studies conducted by 
Carnevale and Ginther (1992), old mares had reduced contractility and tone, 
demonstrating uterine physical impairment, increased intrauterine fluid accumulation 
and inflammation as indicated by endometrial biopsy. Physical clearance of 
intrauterine material was poorer with or without the presence of bacteria (antigenic 
stimulus) in older compared to young mares. Semen is a possible source of uterine 
contamination; however mares in good reproductive health are able to effectively 
clear the uterus and are not affected by exposure to bacteria. Therefore, there is a fine 
line between bacterial pathogenicity and mare’s ability to tackle the inflammation 
(Hughes and Loy, 1975; Watson, 1998). It is known that each mare has differences in 
its susceptibility to persistent uterine infection, and it is also known that the bacteria 
recovery from the uterus or the cervix is not always synonymous of a diseased mare 
(Hughes and Loy, 1975; Hughes, 1980).  
44 
 
During the luteal phase of the oestrous cycle the mare is under the influence of 
progesterone, during this stage uterine infections occur more easily than in the 
follicular phase of the cycle, when the uterus is under the influence of oestrogens and 
consequently more resistant (Hughes, 1980; Evans et al., 1986a; Katila, 2001). This 
happens due to the immune suppression, reduced uterine oedema and diminished 
myometrial contractility caused by high concentrations of progesterone during the 
luteal phase of the oestrous cycle (Hughes, 1980; Evans et al., 1986a; Battut et al., 
1997; Katila, 2001). During the follicular phase of the oestrous cycle, the high 
oestrogen level provides a more resistant uterine environment, enhancing the 
immunological response to infection (Marth et al., 2015a). 
Hughes and Loy (1975) and studies revised by Evans et al. (1986a) propose that 
mares become susceptible to uterine infections when their normal immunological 
and cellular defence mechanisms are disrupted.  However, much research is still 
needed to discover the precise cause of PMIE (Watson, 2000).  
2.5.1 | Physical Clearance 
The physical clearance mechanism is the result of a combination of different factors 
such as cervical relaxation and dilation, fluid secretion from the endometrium and 
from the cervix under the influence of oestrogen, rhythmical and coordinated 
myometrial contractions to expel uterine contents through the relaxed cervix. It has 
been shown that the uterine physical clearance is an important defence mechanism; 
therefore, its impairment or dysfunction is the major problem contributing to chronic 
or recurrent endometritis (Troedsson and Liu, 1991; Nikolakopoulos and Watson, 
1999; Troedsson, 1999; Ley, 2004; Troedsson, 2006). 
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Part of the physical uterine defence mechanism is affected by the contractile activity 
of the myometrium. When susceptible mares are challenged with bacteria their 
electrical myometrial activity is lower than that found in normal mares (Troedsson et 
al., 1993a). LeBlanc et al. (1989) measured the uterine clearance through 
scintigraphy, during the follicular phase and within 48 hours of ovulation. 
Multiparous mares considered reproductively normal cleared the radiocolloids 
consistently. However, mares susceptible to endometritis and nulliparous mares with 
poor cervical dilation showed a delay in the mechanical clearing of the uterus. This 
study suggests that a delay in the mechanical cleaning of the uterus is a factor that 
contributes to susceptibility in some mares. However, mares susceptible to 
endometritis may not always demonstrate a delay in uterine clearance. For this 
reason, further research is needed to clarify the factors underlying resistance and 
susceptibility to PMIE.  
In mares considered susceptible to PMIE, uterine clearance can be stimulated 
through a sterile saline lavage or/and through the administration of uterotonic drugs 
such as oxytocin or PGF2α (Troedsson, 1999). Lavage promotes artificial uterine 
clearance and stimulates lymphatic and uterine blood flow to trigger 
polymorphonuclear neutrophils (PMN) migration into the endometrial lumen and 
into endometrial tissues for cellular defence response. It reduces the number of 
bacteria/fungi/yeast and mitigates their toxicity. Fluids used for uterine lavage 
include sterile saline (0.9 % NaCl), lactated ringers solution, hypertonic saline (9 % 
NaCl), or povidone-iodine solution (0.05-1 % v : v). The temperature of these liquids 
can vary between room temperature (25 °C), body temperature (37 °C) or 42-45 °C, 
higher temperatures are aimed at boosting uterine tone, increase uterine blood flow 
and aid clearance (Ley, 2004). Uterine lavage should be performed from 6 to 24 
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hours after breeding in order not to interfere with fertility, as the sperm transportation 
into the oviduct takes 4 hours to be completed (Troedsson, 2006). 
Spermatozoa placed in an inflamed uterine environment present diminished motility 
and mean path velocity. However, seminal plasma is reported to protect sperm when 
in the presence of inflammation by suppressing complement activation, PMN 
binding and phagocytosis (Troedsson et al., 2001a; Troedsson et al., 2002; Alghamdi 
et al., 2004; Troedsson, 2006). Cryopreserved semen is made by removing the 
seminal plasma (Graham, 1996). Therefore, there is a greater duration of uterine 
inflammation after breeding with frozen/thawed semen. Thus, some mares may 
develop PMIE with frozen/thawed semen; when they do not if mated through natural 
covering or fresh/cooled semen. Mares inseminated with frozen semen have very low 
pregnancy rates because the sperm motility is decreased due to changes to the plasma 
membrane and because there is no suppression of their phagocytosis (Katila, 2001). 
The protection offered by seminal plasma is important when the insemination is 
repeated in the same mare within a 24-hour period, as an MIE environment is created 
for sperm inseminated last (Dahms and Troedsson, 2002). The immunosuppressive 
effect of seminal plasma that protects the sperm from phagocytosis can provide the 
bacteria with a favourable environment for adhesion and growth. Studies suggest that 
bacterial endometritis can contribute to a more aggressive PMIE in mares 
inseminated with frozen-thawed semen (Troedsson, 2006). 
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2.5.2 | Immune System 
2.5.2.1 | Innate Immunity 
The innate immune system is the first line of defence against invading 
microorganisms. This quick-response system is characterized by a group of 
subsystems working through different mechanisms to assure the homeostasis of the 
organism. Inflammation is the most important subsystem of the innate immune 
system (Tizard, 2013). It is important to fully understand the mechanisms underlying 
endometrial inflammation in order to better understand the characteristics involved in 
persistent inflammation and, in the future, develop treatments for PMIE.  
During inflammation, white blood cells and proteins are recruited to the site of 
microbial invasion to destroy them and promote tissue repair. The innate immune 
system is activated either by exogenous or endogenous signals. Pathogen-associated 
molecular patterns (PAMPs) are the exogenous molecules produced by invading 
microorganisms. Damage-associated molecular patterns (DAMPs) are molecules 
produced endogenously by damaged, dying or dead cells. Pattern-recognition 
receptors (PRRs) throughout the body recognize PAMPs and DAMPs and 
consequently, the immune system is activated. Toll-like receptors (TLRs), the 
retinoic acid-inducible gene 1-like receptors (RLRs), nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLRs) and the C-type lectin receptors 
(CLRs) are examples of PRRs. PRRs are located on phagocytic cells such as the 
white blood cells (Medzhitov and Janeway, 1997; Schnare et al., 2001; Tizard, 
2013). However, both endometrial epithelial and stromal cells play roles in the innate 
immunity response by recognizing invaders (Silva et al., 2010; Cronin et al., 2012; 
Marth et al., 2015a).  
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The white blood cells, or leukocytes, are the defensive circulating cells in the 
bloodstream. The PMN is the most predominant type, constituting around 50 % of 
the white blood cells in the horse. PMNs are responsible for the phagocytosis of 
invading microorganisms and for this reason they are the first cells to be attracted to 
inflammation sites by cytokines. Phagocytosis is the continuous process by which a 
PMN engulfs and destroys an invading microorganism, the process of which 
involves PMN activation, chemotaxis, adherence, ingestion, and destruction 
(Underhill and Ozinsky, 2002; Tizard, 2013). PMNs are developed from bone 
marrow stem cells, and move into the bloodstream for a period of 12 hours, after 
which they migrate into the liver, spleen, lungs and bone marrow capillaries. PMN 
have a short life (few days), therefore, they are continuously produced. In the 
presence of infection, PMNs migrate into the bloodstream again and go directly 
towards the site of microbial invasion and damaged tissue, guided by 
chemoattractants (Nathan, 2006; Tizard, 2013). Uterine inflammation is indicated by 
an influx of PMN into the uterine lumen. PMNs aim to clear the contaminants, dead 
and/or defective spermatozoa via phagocytes (Kotilainen et al., 1994; Troedsson, 
1999). The number of uterine luminal PMNs peaks at 8 hours after insemination but 
after 48 hours the numbers are extremely low (Katila, 1995). 
Previous studies attested that PMN activation and functionality indicate uterine 
responses to insemination (Katila et al., 1990; Kotilainen et al., 1994). Nash et al. 
(2010a) conducted an experiment where ponies were intra-uterine treated with 
frozen/thawed semen to induce MIE. At the beginning of the MIE cytological PMN 
numbers varied widely, reaching a peak 8 hours after inflammatory induction. 
However, mares showed decreased PMN count in periods of 16, 24, 48 and 72 hours 
after treatment. Further, uterine luminal PGF2α concentrations increased 16 hours 
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after treatment with sperm and returned to basal concentration 72 hours after 
challenge. Therefore, PMN cytology count might be a valid marker of MIE (Nash et 
al., 2010a). 
Seminal plasma modulates the inflammatory response caused by sperm as it reduces 
the complement activation, PMN-chemotaxis, and phagocytosis in the mare’s uterus 
(Dahms and Troedsson, 2002; Troedsson, 2006). When seminal plasma is included 
in the insemination, the intensity of inflammation is the same but the duration of MIE 
can be shorter.  Fiala Rechsteiner et al. (2002) compared the number of leukocytes in 
uterine flushings after inseminating follicular phase mares with seminal plasma or 
skim milk extender. The inflammatory response after seminal plasma inoculation 
increased progressively up to 4 hours, while the inflammatory response showed 
continuous increase up to 24 hours after milk extender inoculation (Fiala Rechsteiner 
et al., 2002). Therefore, it is believed that seminal plasma has an important role in 
modulating post-breeding inflammation (Troedsson, 1999; Katila, 2001; Troedsson, 
2006). Other studies suggest that seminal plasma provides sperm protection by 
blocking binding and phagocytosis by PMNs (Dahms and Troedsson, 2002; 
Alghamdi et al., 2004; Troedsson, 2006). This selective protection allows a greater 
survival rate of viable sperm,  increasing the quantity reaching the oviduct where 
fertilization occurs (Troedsson, 2006). However, the number of PMNs recovered 
from the equine uterus 6 hours after insemination did no decrease when seminal 
plasma was present (Kotilainen et al., 1994). 
Liu et al. (1986) induced uterine infection by inoculating S. zooepidemicus in mares 
susceptible and resistant to chronic uterine infection. A functional disorder of 
uterine-derived PMNs 12 hours after induction was reported only in susceptible 
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mares. It was thought that this may occur because uterine PMNs from susceptible 
mares show a compromised ability to migrate, facilitating the spread of bacterial 
agents that are already within the uterine lumen. On the other hand, uterine PMNs 
from resistant mares demonstrated significant migration during the same period, 
moving continuously, phagocytising and killing microbes. Resistant mares, 15-25 
hours after bacterial inoculation, showed a decrease in the number of PMNs and a 
reduction in the functional activity of cells obtained from uterine flushings. This 
suggests that there was no continuous recruitment of new PMNs in the peripheral 
circulation in resistant mares, as it is known that peripheral blood PMNs are able to 
maintain their migration activity only for 12-15 hours after venipuncture. PMNs in 
uterine flushings obtained 15 hours after bacterial inoculation in resistant mares only 
corresponded to the initial population of PMNs migrating to the lumen in response to 
the induced infection. Conversely, continuous recruitment of PMNs was seen in 
susceptible mares in response to continuous bacteria presence in the uterus. 
However, circulating PMNs obtained from resistant and susceptible mares and 
uterine-derived PMNs in resistant mares are all equally able to migrate and to remain 
viable. Therefore, the migration dysfunction found in uterine-derived PMNs in 
susceptible mares can be related to the luminal environment inside the uterus (Liu et 
al., 1986). 
Another study suggested by Troedsson et al. (1993a) establishes that uterine PMNs 
from mares susceptible to PMIE are indeed functional when the uterine environment 
is adequate. In reality, PMNs from susceptible mares, when assessing phagocytosis 
and chemotaxis using a standardized chemoattractant, performed better than those in 
resistant mares in the experiment of Troedsson et al. (1993a). On the other hand, 
uterine secretions in susceptible mares were a significantly worse opsonin source 
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when compared to resistant mares. As a result it is believed that the defective 
phagocytosis of uterine-PMNs in susceptible mares correlates not with a PMNs 
dysfunction, but with an altered opsonisation as a result of a non-adequate uterine 
environment. This is thought to be caused by an accumulation of inflammatory 
products in the uterus. In summary, PMNs have an important role in the uterus’ 
immune response, however, they are fully operational both in resistant and 
susceptible mares. It is the uterine secretion in susceptible mares that impairs PMN 
phagocytosis (Troedsson et al., 1993b).  
Cytokines are signalling proteins synthesized and secreted by immune system cells. 
They regulate the immune reaction by communicating between cells, and there are 
many different types of cytokines. Interleukins (IL) control the interaction between 
lymphocytes and other white blood cells. IL-1 is a pro-inflammatory cytokine that 
triggers innate immune reactions and inflammatory responses (Dunne and O'Neill, 
2003; Subramaniam et al., 2004; Weber et al., 2010; Boraschi and Tagliabue, 2013). 
The IL-1 receptor (IL-1R) mediates the effects of IL-1 and it is part of the 
interleukin-1 receptor/toll-like receptor (IL-1R/TLR) superfamily (Dunne and 
O'Neill, 2003). The members of the IL-1R/TLR family are receptors involved in 
inflammatory responses and host defence, including receptors for lipopolysaccharide 
(LPS) derived from gram-negative bacteria (O'Neill and Greene, 1998; Poltorak et 
al., 1998). The protein motifs shared by the IL-1R/TLR family are called toll-
interleukin receptor (TIR) motifs (Kimbrell and Beutler, 2001; Dunne and O'Neill, 
2003).  
Macrophages are also part of the innate immune response acting in the first line of 
defence in the host defence, but they also take part in the adaptive immune response 
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as accessory cells (Ma et al., 2003). They become activated by LPS stimulation from 
gram-negative bacteria such as E. coli, by recognizing the LPS’ PAMPs by PRRs 
called CD14. To signal, CD14 acts together with MD-2, cooperating with a PRR co-
receptor, TLR4 (Akira, 2003; Beutler et al., 2003). Following TLR4 activation 
MyD88 protein is recruited. The TIR domain of MyD88 signals by recruitment of IL 
1-associated kinase (IRAK1) and tumour necrosis factor receptor associated factor-6 
(TRAF-6), inducing nuclear factor-κB (NF-κB) activation (Muzio et al., 1997; 
Beutler et al., 2003; Warner and Nunez, 2013; Hayden and Ghosh, 2014).  
Endometrial mRNA expression of the pro-inflammatory cytokines IL-1β, IL-6,  
TNF-α and IL-8, and the anti-inflammatory cytokine IL-10 was previously analysed 
in PMIE susceptible and resistant mares (Fumuso et al., 2003; Fumuso et al., 2006). 
Twenty-four hours after AI with killed sperm, the endometrial expression of IL-1β, 
IL-6, TNF-α was increased in both resistant and susceptible mares, but the basal 
levels of these pro-inflammatory cytokines during the follicular phase of the oestrous 
cycle was higher in susceptible mares (Fumuso et al., 2003).  On the other hand, 
susceptible mares had higher rates of IL-8 and lower rates of IL-10 when compared 
to resistant mares after AI. The large increase in the pro-inflammatory cytokine IL-8 
after AI is considered normal because spermatozoa can produce an inflammatory 
reaction, and its concentration falls in the luteal phase of normal mares (7 ± 1 days 
after ovulation), but in susceptible mares IL-8 concentrations remain high. Thus, 
susceptible and resistant mares have different IL-8 and IL-10 transcription profiles 
during the untreated oestrous cycle. In basal conditions (control, no AI) and after 
insemination, susceptible mares have higher IL-8 expression during the follicular 
phase, and that may explain their susceptibility (Fumuso et al., 2006).  
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Studies analysed IL-8 expression changes in normal pony mares and in cultured 
endometrial explants and TLR4 in normal pony mares free from acute or persistent 
inflammation (Nash et al., 2010a; Nash et al., 2010b). TLR4 recognizes LPS  on the 
surface of E. coli, a commonly isolated bacterium from PMIE cases (Hughes and 
Loy, 1975). However, it was not possible to find a significant IL8 and TLR4 
response 24 hours after insemination with frozen/thawed semen in reproductive 
normal pony mares (Nash et al., 2010a). Also, cultured endometrial explants 
expressed IL-8 and expression did not change after challenge with washed sperm or 
seminal plasma (Nash et al., 2010b). These studies (Nash et al., 2010a; Nash et al., 
2010b) were based on selected mares and uteri free of acute or persistent 
inflammation.  These observations align with previously mentioned studies (Fumuso 
et al., 2003; Fumuso et al., 2006) and taken together attest that susceptible but not 
resistant mares expressed greater IL-8 levels. Thus, it is reasonable that explants 
from normal mares did not show any variation in IL-8 expression but explants 
collected from susceptible mares may present gene expression changes (Nash et al., 
2010b). 
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Christoffersen et al. (2012) inoculated the uteri of PMIE resistant and susceptible 
mares with 10
5
 colony-forming units (CFU) of E. coli and evaluated the 
inflammatory cytokines response in endometrial tissue and circulating white blood 
cells. The cytokines measured were IL-1β, IL-6, IL-8, IL-10, TNF-α, IL-1 receptor 
antagonist [ra] (IL-1ra) and serum amyloid A (SAA). Immediately after bacterial 
infusion, resistant mares showed increased expression of these cytokines. However, 
within a short period of time (12-24 hours) they returned to baseline expression 
levels. In contrast, susceptible mares expressed these cytokines for 72 hours, perhaps 
because of the imbalance between IL-1β and IL-1ra, pro-inflammatory and anti-
inflammatory cytokines respectively. This study suggests that imbalanced 
endometrial expression of pro and anti-inflammatory cytokines may be involved in 
the pathogenesis of persistent endometritis (Christoffersen et al., 2012). Further, it 
may be that systemic Acute Phase Response (APR) depends on the number of 
bacteria inoculated. In this experiment, a very small dose of bacteria (10
5 
CFU) was 
inoculated and consequently no APR was detected, in contrast to another study 
(Christoffersen et al., 2010) where a higher dose of E. coli was inoculated and APR 
was detected. It was suggested that the expression of inflammatory cytokines in the 
endometrium occurs in a time-related manner, and that peak expression occurs 
immediately after uterine bacteria infusion. Nevertheless, more extensive research is 
required to better understand cytokine expressions in resistant and susceptible mares 
undergoing both MIE and PMIE. 2.5.2.2 | Adaptive Immunity 
Chemoattractants in the uterine fluid such as complement products, prostaglandin E 
(PGE) and PGF2α allow PMN migration, phagocytosis and subsequent bactericidal 
activity (Liu et al., 1986; Troedsson, 1999). Inflammatory reactions start when the 
sperm enters the uterus, activating complement in the uterine secretion. The 
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chemotactic signal to PMNs occurs when the complement C5 factor is cleaved into 
C5a and C5b, resulting in a PMN influx into the uterine lumen. In the presence of 
C3b complement factor, and other independent complement mechanisms, activated 
PMNs bind to sperm and phagocytose it (Troedsson, 2006). Some chemoattractants 
generated by damaged tissue and microorganisms, are the C5a peptide derived from 
complement activation, hydrogen peroxide and a fibrinogen derived peptide, 
fibrinopeptite B. Opsonisation is the process where the electrostatic charge of a 
microorganism is neutralized, so the PMN can adhere and phagocytose it. 
Complement and antibodies are examples of opsonins (Nathan, 2006; Tizard, 2013). 
Immunoglobulins (Ig) are glycoprotein molecules commonly known as antibodies. 
Immunoglobulins A (IgA), D (IgD), E (IgE), G (IgG), and M (IgM) are the five 
different isotypes found in mammal body fluids, especially blood serum. Their role 
in the immune system is to mark foreign antigens that should be destroyed and 
eliminated, by binding to them (Wagner, 2006; Tizard, 2013). Plasma cells in the 
lymph nodes and spleen produce IgG and IgM. IgG is also produced by the bone 
marrow and it is responsible for the systemic defence, while IgM participates mainly 
in the primary immune response. IgA and IgE are produced by plasma cells situated 
under body surfaces (intestine, respiratory tract, urinary system, skin, mammary 
gland). IgA protects the intestinal, respiratory and urogenital tracts and in non-
ruminant animals, it is the dominant immunoglobulin in the external secretions. 
Acute inflammation is triggered by IgE and it is also responsible for immunity 
against parasitic worms and allergies. IgD is an immunoglobulin found attached to B 
cells and its function is still unclear in animals (Wagner, 2006; Tizard, 2013). 
Immunoglobulins have subclasses that differ among species. Horses, specifically, 
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express different subclasses of IgG such as IgGa, IgGb, IgGc, IgGt and IgGb based 
on their electrophoretical and serological properties (Wagner, 2006). 
Williamson et al. (1983) compared immunoglobulins levels in uterine flushings from 
mares with and without current uterine inflammation. Immunoglobulins of classes 
IgA, IgG and IgGt were found, of which IgA was predominant. A higher proportion 
of mares with inflammation showed a measurable amount of IgA than mares with no 
current inflammation. This higher IgA concentration in the uterine washings of 
mares with uterine inflammation in this experiment (Williamson et al., 1983), and 
also in the experiments of Asbury et al. (1980), brought into question the IgA role in 
the uterine defence system. Elevated IgA concentrations indicate that inflammation is 
established, but the presence of such immunoglobulins does not give the assurance 
that the infection will be tackled. The conclusion of this experiment, as well as the 
experiment conducted by Asbury et al. (1980), was that mares with no current 
inflammation have lower levels of IgA in their uterine washings.  
Liu et al. (1986) compared several articles investigating the role of immunoglobulins 
in addressing bacterial invasion in the endometrium. IgA, IgG, IgGt, and IgM were 
found free in the mare’s uterus. The locations from which these immunoglobulins 
were derived confirm the ability of the uterus to locally produce and secrete into the 
endometrial lumen specific classes of immunoglobulins. These studies emphasize the 
preferential production of IgA and the role of the endometrium as a mucosal immune 
system in mares. Troedsson (1999) also compared various immunohistochemical 
endometrial studies showing that different classes of immunoglobulins (IgGa, IgGb, 
IgGc, IgGt, IgA, and IgM) were isolated from the uterus, and the number of free 
immunoglobulins and immunoglobulin containing cells in susceptible mares was 
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equal to, or sometimes greater than, the amount found in resistant mares. Thus, the 
antibody-mediated uterine defence in susceptible mares is indeed functional. The 
pathophysiology involved in the transition from a susceptible to a resistant condition 
is not therefore associated with lack or deficiency of immunoglobulins (Troedsson et 
al., 1993c; Katila, 1996; Troedsson, 1999). 
2.5.3 | Markers of Uterine Inflammation 
PMIE is usually diagnosed late, and prediction of susceptibility is subjected only to 
the mare’s poor reproductive clinical histories and prolonged veterinary assessments 
of reproductive tract over many oestrous cycles. Being able to identify mares 
susceptible to persistent endometritis in advance is critical to increasing pregnancy 
rates.  
Prostaglandins are pro-inflammatory mediators associated to mare endometritis, and 
quantifying its production is of major importance. During the process of PMN 
activation, PGF2α is released from the endometrium as an inflammatory mediator. It 
causes mild myometrial contractions and subsequent removal of accumulated fluid 
and harmful inflammatory products inside the uterus (Troedsson, 1999, 2006).  
PGF2α also initiates a premature luteolysis of the CL, leading to an early embryonic 
loss (Adams et al., 1986). During a live animal experiment conducted by Nash et al. 
(2010a) ponies were evaluated before treatment and at strategic periods of time after 
treatment to test possible cellular and molecular markers of MIE. Among all 
parameters analysed it was concluded that uterine cytology and analysis of PGF2α 
secreted by the uterus of a mare are the most accurate markers of uterine 
inflammation during induced MIE. Therefore utilization of PGF2α as uterine 
inflammation marker both in vivo and in vitro is particularly important as it can be 
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analysed through uterine lavage samples, a clinical routine procedure in mares used 
for reproduction (Nash et al., 2010a; Nash et al., 2010b). 
Endometrial cytology is also a diagnostic method for retrospective assessment of 
presence or absence of active uterine inflammation based on the presence of PMN 
cells, which are the prevailing and most important cells during acute endometritis 
(LeBlanc, 2011; Diel de Amorim et al., 2016). Epithelial cells are the prevalent ones 
in an endometrial cytology, varying from tall columnar during the oestrous cycle to 
cuboidal during the anoestrous season (LeBlanc, 2011).  
Endometrial biopsy quality is an accepted marker for uterine health and endometrial 
pathologies are linked to PMIE (Woodward and Troedsson, 2013). Assessment of 
endometrial quality has been a standard procedure for more than 35 years by taking 
endometrial biopsies for histopathological analysis (Schlafer, 2007). Yet the primary 
method of endometrial assessment is still histopathology of endometrial sections 
stained with haematoxylin and eosin (Brandt and Manning, 1969; Kenney, 1978). 
Depending on intensity and/or severity of uterine inflammation, fibrosis and 
glandular degeneration mares are classified as I, II and III (Kenney, 1978).  
Nevertheless, information retrieved from endometrial histopathology is limited. 
Thus, newer procedures to diagnose endometritis can generate quantitative data, 
removing some subjective aspects of histopathology. Gene expression in the 
endometrium has been analysed by RT-PCR and more detailed information about 
uterine inflammation and health is being studied (Schlafer, 2007). The use of 
transcriptomic analysis such as RNA-Sequencing (RNA-Seq) will allow better and 
fuller understanding of the mechanisms underlying resistance and susceptibility to 
PMIE in mares.  
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2.6 | Equine Tissue Culture Model  
An endometrial explant culture model was developed to analyse prostaglandin 
production by the uterus in response to a physiological challenge with oxytocin, 
spermatozoa, bacteria and/or bacterial LPS (Nash et al., 2008). This explant culture 
endometrial model was conducted by collecting uteri of mares presented for 
euthanasia at a slaughterhouse where uteri with no visual indications of inflammation 
were collected. Explants taken from the uterine horns and histological analysis were 
performed to confirm that there was no current inflammation since it is known that 
pathological degenerative changes caused by an inflammation would hinder the in 
vitro PGF2α secretion. Endometrial explants were viable throughout the experiment 
period. Analyses were conducted in periods of 24 and 72 hours after the explant 
culture was begun, wherein the first period corresponds to the analysis of acute 
inflammation and the second analysis refers to the period where persistent 
inflammation may occur. Also, 24 and 72 hours after oxytocin treatment explants 
showed a PGF2α response, proposing the existence of functional cells. On the other 
hand, during the follicular phase, there was no PGF2α response after treatment with 
extended semen, killed S. zooepidemicus (10, 10
3
 or 10
5
 CFU/mL) or E. coli LPS 
(0.03 and 3 µg/mL) (Nash et al., 2008). 
Nash et al. (2010b) conducted another experiment utilizing the existing endometrial 
explant culture model (Nash et al., 2008) as an in vitro imitation of sperm induced-
induced PMIE. The markers of inflammation chosen were PGF2α and IL-8. The 
explant cultures, 24 and 72 hours after inoculation of 1 or 10 x 10
6 
frozen/thawed 
semen, frozen/thawed extender, chilled semen and washed sperm per ml, did not 
show PGF2α secretion different from the secretion found in the control tissue. Only 
explants challenged with seminal plasma had a higher secretion of PGF2α compared 
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to the control, during the acute inflammation (24 hours) but not at 72 hours. It was 
possible to measure IL-8 expression, even though the expression after challenge with 
washed sperm or seminal plasma was not different from the controls (Nash et al., 
2010b). 
Using abattoir tissues negates the need to collect multiple uteri biopsies from living 
mares, and the entire surface of the uterine horn can be used for in vitro culture, 
allowing the use of different treatments on the same animal (Nash et al., 2010b). 
Tissue culture of intact explants have distinct advantages over isolated cell cultures, 
since the extracellular matrix is not disrupted which may affect cell differentiation 
and function and time is saved because cell culture requires several days or weeks for 
cells to reach confluence (Borges et al., 2012). The equine endometrial explant 
culture model is representative of the functional endometrium of a live mare, 
composed of epithelial, stromal and resident leukocytes (Nash et al., 2008). It is also 
possible to harvest mRNA from cultured explants to measure gene expression. 
Explants were tested in this current study as a model for transcriptomic changes 
synonymous with MIE and PMIE in the whole animal.  
2.7 | RNA-Sequencing 
Next-generation sequencing (NGS) produces a substantial amount of genomic or 
transcriptomic sequence data. NGS may be broadly used to better understand genetic 
changes associated with health and disease by resequencing genomes. All sequencing 
technologies are divided into template preparation, sequencing and imaging, and data 
analysis. Different technologies use specific protocols and, therefore, produce 
distinct types of data (Metzker, 2010). 
61 
 
RNA-Seq, or whole transcriptome sequencing, is an NGS technology used to 
catalogue the transcriptome of cells, tissues and organisms (Metzker, 2010; Roberts 
et al., 2011). The transcriptome represents the entire set of transcripts in a cell, tissue 
or organisms. Messenger RNA (mRNA), non-coding RNAs and small RNAs are 
species of transcripts (Wang et al., 2009). RNA-Seq allows the catalogue of 
transcripts, determination of the 5’ start and 3’ end sites of genes, analysis of splicing 
patterns, quantification of gene expression levels and identification of expression 
changes at different development stages and during various other conditions (Wang 
et al., 2009). RNA-Seq is a valuable tool to understand transcriptomic transitions and 
biological dynamics during normal developmental changes in an organism. 
Biomedical samples can be analysed, and changes in the transcriptome between 
healthy and unhealthy tissue can also be contrasted and studied. The understanding 
of transcriptomics is applied to sub classify illness and disease states, and RNA 
assessments may be used for clinical diagnosis (Wang et al., 2009; Ozsolak and 
Milos, 2011).  
RNA-Seq requires an RNA population to be converted into cDNA fragments 
containing adaptors attached to its ends. These fragments constitute the library. 
Molecules are then amplified to be sequenced in a high-throughput manner. The 
results are single-end sequencing (short reads from one end) or paired-end 
sequencing (short reads from both ends). The sequencing results should be aligned to 
a previously published reference genome or to reference transcripts. If the absence of 
a reference, results are assembled de novo to generate a transcriptional map including 
gene expression levels and/or gene transcriptional structure (Wang et al., 2009). 
When aligned to a reference genome, the gene expression level is calculated, as well 
as the number of mapped reads. Using statistical analysis the differential gene 
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expression is determined. Depending on the requirements for each experiment a 
range of bioinformatics tools are available, with different and specific applications 
(Mutz et al., 2013). Data generated is immense, and presents a bioinformatic 
challenge. Efficient processing, storing and retrieval methods minimise imaging 
analysis errors and removal of low-quality reads (Wang et al., 2009). 
A previous study conducted by Christoffersen et al. (2012) investigated the 
expression of a few inflammatory and immune endometrial genes that have a role in 
the process of endometritis in resistant and susceptible mares. Considering that the 
inflammatory and immune responses are multifaceted, analysing only a group of 
genes is not enough for a complex and meaningful analysis of the disease. Thus, 
using new technologies to perform endometrium genome-wide profiling is necessary. 
Then it will be possible to characterise the interactions and changes occurring in the 
genes during uterine inflammation to advance the understanding of the underlying 
mechanisms involved in the progression from normal MIE to clinically important 
PMIE. 
Recently Marth et al. (2015b) analysed the global gene expression of the healthy 
equine uterus of resistant mares under the normal effect of ovarian hormones. Global 
uterine profiles during the follicular and luteal phases were created using RNA-Seq 
and the differential gene expression between these two stages of oestrous cycle was 
investigated. Results revealed that mRNA expression profiles between the follicular 
and luteal phases were significantly different. Genes involved in the immune 
response were highly expressed during the follicular phase while those related to 
metabolic functions predominated during the luteal phase. During follicular phase a 
total of 1577 genes from immune system, cellular metabolism and extracellular 
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matrix complex were upregulated. Toll-like receptor 1 (TLR1), chemokines such as 
C-X-C motif chemokine ligands 6 (CXCL6), 10 (CXCL10), 16 (CXCL16), 17 
(CXCL17), C-C motif chemokine ligand 5 (CCL5) and C-X3-C motif chemokine 
ligand 1 (CX3CL1), chemokine receptors such as C-X-C chemokine receptor type 4 
(CXCR4) and type 7 (CXCR7), antigen/chemokine receptor (DARC), interleukins 
such as IL-8, IL-15 and IL-34, interleukins receptors for IL-1 and IL-17, and the 
TNF family were significantly upregulated during the follicular phase. High 
regulation of immune pathways during the follicular phase is correlated with the 
physiological uterine preparation for breeding, where foreign material may enter the 
uterus. This study is one of the first analysing equine endometrial gene expressions 
by using RNA-Seq and it supplies a baseline of endometrial immune regulation 
during the follicular phase in resistant mares free of inflammation, and it may be 
used as a reference transcript for future studies. Additionally, Marth et al. (2015a) 
focused on the immune response and characterized endometrial gene expression 
changes by using RNA-Seq in PMIE resistant mares in follicular and luteal phases. 
Uterine health was confirmed at the first oestrous cycle by bacteriological culture 
and animals were randomised into two groups. Experiments were done in a crossover 
design and endometrial inflammation was induced by E. coli inoculation in both 
groups. At the second oestrous cycle, bacterial inoculation took place during the 
follicular phase in group 1, and during the luteal phase in group 2. During the third 
and last oestrous cycle, bacterial inoculation for groups 1 and 2 were done during the 
luteal and follicular phases respectively.  Uterine biopsies were taken 0 hours and 3 
hours post-inoculation in all animals. RNA-Seq was performed using Illumina HiSeq 
sequencing, generating paired-end sequencings. It was found that 2422 genes were 
upregulated and 2191 genes were down-expressed in response to E. coli inoculation, 
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and similar to that found before (Marth et al., 2015a) it was shown that most of the 
up-regulated genes relate to the immune response.  
After E. coli inoculation genes from the Toll-like receptors and NOD-like receptors 
(TLR2, TLR4, NLRC4, NLRC5, NLRP3 and NLRP12) were significantly up-
expressed in the follicular and luteal phases (Marth et al., 2015a). TLR4 is important 
as it recognizes LPS produced by gram-negative bacteria (Chow et al., 1999), 
explaining the relationship between its high expression when inflammation is 
induced by bacteria inoculation. Observations emphasize the complexity involved in 
the balance between pro- and anti-inflammatory factors when there is current uterine 
inflammation. Therefore, more complex studies in endometrial gene expression are 
required to identity genes involved in the process of physiological and persistent 
endometritis (Marth et al., 2015a).  
2.8 | Aims and Objectives 
The aim of this study is to use transcriptome technology to better understand the 
mechanisms of resistance and susceptibility to PMIE. The identification of 
susceptible mares at the earliest possible stage ie. at pre-breeding examination will 
improve clinical management of equine endometritis. Therapies and prophylaxis may 
be improved and investigated once the underlying cause of susceptibility is better 
understood at the transcriptome level. New endometritis treatments that seek to 
immuno-modulate uterine response to the challenge may be tested by analysing their 
ability to restore the transcriptome of an inflamed uterus to the “base profile” 
transcriptome.  
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To achieve this, the first aim of this project was to establish whether an endometrial 
ex vivo tissue culture system has the potential to be used as a model to study the 
equine endometrium, negating the need for whole-animal research. Biopsies were 
taken from resistant pony mares in the follicular phase of the oestrous cycle at an 
abattoir for immediate analysis of RNA-Seq (0 hours), and cultured explants were 
harvested at 24, 48 and 72 hours and subjected to RNA-Seq. It was determined 
whether the transcriptome profiles of cultured explants were altered once in culture 
and whether they were representative of the in vivo scenario for native ponies free 
from uterine inflammation. The second aim was to characterise and compare the 
global gene expression profiles of unchallenged endometrial cultured explants from 
the follicular and luteal and anoestrous period to better understand the differences in 
transcriptome profiles due to hormonal changes throughout the oestrous cycle in 
mares. The third aim was to challenge cultured explants with inflammatory uterine 
stimulants, use RNA-Seq to determine the changes in transcriptome profiles during 
inflammation and investigate expression changes that might be linked with the 
progression of MIE to PMIE. Thereafter, the fourth aim was to compare the 
transcriptome of pony mares known to be resistant to PMIE with the transcriptome of 
mares thought to be susceptible to PMIE before breeding, enabling the analysis of 
genes involved in susceptibility and resistance to PMIE.   
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CHAPTER 3  
 
GENERAL MATERIALS AND METHODS 
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3.1 | Animals 
Uteri from native pony mares presented for euthanasia were collected at a 
commercial abattoir (F. Drury & Sons Ltd, Swindon, United Kingdom). Mares were 
slaughtered by free bullet. Management of the animals, age or reproductive history 
were unknown. Collection of blood and uteri from mares during the follicular and the 
luteal phase of the oestrous cycle was carried out between June and August, while 
collection of samples during the anoestrous phase was carried out in January.  
3.2 | Blood Sampling and Tissue Collection 
Blood from all native pony mares was collected immediately after death from the 
jugular vein into a plain vacutainer (367895, BD Vacutainer, Plymouth, UK), kept at 
room temperature for 1 hour and subsequently kept on ice. Uteri from the same 
mares were collected and stored on ice along with its corresponding blood tube. In 
order to predict which mares were in the follicular or luteal phase of the oestrous 
cycle, as well as during anoestrous period before blood hormone analyses were 
complete, uteri and ovaries were examined at the abattoir. Uteri and cervix were 
physically and visually assessed. Ovaries were immersed in a bucket with water and 
were analysed using an ultrasound scanner (Concept M6, Digital Ultrasound 
Diagnostic Imaging System, Livingston, UK) for assessment of ovarian structures 
and follicle measurements. The stage of the oestrous cycle was determined based on 
the number of fingers passed through the cervical os, the colour and appearance of 
the cervix, presence/absence of corpus luteum and follicle size (Table 3.1) as 
previously described (Nash et al., 2008).  
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Uteri with typical characteristics relating to the appropriate phase of the oestrous 
cycle required for specific experiments were selected. Blood and uteri were kept on 
ice and transported back to the laboratory in Aberystwyth within 7 hours. 
Immediately after arriving at the laboratory, the blood samples were stored at 4 
degrees Celsius (°C) for 24 hours and then centrifuged for 10 minutes at 700 x g.  
Serum was pipetted to 1.5 mL tubes (11926955, Fisherbrand, UK) and frozen at -20 
°C until analysis. Serum progesterone (P4) concentration was measured by an 
enzyme-linked immunosorbent assay (ELISA) kit (EIA 1561, DRG Diagnostics, 
Germany) following the manufacturer’s instructions (Appendix 3.1) to 
retrospectively confirm the phase of the oestrous cycle for each animal at the time of 
death.  
For uteri collected during the summer months (June-August), which is the period of 
the year when mares are cycling, P4 concentrations lower than 2 ng/mL indicated 
that the mare was in the follicular phase and concentrations higher than 2 ng/mL 
indicated that the mare was in the luteal phase. For uteri collected during the winter 
(January), a P4 concentration lower that 1 ng/mL indicated that the mare was in 
anoestrous (Ginther et al., 2006; Nash et al., 2008); (Table 3.1). Equine male serum 
and female equine serum from a pregnant mare were used as negative and positive 
controls respectively. The mean intra (n = 3) and inter-assay coefficients of variation 
(CV) for a low (0.3 ng/mL), medium (2.5 ng/mL) and high (15 ng/mL) were 2.99 % 
and 10.1 %; 5.25 % and 13.9 %; and 3.21 % and 15.5 % respectively.  
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Table 3.1.  Characterization of the phase of the oestrous cycle. Based on an ultrasonic view 
of ovaries and physical aspect of the cervix (Addapted from Ginther and Pierson, 1984; 
Squires et al., 1988; Nash et al., 2008; Miro, 2012). 
Stage of 
the cycle
 
Ovaries
 
Cervix 
Progesterone 
concentration 
Follicular 
One or occasionally two 
dominant follicles (>35 mm 
in diameter), absence of 
corpus luteum, follicle wall 
increasingly echogenic and 
follicle changing from 
spherical to irregular shape 
before ovulation. 
Cervix is red in colour, soft, 
open and with a ‘rose 
flower’ characteristic. Two 
to three fingers can be 
passed through the cervix. 
< 2 ng/mL 
Luteal 
Follicles between 5 to 25 
mm in diameter, increasing 
in size as luteal phase 
progresses. Presence of 
corpus luteum.   
Cervix is pale, closed and 
with a ‘close bud’ 
characteristic. No finger can 
be passed through cervix at 
early luteal phase, whereas 
one to two fingers can be 
passed through at late luteal 
phase. 
> 2 ng/mL 
Anoestrous 
Few small follicles (<15 
mm). Absence of corpus 
luteum.  
Cervix is pale in colour. 
Little cervical tone, one 
finger can be passed 
through the cervical os. 
<1 ng/mL 
 
3.3 | Endometrial Cytology 
At the abattoir, endometrial samples for cytology were collected from each uteri 
using a sterile cytobrush (Cytobrush plus GT, C0112, Carefusion, UK). To avoid 
contamination that is normally found in the cervix, a sterile plastic pipette 
(10732742, 25 mL, Corning, Fisher, UK) cut in half was introduced into the cervix to 
serve as a channel to guide the cytobrush. If the brush contacts the cervix a false-
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positive result may appear, given that the amount of bacteria isolated from the cervix 
is three times higher than that isolated from the uterus (Baker and Kenney, 2007). 
The cytobrush was inserted into the cervix, cells were harvested from the uterine 
body and the uterine secretion smeared onto a microscope slide (S8902, Sigma, UK) 
and left to air dry before transporting back to the laboratory.  
In the laboratory, slides were fixed and stained with eosin and methylene blue 
(Shandon Kwik-Diff Kit, 9990700, ThermoFisher Scientific, UK) by dipping the 
slide five times (1 second per dip) into the fixative liquid, six times into eosin, and 
five times into methylene blue. Slides were rinsed by dipping in distilled water. 
Excess solution was allowed to dry and edges blotted on absorbent paper after every 
solution. Once dried, the slides were mounted with Canada balsam (C1795, Sigma, 
UK) and a coverslip (12323138, Fisher, UK) and stored at room temperature.  
The cytology slides were evaluated by recording the number of neutrophils per high 
power field (hpf) (400x) across 10 fields (Diel de Amorim et al., 2016; Leblanc, 
2011). Findings were classified as: normal (0 to 2 neutrophils/hpf), moderate 
inflammation (2 to 5 neutrophils/hpf) and severe inflammation (>5 neutrophils/hpf) 
(Knudsen, 1964; Brook, 1984; Riddle et al., 2007). Uteri showing moderate to severe 
inflammation were discarded from the explant culture experiments. 
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Figure 3.1. Endometrial cytological smear (LeBlanc, 2011). Epithelial cells are marked by white 
arrows and neutrophils marked by black arrows.  
 
3.4 | RNA-Sequencing Biopsy 
At the abattoir, biopsies were taken from the uterine horn bifurcation with the aid of 
a sterilized biopsy instrument (Equivet uterine biopsy forceps 62cm, 141965, Kruuse, 
UK). Duplicated biopsies from each uterus were collected and placed into 1.5 mL of 
RNALater (10437114, Fisher, UK) in RNase/DNase free 2 mL tubes (11598252, 
Fisher, UK), and kept at 4 °C for 24 hours. RNALater was removed from the tubes 
and tissues were stored at -80 °C until RNA extraction and retrospective RNA 
sequencing. These were termed the “0 hours” endometrial biopsies, best representing 
the whole mare, for RNA-Sequencing (RNA-Seq) analysis. 
3.5 | Histology 
Immediately after arriving at the laboratory the uteri were dissected. The bench used 
for dissection was cleaned with 70 % industrial methylated spirit (IMS) twice, 
aluminium foil was placed on the bench and 70 % IMS was used to clean the coated 
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bench top. One uterus was then placed on top of aluminium foil. With the aid of a 
surgical blade, a biopsy of approximately 1x1 cm
2
 was taken from the uterine body 
including the three layers of the uterus (endometrium, myometrium and perimetrium) 
and immediately placed in a 15 mL tube (525-0400, VWR, UK) containing 10 mL of 
Bouin's Fixative Fluid (10821910, Fisher, UK). Biopsies were stored for a maximum 
period of 6 months at room temperature until used for histological assessment.  
After fixation with Bouin’s liquid, tissues were subjected to several changes of 70 % 
ethanol until the yellow colour disappeared. Then, tissues were sectioned and placed 
into histological cassettes (U4635-1CS, Sigma Aldrich, UK) and subjected to 
dehydration: 1 hour in 70 % ethanol, 1 hour in 95 % ethanol, 2 hours in a change of 
100 % ethanol, another 2 hours in a new change of 100 % ethanol and 2 hours in a 
final change of 100 % ethanol. Following dehydration, tissues were subjected to 3 
different changes of fresh xylene (10588070, Fisher, UK) for 2 hours each (total of 6 
hours). Cassettes were then submerged in molten wax at 60 to 65 
o
C overnight, 
followed by 3 hours in a change of molten wax and then a final and fresh change of 
molten wax for 3 more hours. Tissues were embedded into wax moulds using the 
cassettes as mounts for the blocks and transferred to a container filled with cold 
water to float and harden. Each block was trimmed using a blade to ensure a clear 
surface of the tissue and placed on the microtome. Blocks were cut upon a 
microtome (Minot 1212 rotary microtome, Leitz Wetzlar) into sections of 8 μm, 
floated out on a water bath at 50 
o
C, placed onto a microscope slide (10149870, 
Fisher, UK) and placed on a hot plate at 40 
o
C to stretch the section. Slides were left 
to drain for at least 30 min.  
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Sections were placed in a glass slide holder and de-waxed by immersing in two 
changes of xylene for 4 min each, followed by rehydration in descending 
concentrations of ethanol (5 min in absolute ethanol, 2 min in 90 % ethanol, 2 min in 
70 % ethanol), and then rinsed in distilled water (4 dips). Sections were stained with 
Harris haematoxylin (Appendix 3.2) for 15 min, washed in tap water (4 dips) and 
differentiated in 1 % acid alcohol for 5 sec. Slides were washed in tap water for 10 
min and rinsed (4 dips) with absolute alcohol before staining with alcoholic 1 % 
eosin (Appendix 3.2) for 5 min. Slides were subjected to three changes of 100 % 
ethanol for 1 minute each. Slides were then cleared in xylene three times (3 min 
each) and mounted with a Histomount solution (008030, Life Technologies, UK) and 
a coverslip. Slides were left to dry and analysed under a light microscope. 
Histology slides were assessed by a Board Certified Veterinary Pathologist (Roger 
Alison) following the Kenney classification (Kenney, 1978); (Table 3.2) to indicate 
pathological or degenerative endometrial changes.  
Table 3.2. Kenney classification of the endometrium (Kenney, 1978). 
Category
a 
Endometrial findings
 
I Endometrium is considered normal, with no pathological changes and absence 
of atrophy and/or hypoplasia; or pathologic changes are slight and scattered. 
II Light to moderate diffuse infiltrations, or scattered but frequent foci in the 
stratum compactum and the stratum spongiosum. Fibrotic changes such as 
frequent scattered involvement of individual gland branches or nests of 
branches (average of 3 fibrotic gland nests per 5.5 mm in 4 linear fields). 
Scattered lymphatic lacunae. 
 
III 
Widespread periglandular fibrosis (average of 5 or more fibrotic gland nests per 
5.5 mm in 4 linear fields). Widespread inflammatory changes (continuous 
infiltration). Infiltration of plasmocytes if moderate or heavy. Endometrial 
hypoplasia. Extensive lymphatic lacunae.  
a 
Grading/categorical system for equine endometrial biopsies 
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As a result of the histological assessment, mares showing pathological or 
degenerative endometrial changes correspondent to category III (as described in 
Table 3.2), were discarded from tissue culture. 
3.6 | Endometrial Explant Culture 
Supplemented William’s Medium  
William’s Liquid E Medium (William’s phenol red free, 500 mL, A12176-01, Life 
Technologies, UK) was supplemented with 0.01 µg/mL epidermal growth factor 
(EGF) (Recombinant Human Protein, 10605-HNAE-250, Life Technologies, UK) 
(Appendix 3.2), 0.1 mg/mL neomycin (N6386, Sigma, UK) and streptomycin 
(S6501, Sigma, UK) solution (Appendix 3.2), 2 miliMolar (mM) of L-Glutamine 
(25030-032, Life Technologies, UK), 2.5 µg/mL amphotericin B (A2942-20ML, 
Sigma, UK), 5 mL of insulin-transferrin-selenium (ITS) (Gibco, 100X, 10524233, 
Fisher, UK) and 50 mL of batch tested foetal bovine serum (FBS) (Invitrogen FBS 
Heat Inactivated 500 mL, 10695023, Fisher, UK). The supplemented medium was 
stored at 4 °C for a maximum period of 7 days. 
Supplemented Hank’s Balanced Salt Solution  
A volume of 100 mL of Hank’s Balanced Salt Solution (HBSS) (1X, 500 mL, no 
calcium no phenol red, 14175053, Life Technologies, UK) was supplemented with 
0.1 µg/mL EGF, 1 mL of 10 mg/mL neomycin and streptomycin solution (Appendix 
3.2), 2 mM of L-Glutamine, 2.5 µg/mL Amphotericin B, 1 mL of ITS and 10 mL of 
FBS. Supplemented HBSS was stored at 4 °C for a maximum period of 2 days. 
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Endometrial culture procedure 
With a surgical blade, the uterine horns were dissected and endometrium was 
exposed. With the aid of a sterile biopsy punch (8 mm Kai Biopsy punch, BP-80F, 
Northumbrian Medical Supplies, UK), sterile scissors and tweezers, endometrial 
biopsies were collected (Figure 3.2., A). Punch biopsies were immediately placed in 
a 50 mL sterile tube (525-0402, VWR, UK) containing 20 mL of warm 
supplemented HBSS. Each uterus was processed using a different sterile set of punch 
biopsies, scissors and tweezers. Tubes containing biopsies in supplemented HBSS 
were left in the incubator (5 % CO2, 38 °C) while biopsies from other uterus were 
being collected.  Once biopsies had been collected from all uteri, the tissue culture 
was assembled in a laminar flow hood (Microflow Biological, Bioquell, Hampshire, 
UK). Tubes containing endometrial punch biopsies were removed one mare at the 
time and taken to the hood, while the other tubes of the remaining mares were kept in 
the incubator. Once in the flow hood, the supplemented HBSS in the tube was 
discarded and the biopsies were washed twice with 20 mL of un-supplemented 
HBSS. With the help of a sterile pipette tip, the punch biopsies were individually 
placed in a sterile petri dish (11329283, Fisher, UK; Figure 3.2 B), weighed and the 
weight recorded.  
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A)   B)  
 
Figure 3.2. Preparation of equine endometrial explants for the tissue culture. (A) 
Collection of endometrial explants using a sterile punch biopsy and (B) An intact 
endometrial explant in a sterile petri dish after being washed with HBSS ready to be weighed 
and placed in the culture medium.   
During the initial experiments of the tissue culture model (Chapter 4), the protocol 
previously described by Nash et al. (2008) was followed. Briefly, sterile wire gauze 
platforms were placed into each well of the culture plate and onto it a piece of sterile 
lens cleaning tissue (11769994, Fisher, UK) was added, as shown in Figure 3.3 (A). 
To accomplish this, an aluminium mesh and lens cleaning tissue were cut into 
squares that could fit within the wells. All aluminium squares had their top and 
bottom edges folded inwardly so that they formed a platform. Both wire gauze 
platforms and lens cleaning tissue were autoclaved at 121 °C for 20 minutes before 
use. Each biopsy was placed individually into one well of a six-well culture plate 
(10578911, Fisher, UK), on top of the lens-tissue lined wire platform. Into each well 
4.25 mL of supplemented William’s medium was added. However, after a 
preliminary radioimmunoassay (RIA) analysis of Prostaglandin F2α (PGF2α) 
production as a marker of inflammation after Escherichia coli (E. coli) 
lipopolysaccharide (LPS) challenge, it was determined that the greater volume of 
medium might be diluting the production of PGF2α by the explants (data not shown). 
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Therefore, the volume of supplemented William’s medium added to each well was 
decreased to 3 mL. Furthermore, following the decrease in media volume, the wire 
platforms and the lens tissue were removed, following the protocol described by 
Borges et al. (2012) as also shown in Figure 3.3 (B). Due to the difficulty in 
collecting samples at the correct stage of the oestrous cycle, especially those at 
follicular phase, explants cultured in both volumes of supplemented William’s media 
were used in this study.  
 
Figure 3.3. Preparation of each well for tissue culture. (A) Individual well with 4.25 mL 
of supplemented William’s medium and explant placed on top of a wire platform covered 
with lens tissue and (B) Individual well with 3 mL of supplemented William’s medium and 
explant place directly on the bottom of the well.  
 
Uterine inflammation was induced in the laboratory by challenging the explants with 
different concentrations of LPS (LPS-EB ultrapure tlrl-3pepls, E.coli 0111:B4 strain, 
Invivogen, UK). A 5 mg/mL stock solution of LPS was prepared by adding 1 mL of 
endotoxin-free water to the lyophilized LPS vial and mixing by pipetting followed by 
gentle vortexing. Upon resuspension, aliquots were prepared and stored at -20 °C for 
a maximum period of 6 months.  
The explant culture was performed in triplicate for group/treatment per animal. For 
all experiments, the tissue explants were incubated at 38 °C in 5 % CO2 in air, in a 
humidified incubator. After periods of 24, 48 and 72 hours the explants appropriate 
to treatments and the specific experiment were removed from the well and stored in 
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1.5 mL of RNALater for a 24 hour period at 4 °C. After that, the RNLater was 
removed and the tissue was stored at -80 °C for future RNA extraction. Depending 
on the experiment, 1 mL of the medium from each well was also removed in 
duplicate at each time point using a Pasteur pipette (BR747775, Sigma, UK), stored 
in 2 mL tubes (11598254, Fisher, UK) and frozen at -20 °C. Culture medium was 
subjected to RIA for retrospective analysis of PGF2α concentration.  
3.7 | Prostaglandin F2α Radioimmunoassay 
Radioimmunoassays were performed to quantify PGF2α production by the cultured 
explants in the medium (Cheng et al., 2001); (Appendix 3.3). The standard curve for 
the assay was prepared in 0.05 molar (M) tris buffer containing 1 g gelatin 
(440454B, BDH), 0.2 g sodium azide (S-8032, Sigma, UK), 6.61 g tris HCl (T-3253, 
Sigma, UK) and 0.97 g tris base (T-1503, Sigma, UK) in 1 L of distilled water at 7.4 
pH. Samples of cultured medium were diluted in Tris buffer in a 1:50 dilution. 
Briefly, PGF2α tracer (NET433250UC, Perkin Elmer, UK) was used in a working 
concentration of 10000-12000 counts per minute (cpm)/mL and the chosen dilution 
for PGF2α antiserum was 1:1000. A stock solution of 1 mg/mL of PGF2α standard 
(P0314-1MG, Sigma, UK) was made up by adding 1 mL absolute ethanol to a 1 mg 
vial of PGF2α (P0314-1MG, Sigma, UK). Eight standard concentrations were made 
up (0.025, 0.05, 0.10, 0.25, 0.5, 1, 2.5 and 5 ng/mL) by dissolving the stock solution 
in Tris buffer. Each standard was run in triplicate and samples were run in duplicate. 
The assay procedure included tubes (11778908, Fisher, UK) allocated for Buffer 
blanks (NSB), standards (Std), total binding (TB), total counts (TC), quality controls 
(QC) and test samples. Reagents were added as follows: 100 µL of tracer to all tubes; 
100 µL of antiserum to all tubes except TC and NSB; 500 µL of buffer to TC, 300 
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µL of buffer, 200 µL of buffer to TB and 100 µL of buffer to Std, QC and tests; 100 
µL of sample to QC and tests and 100 µL of standards to Std.  
Tubes were vortexed and incubated at 4 ˚C for 16-24 hours. Two hundred microliters 
of charcoal dextran solution containing 0.4 % dextran (3190, Sigma, UK) and 2 % 
activated charcoal (C404053, Fisher, UK) were added to each tube except TC. Tubes 
were vortexed, incubated for 10 min at 4 ˚C and centrifuged at 1000-1500 x g at 4 
˚C. The supernatant was decanted into labelled 6 mL scintillation tubes (E1412-7000, 
Star Lab, UK). Four millilitres of scintillation liquid (1200-436, Perkin Elmer, UK) 
were added to each tube. Tubes were counted as cpm for 2 min. Normalised percent 
bound for each standard/sample was gained with the following equation: 
%𝐵/𝐵0 =
(𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑜𝑟 𝑠𝑎𝑚𝑝𝑙𝑒 𝑐𝑝𝑚 − 𝑁𝑆𝐵 𝑐𝑝𝑚)
(𝐵0 𝑐𝑝𝑚 − 𝑁𝑆𝐵 𝑐𝑝𝑚)
𝑥 100% 
A standard curve was generated by plotting the normalised percent bound as a 
function of the log10 PGF2α concentrations. The mean intra-assay (n=2) and inter-
assay CV for a low (0.05 ng/mL), medium (0.50 ng/mL) and high (5.00 ng/mL) 
samples were 2.29 % and 8.66 % (low), 3.87 % and 15.6 % (medium) and 4.92 % 
and 9.56 % (high), respectively.  
3.8 | RNA Extraction and RNA-Sequencing  
Total RNA was extracted from endometrial samples using an RNA purification kit 
(GeneJET RNA Purification Kit, Thermo Scientific, UK) following the 
manufacturer’s instructions (Appendix 3.4). Briefly, frozen endometrial tissue was 
placed in a safe lock tube (0030123328, Fisher, UK) containing 300 µL of 
supplemented lysis buffer and a stainless-steel bead (69989, 5mm, Qiagen, UK). The 
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tissue was disrupted using a rotor-stator homogenizer (TissueLyser LT, 85600, 
Qiagen, UK) and centrifuged for 2 minutes at 12000 x g to pellet any cell debris. The 
supernatant was transferred to a RNA/DNAse free tube (11598252, Fisher, UK) 
containing 600 µL of diluted Proteinase K and incubated at 15-25 °C for 10 minutes. 
Tubes were centrifuged for 10 min at 12000 x g, the supernatant was transferred into 
a new RNAse-free tube and 400 µL of 100% ethanol was added to each tube. The 
lysate was transferred to a purification column inserted in a collection tube, 
centrifuged for 1 min at 12000 x g, the flow-through was discarded and the 
purification column was placed back in the collection tube. When all lysate was 
transferred and centrifuged, the collection tube was discarded. The purification 
column was placed into a new collection tube, 700 µL of supplemented wash buffer 
1 were added to the RNA purification column and centrifuged for 1 min at 12000 x 
g. The flow-through was discarded, the purification column was placed back into the 
collection tube, 600 µL of supplemented wash buffer 2 were added into the 
purification column and centrifuged for 1 min at 12000 x g. The flow-through was 
discarded, the purification column was placed back into the collection tube, 250 µL 
of supplemented wash buffer 2 were added to the purification column and 
centrifuged for 2 min at 12000 x g. Finally, the collection tube containing the flow-
through solution was discarded and the purification column was transferred to a 
sterile tube, where 100 µL nuclease/RNAse-free water was added to the purification 
column membrane and centrifuged for 1 min at 12000 x g to elute RNA. 
The kit produced a final volume of 100 µL purified RNA for each sample. The 
NanoDrop 1000 Spectrophotometer (Thermo Scientific, UK) was used to check 
RNA concentration and purity by pipetting 1 µL of total RNA sample onto the 
measurement pedestal. In addition, RNA samples were subjected to gel 
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electrophoresis to assess RNA integrity before gene expression analysis. A 1 % 
agarose gel was prepared by dissolving 1.5 g of agarose (16500100, Life 
Technologies, UK) in 150 mL of Tris base, acetic acid and EDTA (TAE) buffer 
(B49, Life Technologies, UK) by heating in a microwave, the solution was allowed 
to cool down and 1.5 µL of gel red (41003, VWR, UK) was added. The gel and the 
tray were set inside the electrophoresis chamber, sufficient TAE was added to cover 
the entire gel and the comb was removed. Six microliters of RNA sample was mixed 
with 6 µL of loading dye (R0641, Life Technologies, UK), incubated for 10 minutes 
at 4 
o
C and loaded into the gel. Four microliters of RNA Ladder were mixed with 4 
µL of loading dye and loaded in the gel. Gel electrophoresis was run at 100 volts and 
3.00 amperes for 75 minutes. Gels were imaged using the U: Genius Syngene 
machine (12814068, Fisher, UK). Integrity of RNA samples was confirmed through 
visualization of distinct 28S and 18S ribosomal RNA bands as shown in Figure 3.4. 
RNA samples were stored at -80 
o
C until used for RNA seq. 
 
Figure 3.4. Agarose gel electrophoresis (1% agarose) of RNA extracted samples. Lanes 1-10 
represent the RNA extracted from 10 different samples. The 18S and 28S ribosomal RNA bands 
indicate the RNA samples were intact. Lane M, RNA loading dye + ladder marker.  
 
Preparation of RNA samples was performed by Dr Matt Hegarty at the Translational 
Genomics facility based at the Gogerddan Campus, Aberystwyth University.  
According to the manufacturer’s instructions, the Illumina TruSeq Stranded mRNA 
M      1      2       3      4      5       6      7       8       9     10    M 
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kit (20020594, Illumina) was used to prepare the dual-indexed next-generation 
sequencing libraries. Briefly, from each sample poly-A messenger RNA (mRNA) 
was purified, fragmented and reversed transcribed into complementary DNA 
(cDNA). The cDNA was end-repaired and connected to adaptors that contained 
unique indexes for each sample. The connected products were amplified by a 
polymerase chain reaction (PCR) for approximately 15 cycles, followed by 
purification with AMPure (A63882, Beckman Coulter, UK) to remove PCR reagents 
and adaptor dimers. Product quantity in ng/µL was assessed using a Qubit 
fluorescence spectrophotometer (Thermo Fisher Ltd). After calculation of the 
molarity, each sample was diluted in Tris buffer to 10 nanomolar (nM) and equally 
pooled to obtain a 10 nM pool. Another dilution to 1 nM was made with additional 
buffer and also 0.1 M NaOH to denature DNA and, to consequently make it single-
stranded. Following denaturation, Illumina hybridisation buffer was added to dilute 
to 20 picomolar (pM) and from there a final dilution based on the type of library was 
chosen for each experiment.  
RNA-Seq was performed at the Translational Genomics facility (Goggerddan 
Campus, Aberystwyth University, Aberystwyth, Wales, UK) and also at the Wales 
Gene Park Institute (Institute of Medical Genetics, Cardiff University, Cardiff, 
Wales, UK). The diluted library was loaded, bound and amplified onto a flowcell 
using an Illumina cBOT platform. The flowcell was then transferred to the 
HiSeq2500 or HiSeq4000 sequencer platform for sequencing, depending on the 
experiment. Paired-end sequencing runs in the 2x75 bp format or in the 2x216 bp 
format were performed. Raw reads retrieved from RNA-Seq were stored as FASTQ 
files in the High Performance Computing (HPC) at Aberystwyth University.  
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3.9 | Data Processing and Gene Expression Analysis 
The following steps of the analysis were operated through the UNIX shell; no 
graphical user interface was included. Raw reads were subjected to quality analysis 
using FastQC software (version 0.11.2) and filtering using Trimmomatic software 
(version 0.33) when needed. After trimming, filtered reads were assessed using 
FastQC one more time. Reads were mapped to the Equus caballus reference genome 
(Ensembl, EquCab2; GCA_000002305.1) using Bowtie software (versio 2.2.3) and 
TopHat software (version 2.0.14), resulting in a binary format (BAM) alignment file 
for each read. The number of reads/fragments assigned to genomic features for each 
sample were counted using the BAM files and the Equus caballus annotation file 
available from Ensembl website (version EquCab2.89) using the FeatureCounts 
software (version 1.5.2). The computer codes used are described in Appendix 3.5.  
At first, the RNA-Seq analysis for differentially expressed genes (DEG) was carried 
out following the Tuxedo Protocol (Trapnell et al., 2012). The workflow aimed to 
compare the transcriptome profiles of two or more biological conditions. Cufflinks 
assembled the reads into transcripts for each condition by using the reference 
genome. These assemblies were then merged together and used to calculate the 
expression levels for all samples. Cuffdiff then tested the statistical significance of 
each change in expression between all samples. Genes with fragments per kilobase 
million (FPKM) values smaller than 1.0 were removed, as well as genes not mapped 
to the genome. DEGs were then submitted to the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) website (Huang et al., 2009) 
(https://david.ncifcrf.gov).  
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However, after analysing the RNA-Seq data from the first experiment, it was noted 
that Cuffdiff was not the best statistical package to analyse the data for this study. It 
models the length of the fragments created from each transcript across samples and it 
is also excessively conservative by over controlling the false positive rate of the 
algorithms (Trapnell et al., 2012; Love et al., 2014). Therefore, DEGs were 
identified using the DESeq2 R/Bioconductor version 1.16.1 (Anders and Huber, 
2010; Love et al., 2014).  
DESeq2 uses raw RNA-Seq counts to identify DEG (Gentleman et al., 2004). Based 
on the data of each individual gene the gene-wise dispersion is estimated, modelling 
the variability between replicates (Love et al., 2014). The estimation assumes that 
genes have similar dispersion if they show similar average expression strength, and a 
precise estimation of gene dispersion is crucial for the analysis of differential 
expression. Figure 3.5 represents the shrinkage for dispersion estimation, where the 
black dots represent the gene-wise dispersion estimates of individual genes, with a 
red curve fitted to it to capture the overall trend of the dispersion and blue dots 
representing the shrinkage of the gene-wise estimates towards the red line (Love et 
al., 2014).  
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Figure 3.5. Shrinkage estimation of dispersion. Black dots represent gene dispersion of 
each gene. The red line represents the overall trend of dispersion-mean dependence. Blue 
dots represent the shrinkage gene-wise final dispersion values based on the red line.   
 
The null hypothesis used by DESeq2 is that there is no effect of the different time 
points on the genes and that the observed difference between time points is random 
or due to experimental variability. For each gene, DESeq2 performs a hypothesis test 
to decide against the null hypothesis or not. The result of the statistical test is 
reported as a P value. DESeq2 uses the log fold change to estimate the gene’s 
expression changes between time points, which is a value reported on a logarithmic 
scale to base 2 (Log2FC). The P value expresses the probability that the observed 
fold change for each gene is observed under the situation described by the null 
hypothesis (Gentleman et al., 2004). The Benjamini-Hochberg (BH) false discovery 
rate (FDR) method (Benjamini and Hochberg, 1995) was performed in R (version 
3.4.1) to correct for multiple testing. Genes were considered differentially expressed 
at an FDR of 0.05 with a Log2FC greater or equal to 2. 
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The principal component analysis (PCA) plot is an effective tool for RNA-Seq 
quality control and outlier sample removal (Gabriela et al., 2016). Using the R 
“ggplot” visualization package (version 2.2.1) PCA plots were created, displaying 
each sample in the data set and visually representing the overall effects of 
experimental conditions and individuals (mares) for each experiment. 
Genes with reading count lower than 1000 across all samples were removed from the 
enrichment analysis. DEGs were then submitted to the Search Tool for the Retrieval 
of Interacting Genes/Proteins (STRING) database (Szklarczyk et al., 2015) 
(http://string-db.org) for retrieval of protein-protein interactions (PPI), network 
analysis and gene associations discovery. Also, KEGG (Kyoto Encyclopedia of 
Genes and Genomes;) (Kanehisa and Goto, 2000) (http://www.genome.jp/kegg) 
pathways retrieved from STRING were listed for each experiment, as well as 
submitted to the advanced KEGG pathway mapping tool “Search&Color Pathway” 
to produce graphical images of the differentially expressed genes within the 
pathways. Furthermore, the Gene Ontology (GO) (Ashburner et al., 2000) terms 
retrieved from STRING were discussed for each experiment.  
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CHAPTER 4 
 
 
CHARACTERIZATION OF CULTURED EQUINE 
ENDOMETRIAL TRANSCRIPTOME AT 
DIFFERENT TIME POINTS TO STUDY THE 
EXPLANT TISSUE CULTURE  
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4.1 | Introduction 
Endometritis is one of the most common and important reproductive conditions 
causing infertility in mares (Watson, 2000; Troedsson and Woodward, 2016). After 
natural mating or artificial insemination, a normal and transient endometrial 
inflammation takes place in response to the presence of bacteria and semen in the 
uterus, which is resolved within 36-48 hours post-mating. However, persistent 
endometritis causes infertility in mares unable to resolve inflammation within this 
time (Kotilainen et al., 1994; Troedsson, 1999; Watson, 2000). The mechanisms 
underlying the transition of normal mating-induced endometritis (MIE) to the 
pathological persistent post-mating induced endometritis (PMIE) are still not well 
elucidated. Depending on each individual susceptible mare, many different variables 
can be associated with endometritis (Hurtgen, 2006).   
An ex vivo equine endometrial explant system has been used previously to measure 
endometritis via biomarker secretion such as Prostaglandin F2α (PGF2α). It has been 
proven that endometrial explants maintained their colour and appearance throughout 
the 72 hours culture period. It has also been observed that explants from the uterine 
horns tend to be more responsive to biomarkers of inflammation than explants from 
the uterine body (Nash et al., 2008). It is proposed that the equine explant system is 
representative of the whole endometrium considering that tissues are composed of 
epithelial, stromal and resident leukocytes (Nash et al., 2008).  Nonetheless, it was 
not known how the transcriptome from explants is modified once in culture. 
Establishing an ex vivo cultured explant model at the transcriptomic level is crucial 
for studying the equine endometrial innate immunity as a baseline for future studies 
studying inflammation in the endometrium using this model. 
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Alternative model systems include epithelial and stromal cell culture, yet as a model, 
these do not necessarily represent the whole animal because of disruption of the 
endometrial architecture and also cell damage. Additionally, most tissue explant 
models mechanically chop the tissue aiming for better oxygenation and perfusion of 
nutrients, which also leads to damage and disruption of tissue architecture (Borges et 
al., 2012). Damage-associated molecular patterns (DAMPS) are intracellular and 
extracellular molecules typically released by the extracellular matrix after cell death 
and/or injury. DAMPS therefore modulate the innate immune system, triggering 
inflammation even under sterile conditions (Chen and Nuñez, 2010; Krysko et al., 
2011). Previous ex vivo bovine studies have adopted an intact biopsy endometrium 
model that better mimics the whole cow (Borges et al., 2012; Saut et al., 2014). 
Thus, it was proposed that a similar ex vivo equine endometrial explant model may 
act in a similar way in the equine endometrium. The present study used such an 
equine endometrial explant culture, proposed by Nash et al. (2008), but substituting 
the mechanical tissue chopper for sterile punch biopsies, used by Borges et al. 
(2012), to tackle the issues described above. 
Therefore, the aim of the present study was to determine whether ex vivo endometrial 
explants collected from native pony mares cultured over a period of 72 hours were 
representative of the in vivo scenario for native ponies in the pre-breeding, non-
inflammatory state on the transcriptome level. If cultured explants  provide a true 
baseline transcriptome before challenge, they have potential application for future 
study of endometritis.   
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4.2 | Materials and Methods 
4.2.1 | Animals 
Uteri from native mares (n=8) presented for euthanasia at an abattoir were collected 
during the follicular phase of the oestrous cycle and transported back to the 
laboratory on ice. The population sampled represented a random selection of native 
mares available at the abattoir and information regarding these animals was 
unknown.  
4.2.2 | Sample Collection  
Sample collection was performed as described in Chapter 3. Briefly, blood for all the 
native pony mares was collected from the jugular vein immediately after death, 
except for mare number 7. At the abattoir, ovaries were scanned and the cervix 
physically examined to assess the phase of the oestrous cycle. Blood samples were 
stored at 4 
o
C for 24 hours, centrifuged and blood serum used to analyse 
progesterone concentration to confirm the phase of the oestrous cycle retrospectively. 
Records of criteria used in the abattoir to predict the stage of the oestrous cycle and 
serum progesterone concentrations are described in Table 4 1. 
Endometrial smears for cytology were collected using a cytobrush and microscope 
slides, fixed and stained as previously described (Chapter 3). Neutrophil counts for 
the eight mares were < 2 per high power field (400x), therefore endometrium was 
classified as normal (non-inflamed). Based on these criteria all uteri collected were 
included in the experiment. At the abattoir, endometrial biopsies from the uterine 
bifurcation were collected in duplicate with the aid of a sterile biopsy instrument and 
stored in 1.5 mL of RNALater at 4 
o
C for 24 hours. After a period of 24 hours, 
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RNALater was removed and samples stored at -80 
o
C until RNA extraction. These 
biopsies represent the “0 hours” samples, representing the whole mare. Uteri and 
blood samples were placed on ice and transported back to the laboratory within 7 
hours. 
After transportation to the laboratory, from each uteri a 1x1 cm
2
 biopsy was taken 
from the uterine body and stored in 10 mL of Bouin’s fixative liquid for a period of 
2-6 months for posterior histological analysis of pathological or degenerative 
endometrial changes. The histology report of mares providing endometrial explants 
for this experiment is summarised in Appendix 4.1.  
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Table 4.1. Summary of mares sampled at the abattoir. Information regarding ovarian structures, cervical analysis and serum progesterone 
concentration. 
 
Mare 
 
Ovaries
a
 
 
Cervix
b
 
Progesterone 
Concentration 
(ng/mL)
c
 
1 One 41 mm x 32 mm follicle on left ovary. Small follicles (around 7 mm in 
diameter) on right ovary. 
Cervix pale in colour. Two fingers were passed through cervix 1.95 
2 One small (10 mm in diameter) follicle on left ovary. One 33 mm x 37 mm 
on right ovary. 
Cervix pale in colour. Three fingers were passed through cervix. 0.16 
3 Two follicles (42 mm x 48 mm ; 39mm x 39 mm) on left ovary. Small 
follicles (around 15 mm in diameter) and a regressing CL on right ovary.  
Cervix pale in colour. One to two fingers were passed through the cervix. Undetectable  
4 One 38 mm x 45 mm follicle on left ovary. Regressing CL on right ovary. Cervix pink in colour, soft and open. Two to three fingers were passed 
through the cervical os. 
0.32 
5 One 39 mm x 49 mm follicle on left ovary. Regressing CL on right ovary. Cervix had a colour that varied from pale to light pink. Three fingers were 
passed through the cervical os. 
0.47 
6 One 30 mm x 30 mm and a few small follicles on the left ovary. Regressing 
CL on left ovary. One 30 mm x 25 mm follicle on right ovary.  
Cervix was becoming red. One to two fingers were passed through the 
cervical os. 
0.64 
7 Two follicles (52 mm x 39 mm ; 50 mm x 30 mm) on left ovary. Regressing 
CL on left ovary. Small follicles (10 mm in diameter) on right ovary.  
Cervix pale in colour. One finger was passed through the cervical os.  No blood 
8 Small follicles on left ovary. One 42 mm x 36 mm follicle on right ovary. Cervix pink in colour. Four fingers were passed through the cervical os. 0.05 
a  
Ultrasonographic measurements of ovaries. 
b  
Physical examination of cervix. 
c 
 ELISA serum progesterone analysis for confirmation of stage of the oestrous cycle. 
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4.2.3 | Endometrial Tissue Culture 
Following the protocol described in Chapter 3, endometrial punch biopsies were collected 
from each uterus and placed into warm supplemented HBSS and left in the incubator (5% 
CO2, 38 °C) while the other uteri were being processed and before tissue culture began. 
Biopsies were washed twice with unsupplemented HBSS before tissue culture was initiated. 
Each punch biopsy was weighed in a sterile petri dish and individually placed into a different 
well of the 6-well culture plate, on top of the lens tissue-lined wire platform. To each well, a 
volume of 4.25 mL of supplemented William’s medium was added. All explants were 
cultured in triplicate.  
Plates were incubated in a humidified incubator at 38 °C in 5 % CO2 for 24, 48 and 72 hours. 
At each time point, the three explants from each mare were removed from their respective 
well and individually stored in 1.5 mL of RNALater for 24 hours at 4 
o
C, after which 
RNALater was removed and samples were frozen at -80 
o
C until RNA-extraction. 
4.2.4 | RNA Extraction and RNA-Sequencing  
Total RNA was extracted from all samples resulting in a total of 32 RNA samples. The 
Nanodrop machine was used to check RNA concentration and quality. In addition, RNA 
samples were subjected to electrophoresis gel to assess RNA integrity before gene expression 
analysis. Samples were diluted in DNase/RNase free water to the final concentration of 30 
ng/µL in a total volume of 50 µL and sent to RNA-Sequencing (RNA-Seq).  
RNA-Seq was performed by Dr Matt Hegarty at the Translational Genomics facility based at 
the Gogerddan Campus, IBERS, Aberystwyth University. Each sample of total RNA was 
reverse transcribed into a cDNA sequencing library using the TrueSeq RNA sample 
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preparation kit and paired-end sequences were created using the Illumina HiSeq 2500 
machine. For this experiment, the final library dilution was 8 pM. 
4.2.5 | Data Processing and Gene Expression Analysis  
The pair-end sequencing produced forward and reverse reads for each sample, totalling 64 
raw reads. The quality of each raw read was checked as previously described in Chapter 3, 
using the FasQC software. Reads were then filtered by the following Trimmomatic (version 
0.33) steps: sequencing adapters were removed (i.e. ILLUMINACLIP), bases off the start of 
a read were removed if the quality was below 30 (i.e. LEADING = 30), bases off the end of a 
read were removed if the quality was below 30 (i.e. TRAILING = 30), a sliding window 
trimming approach was performed once the average quality within the window fell below 30 
(i.e. SLIDINGWINDOW 4:30), reads were dropped if they were below a specific length of 
100bp (i.e. MINLEN = 100), and a specified number of 10 bases from the start of the read 
were removed (i.e. HEADCROP = 10). The quality of the trimmed reads was assessed by 
FASTQ. The 32 reads were mapped to the Equus caballus reference genome (Ensembl, 
EquCab2; GCA_000002305.1) using TopHat software (version 2.0.14) as described in 
Chapter 3, resulting in 32 BAM alignment files. Total count of reads assigned to genomic 
features for each sample was retrieved from both the BAM files and the equine annotation 
file (Ensembl website, EquCab2.89) using FeatureCounts software (version 1.5.2). Computer 
codes used in this chapter are shown in Appendix 4.2 and Table 4.2 compares information 
about each sample.  
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Table 4.2. Summary of the 32 RNA-Sequencing samples. 
Sample Mare 
Time 
point
a 
Total sequences 
Raw reads
b 
Sequences after 
trimming
c 
Mapped 
reads
d 
Alignment 
rate
e 
Total 
count
f 
1 1 0h  19717258 8502094 7038297 82.5% 4935705 
2 1 24h 67308470 32342562 27290172 84.1% 20643708 
3 1 48h 19839515 9954298 8415638 84.3% 6389708 
4 1 72h 14432128 7358130 6262279 84.7% 4618836 
5 2 0h  18178744 9085634 7476789 82.1% 5301029 
6 2 24h 12681202 6069612 5153439 84.6% 3966757 
7 2 48h 30143876 15499068 13394112 86% 10212117 
8 2 72h 12826353 6530807 5634759 85.9% 4232183 
9 3 0h  20960250 10117417 8728814 86.0% 5970499 
10 3 24h 15509308 7851773 6745965 85.7% 
85.7% 
5082456 
11 3 48h 16948027 8578848 7405235 86% 5642663 
12 3 72h 25647761 13313650 11604766 86.8  8782806 
13 4 0h  28670134 13715002 11290844 82.0% 8083377 
14 4 24h 20422712 10795659 9354169 86.4% 7080569 
15 4 48h 15788862 8014918 6990433 86.9% 5260783 
16 4 72h 18383955 9131700 7871686 85.9% 6013728 
17 5 0h  22947695 9857331 8497119 85.9% 6103661 
18 5 24h 21849937 10419618 8921018 85.4% 6717715 
19 5 48h 24772671 12453536 10832088 86.7% 8256983 
20 5 72h 23018161 11156075 9762271 87.2% 7511617 
21 6 0h  18112353 9450237 8129631 85.8% 5743608 
22 6 24h 18419612 10260890 8858564 86.1% 6704169 
23 6 48h 19130571 10543071 9249797 87.4% 6885048 
24 6 72h 18810862 10857330 9744804 89.4% 7217846 
25 7 0h  18438679 8526023 7439831 86.9% 5339891 
26 7 24h 20176785 10709870 9454038 87.9% 7122759 
27 7 48h 25947827 14121856 12386310 87.4% 9565446 
28 7 72h 21821418 11656927 10321964 88.2% 8111957 
29 8 0h  24180545 13500189 11858759 87.5% 8700692 
30 8 24h 18784516 9993324 8813179 87.8% 6835047 
31 8 48h 22175150 11562073 10131838 87.3% 7462079 
32 8 72h 19340153 9988254 8757692 87.3% 6209711 
a  
Specific time-points when explants were removed from culture. 
b  
A count of the total number of sequences processed. 
c  
Number of sequences actually used for the rest of the analysis after quality filtering. 
d 
 Number of reads mapped to the annotated equine genome. 
e  
Percentage of reads mapped to the annotated equine genome. 
f 
 Counts of reads assigned to genomic features. 
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Firstly, RNA-Seq analysis was carried out following the Tuxedo Protocol (Trapnell et. al., 
2012). Two different approaches for analysis of differentially expressed genes (DEGs) were 
performed by executing two different Cuffdiff scripts (Appendix 4.2). The first approach 
analysed the DEGs sample by sample, whereas the second approach analysed DEGs at each 
of the four different time points (0, 24, 48 and 72 hours), using the samples from each animal 
as replicates. DEGs were submitted to the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) website (Huang et al., 2009) (https://david.ncifcrf.gov) for 
investigation, functional annotation and enrichment analysis of genes of interest.  
DEGs were also identified using the DESeq2 package (version 0.11.2) (Appendix 4.2) to 
enable comparison of results. Three tests were performed in total: between the 0 and 24 
hours, between 24 and 48 hours and between 48 and 72 hours. DEGs from DESeq2 were 
submitted to the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) 
database (Szklarczyk et al., 2015) (http://string-db.org) for the discovery of functional gene 
associations and protein-protein interaction (PPI) networks.  
The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (Kanehisa and Goto, 
2000; Kanehisa et al., 2016; Kanehisa et al., 2017) (http://www.genome.jp/kegg) and Gene 
Ontology terms (GO) terms (Ashburner et al., 2000) were used to identify significantly 
enriched pathways.  
4.2.6 | Statistical Analysis 
Cuffdiff package 
Reads mapped to each transcript were calculated and normalized by the length of each 
transcript to calculate the transcripts’ individual expression level. The linear statistical model 
with maximum likelihood estimated transcripts abundancy was performed by Cuffdiff 
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(Trapnell et al., 2010; Trapnell et al., 2012).  Cuffdiff revealed DEGs at the default false 
discovery rate (FDR) of 0.05 (Benjamini and Hochberg, 1995). Significance was assumed 
where P < 0.05.  
DESeq2 package  
The negative binomial distribution was used to perform statistical inference on differences. 
The P value for multiple tests was corrected using the FDR method (Benjamini and 
Hochberg, 1995). Genes with a reading count lower than 1000 across all samples were 
removed from the differential analysis. Genes were considered differentially expressed at an 
FDR of 0.05 with a logarithmic fold change (Log2FC) greater or equal to ± 2.  
4.3 | Results 
4.3.1 | Cuffdiff  
Sample to sample analysis  
Sample by sample results were analysed and from a total of 13212 genes found to be 
expressed, none were statistically significantly differentially expressed. A heat map was 
created (Figure 4.1) for the gene expression data, displaying a cluster analysis to illustrate the 
association between experimental conditions. The highest value was 1.0 where the 
association between conditions was identical (colour red) and the lowest value was 0.5 
(colour green). Mid-range values were correlations of 0.7 and 0.8, which correspond to 
transition between these two extremes. The gene expression in unstimulated explants at 0 
hours (expressing the gene expression for mares at a time as close as possible post-mortem) 
was characterized by the red area in the left corner. The correlation was high (between 0.8 
and 1); showing that the ex vivo 0 hours samples are similar to each other (Figure 4.1). 
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Similarly, the gene expression of cultured explants (24, 48 and 72 hours) is shown in the red 
area on the top right-hand side. Likewise, the correlation between the in vitro cultured 
explants was high (between 0.8 and 1; Figure 4.1).  
 
Figure 4.1. Cuffdiff sample-to-sample distances. Sample-to-sample gene expression variation calculated from 
fragments per kilobase of exon per million reads (FPKM) in eight horses from which equine endometrial 
explants were sampled at 0 hours then cultured for 24, 48, and 72 hours. Samples identity are as follow: “M” – 
Mare, numbers “1” to “8” refers to mares’ numbers (Table 4.1).  
 
When comparing the three-time points (either 24, 48 or 72 hours) to samples at 0 hours a 
correlation can also be seen. The most predominant colour was black, indicating that the 
correlation is around 0.8 (between 0.7 and 0.9). From a total of 13212 genes found to be 
expressed, none was statistically significantly differentially expressed (P < 0.05) when 
comparing the 32 samples at the four-time points between themselves.           
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Time point analysis 
From the Cuffdiff output, the pairwise comparisons between 0 and 72 hours were retrieved. A 
list containing 3523 unique DEGs (P < 0.05) when comparing the 0 hours (control) to the 72 
hours transcriptome was created and fed into DAVID. The Functional Annotation Chart from 
DAVID reported 46 significantly enriched GO terms (P < 0.05) (Appendix 4.3). The majority 
of genes were enriched for cellular component terms such as extracellular exosome, 
cytoplasm, focal adhesion, external side of plasma membrane correlated with biological 
processes such as cell adhesion (Table 4.3).  
Table 4.3. Summary of the 5 most enriched GO terms between 0 hours (control) and 72 
hours sorted. Table created using the “Functional Annotation Chart” from DAVID website. 
Results sorted by p-value.  
GO Category
a
 Term name
b
 Description
c
 Count
d
 FDR p-value
e
 
GO Component GO.0070062 Extracellular exosome 644 2.06 x 10
-41
 
GO Component GO.0005925 Focal adhesion 130 2.71 x 10
-19
 
GO Component GO.0005737 Cytoplasm 598 9.30 x 10
-12
 
GO Component GO.0009897 External side of plasma membrane 68 3.37 x 10
-10
 
Go Biological Process GO.0007155 Cell adhesion 56 1.12 x 10
-07
 
a
 GO domains (cellular component, biological process and molecular function). 
b
 Term associated with gene ontology biological processes. 
c
 Description of each GO category.   
d
 The number of genes involved in each biological process term. 
e  
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
Genes were also clustered by DAVID into smaller biological annotation modules, organizing 
redundant terms within the cluster groups based on the enrichment score. Enrichment scores 
categorize the overall importance of genes clusters, therefore a high score (> 1.3) indicates 
that genes in the clusters perform an important role in the study (Huang et al., 2009). A total 
of 19 high score (> 1.3) clusters were retrieved (Appendix 4.4), however only two of them 
were significant (P < 0.05) as shown in Tables 4.4 and 4.5.  
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Table 4.4. First most enriched cluster between 0 hours (control) and 72 hours. Table created 
using the “Functional Annotation Clustering” from DAVID website. 
Annotation Cluster 1 - Enrichment Score: 5.99 
Category
a
 Term
b
 Count
c
 FDR p-value
d 
UP_KEYWORDS Integrin 19 0.000 
INTERPRO IPR013649:Integrin alpha-2 14 0.001 
INTERPRO IPR000413:Integrin alpha chain 14 0.001 
INTERPRO IPR018184:Integrin alpha chain, C-terminal cytoplasmic 
region, conserved site 
13 0.002 
INTERPRO IPR013519:Integrin alpha beta-propellor 14 0.004 
INTERPRO IPR013517:FG-GAP repeat 13 0.014 
SMART SM00191:Int_alpha 14 0.020 
a
 Gene functional categories. 
b
 Term associated with each category. 
c
 The number of genes involved in each biological process term. 
d  
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
Table 4.5. Second most enriched cluster between 0 hours (control) and 72 hours. Table 
created using the “Functional Annotation Clustering” from DAVID website. 
Annotation Cluster 2 - Enrichment Score: 4.06 
Category
a
 Term
b
 Count
c
 FDR p-value
d 
UP_KEYWORDS EGF-like domain 38 0.026 
INTERPRO IPR001881:EGF-like calcium-binding 37 0.075 
INTERPRO IPR000152:EGF-type aspartate/asparagine hydroxylation 
site 
31 0.099 
SMART SM00179:EGF_CA 37 1.731 
a
 Gene functional categories. 
b
 Term associated with each category. 
c
 The number of genes involved in each biological process term. 
d  
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
4.3.2 | DESeq2  
Analysis was carried out using DESeq2 (Anders and Huber, 2010; Love et al., 2014) to 
identify significantly DEGs and associated over-represented biological pathways across the 
endometrial transcriptome. Based on the data of each individual gene the gene-wise 
dispersion was estimated, modelling the variability between replicates (Love et al., 2014). 
Figure 4.2 shows the distance between samples’ matrix. The dark navy blue colour is set for 
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distance 0, meaning that the samples being compared are identical. The blue colour fades as 
the distance between samples increase.  
 
Figure 4.2. DESeq2 sample-to-sample distances. The Euclidean distances between samples calculated from 
the regularized log transformation of the count reads in eight horses from which equine endometrial explants 
were sampled across the 4-time points (0, 24, 48 and 72 hours). Samples identity are as follow: “M” – Mare, 
numbers “1” to “8” refers to mares’ numbers (Table 4.1). 
 
The PCA plots (Figures 4.3 and 4.4) display each sample in the data set, visually representing 
the overall effect of experimental conditions and mares on the count matrix. In both figures 
there is a clear separation of control (0 hours) groups and cultured samples by the first 
component (PC1). However, from Figure 4.3 it can be seen that there is an outlier.  
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Figure 4.3. PCA plot of the gene expression profiles for the eight horses. Biopsies taken at 0 hours and 
explants cultured up to 24, 48 and 72 hours (n=8). The plot displays each sample in the dataset, where each 
horse is represented by a unique shape: Mare 1 (), mare 2 (), mare 3 (), mare 4 (), mare 5 (), mare 6 
(), mare 7 () and mare 8 ().  The analysis clearly demonstrates clustering for the 0h (control, representing 
the whole mare) and another cluster for the cultured samples (24, 48 and 72 hour time points). Horse 8 () is 
clearly an outlier, not clustering well with the other seven horses across all time points.  
 
 
Figure 4.4. PCA plot of the gene expression profiles for the seven mares included in the analysis. Biopsies 
taken at 0 hours and explants cultured up to 24, 48 and 72 hours excluding Mare number 8 () (n=7). The plot 
displays each sample in the dataset, where each time point is represented by a unique colour and each horse by a 
unique shape: Mare 1 (), mare 2 (), mare 3 (), mare 4 (), mare 5 (), mare 6 (), mare 7 (). Analysis 
still demonstrates clusters for 0h and for cultured samples (24, 48 and 72 hours). Variance is lower after removal 
of the outlier horse.  
 
Mare number 8 was responsible for the majority of variance when comparing Figures 4.3 and 
4.4. Maintaining this horse in the differential expression analysis could bias the results, 
leading to unreliable analysis (Gabriela et al., 2016). For this reason, horse 8 was removed 
and analysis for DEGs was performed with DESeq2.   
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Differential gene expression analysis between time points was performed (n=7). The null 
hypothesis for each gene tested using DESeq2 was that there was no difference in its 
expression between time points. The null hypothesis was rejected when the observed 
difference in expression of a gene was greater than expected by random chance (using an 
adjusted p-value of 0.05). 
When comparing control (0 hours) to 24 hours a total of 11266 genes were found to be 
expressed, 385 of which were shown to be statistically significantly differentially up-
regulated and 589 shown to be statistically significantly differentially down-regulated, both 
at a FDR of 0.05 and Log2FC ≥ ±2. Similarly, when comparing the gene expression between 
24 and 48 hours, 11266 genes were found to be expressed. At FDR of 0.05 and Log2FC ≥ ± 
2, only 17 genes were significantly differentially up-regulated while 50 genes were 
significantly down-regulated. Again, 11266 genes were found to be expressed between 48 
hours and 72 hours, however not even one gene was shown to be statistically significantly 
up-regulated, and only 1 gene was down-regulated at an FDR of 0.05 and ≥ ± 2 Log2FC.  
The STRING functional enrichment analysis of DEGs between 0 hours (control) and 24 
hours using the 11266 total expressed genes as the statistical background was performed. A 
PPI (protein-protein interaction) p-value of 1.0
-16
 was retrieved, meaning that the 
genes/proteins show more interactions between themselves than that evident in a similar size 
of random genes. The predicted STRING network was composed of 924 nodes and 792 
edges. The STRING enrichment analysis returned a total of 45 KEGG pathways associated 
with Log2FC ≥ ±2 at an FDR of 0.05 when comparing the transcriptome of 0 relative to 24 
hours (Appendix 4.5). The five most statistically significant KEGG terms were 
“Complement and coagulation cascades”, “Hematopoietic cell lineage”, “Cytokine-cytokine 
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receptor interaction”, “PI3K-Akt signalling pathway” and “ECM-receptor interaction” 
which are shown in more detail in Table 4.6.  
Table 4.6. Summary of the 5 most enriched KEGG pathways when comparing the transcriptome at 0 
hours relative to the transcriptome at 24 hours. Associated with Log2FC ≥ ±2 and sorted by p-value. 
Table created using the STRING website. 
Pathway code
a
 Description
b
 Count
c
 FDR p-value
d
 
04610 Complement and coagulation cascades 26 6.33 x 10
-15
 
04640 Hematopoietic cell lineage 49 4.8 x 10
-11
 
04060 Cytokine-cytokine receptor interaction 24 1.01 x 10
-9
 
04151 PI3K-Akt signalling pathway 18 1.51 x 10
-9
 
04512 ECM-receptor interaction 22 2.69 x 10
-9
 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c
 The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
DEGs linked to the “Complement and coagulation cascades” and in the “Cytokine-cytokine 
receptor interaction” were fed to the “KEGG Color and Pathway Search” (Figure 4.5 and 4.6 
respectively).  
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Figure 4.5. DEGs in the KEGG Complement and coagulation cascade between 0 hours (control) and 24 hours. Green boxes are genes in the equine transcriptome, but not 
differentially expressed. White boxes are genes not described as horse KO terms. Yellow boxes are DEGs. Image created using the KEGG Online “Search and Color Pathway” tool. 
106 
 
 
 
Figure 4.6. DEGs in the KEGG Cytokine-cytokine receptor interaction between 0 hours (control) and 24 hours. Green boxes are genes in the equine transcriptome, but not 
differentially expressed. White boxes are genes not described as horse KO terms. Yellow boxes are DEGs. Image created using the KEGG Online “Search and Color Pathway” tool. 
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A total of 71 redundant GO terms (Appendix 4.5) were retrieved from the enrichment 
analysis between 0 (control) and 24 hours. The five GO terms with the highest enrichment 
were “Extracellular region”, “Extracellular region part”, “Cellular component”, “Biological 
process” and “Single-organism process” (Table 4.7).  
Table 4.7. Summary of the 5 most enriched GO terms when comparing the transcriptome at 0 hours 
relative to the transcriptome at 24 hours. Associated with Log2FC ≥ ±2 sorted by p-value. Table 
created using the STRING website. 
GO Category
a
 Term name
b
 Description
c
 Count
d
 FDR p-value
e
 
Cellular component GO.0005576 Extracellular region 24 5.94 x 10
-11
 
Cellular component GO.0044421 Extracellular region part 20 1.33 x 10
-9
 
Cellular component GO.0005575 Cellular component 33 2.65 x 10
-9
 
Biological process GO.0008150 Biological process 33 2.10 x 10
-8
 
Biological process GO.0044699 Single-organism process 29 6.84 x 10
-8
 
a
 GO domains (cellular component, biological process and molecular function). 
b
 Term associated with gene ontology biological processes. 
c
 Description of each GO category.   
d
 The number of genes involved in each biological process term. 
e  
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
With respect to extracellular matrix (ECM) and extracellular region, collagen coding genes 
such as COL1A2, COL12A1, COL14A1, COL17A1, COL21A1 and COL4A6 and laminin 
coding genes such as LAMA2 and LAMA4 were shown to be up- and down-regulated when 
comparing the transcriptome at 0 hours (control) relative to the transcriptome of 24 hours, 
with Log2FC between -2.6 and 4.3.   
Pathways related to inflammation and immune system were also reported in the GO 
enrichment analysis, despite not being in the top 5 most enriched GO terms identified in 
Table 4.7. The aim is to use the explant model as a baseline for further studies into 
endometritis, therefore the inflammatory and immune genes and pathways are the most 
relevant for the assessment of the culture model, validating its suitability for future challenges 
with bacteria to begin modelling endometritis. Table 4.8 presents an overview of GO 
biological processes related to inflammation and immune system from the STRING 
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enrichment analysis. The “Genes” column of the table shows the list of genes related to each 
GO term. From table 4.8, it can be seen that genes overlap within the four described GO 
terms, and they are more comprehensively illustrated in Figure 4.7. Closer inspection of table 
4.8 shows that most genes were also involved in the KEGG Cytokine-cytokine receptor 
interaction (Figure 4.6).   
Table 4.8. Summary of the 4 enriched GO terms related to inflammation when comparing the 
transcriptome at 0 hours relative to the transcriptome at 24 hours. Associated with Log2FC ≥ ±2 and 
sorted by p-value. Table created using the STRING website. 
GO 
Category
a
 
Term name
b
 Description
c
 Genes  Count
d
 FDR p-
value
e
 
Biological 
process 
GO.0006954 Inflammatory 
response 
CCL2, IL1B, IL1A, IL1RN, 
IL23A, IL4R, IL6, IL8, PTGS2, 
SPI2, Spi2-8 
11 2.04 x 10
-6
 
Biological 
process 
GO.0002376 Immune system 
process 
CCL2, CD40, CXCL6, IL1B, 
IL1A, IL23A, IL6, IL8, LTF, 
PLG, TFRC 
11 2.59 x 10
-4
 
Biological 
process 
GO.0006953 Acute-phase 
response 
IL1B, IL1A, IL1RN, IL6, SPI2, 
Spi2-8 
6 3.83 x 10
-4
 
Biological 
process 
GO.0006955 Immune response CCL2, CXCL6, IL1B, IL1A, 
IL23A, IL6, IL8, LTF 
8 0.002 
a
 GO domains (cellular component, biological process and molecular function). 
b
 Term associated with gene ontology biological processes. 
c
 Description of each GO category.   
d
 The number of genes involved in each biological process term. 
e  
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
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Figure 4.7. STRING predicted PPI network of the DEGs related to immune response and inflammation GO terms between the 0 hours (control) and 24 hours. Red nodes 
represent genes that belong to “Inflammatory response” (GO Biological Process), blue nodes represent genes that belong to the “Immune system process” (GO Biological Process), green 
nodes represent genes that belong to the “Acute-phase response” (GO Biological Process) and yellow nodes represent genes that belong to the “Immune response” (GO Biological 
Process). The interaction score between nodes was set to high confidence (0.7), where the thickness of the lines between nodes indicate the degree of confidence prediction of the 
interaction. Disconnected nodes are hidden in the network. Image created using the STRING website. 
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Figure 4.8. STRING predicted PPI network of the DEGs related GO terms and KEGG pathways related to immune response and inflammation between 0 hours (control) and 
24 hours. Red nodes represent genes the “Inflammatory response” (GO Biological Process), blue nodes represent the “Immune system process” (GO Biological Process), light-green 
nodes represent the “Acute-phase response” (GO Biological Process) and yellow nodes represent the “Immune response” GO terms. Pink nodes represent the “Complement and 
coagulation cascades” (KEGG) and dark-green nodes the “Cytokine-cytokine receptor interaction” (KEGG). The interaction score between nodes was set to high confidence (0.7), where 
the thickness of the lines between nodes indicates the degree of confidence prediction of the interaction. Disconnected nodes are hidden in the network. The network is zoomed-in for 
better visualization of target genes.  
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The genes overlapping between the “Complement and coagulation cascade” KEGG 
pathway (Figure 4.5), the “Cytokine-cytokine receptor” KEGG pathway (Figure 4.6) 
and the GO terms in Table 4.8 are considered DEGs relate to innate immunity when 
comparing the transcriptome of 0 hours relative to the 24 hours. Overlapping genes 
are CCL2, CD40, IL1A, IL1B, IL23A, IL4R and IL6, showing a Log2FC down-
regulation between -2.7 and -6.10.  
The STRING enrichment analysis of DEGs when analysing the transcriptome at 24 
hours relative to the transcriptome at 48 hours was performed using the same 
statistical background. A PPI p-value of 1.0
-16
 was retrieved, indicating that the 
network had significantly more interactions than expected. There were 63 nodes and 
66 edges in the PPI network. Only 2 KEGG pathways were significantly enriched in 
this network (Table 4.9) and no GO terms were retrieved from the enrichment 
analysis.  
Table 4.9. Summary of the 2 enriched KEGG pathways when comparing the transcriptome 
at 24 hours relative to the transcriptome at 48 hours. Associated with Log2FC ≥ ±2 sorted by 
p-value. Table created using the STRING website. 
Pathway 
code
a
 
Description
b
 Count
c
 FDR p-value
d
 
05134 Legionellosis 4 0.0248 
04110 Cell cycle 5 0.049 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c
 The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
Analysis of 48 hours relative to 72 hours returned only one down-regulated gene 
called Collagenase 3 Precursor or MMP13. The PPI p-value was 1, indicating that 
the predicted network did not have more expected and no enrichment for this gene 
was retrieved.  
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4.4 | Discussion 
As described in Table 4.1, blood from mare number 7 was not collected and 
consequently the progesterone concentration at the time of the death was unknown. 
However, this mare was selected at the abattoir based on the criteria to predict the 
follicular stage of the oestrous cycle (Table 4.1). Also, based on the PCA plots 
(Figures 4.3 and 4.4) mare number 7 clustered together with the other mares, 
demonstrating that it was in the follicular phase of the oestrous cycle. Therefore, 
mare number 7 was kept in this study.  
RNA-Seq analysis has been proven to be challenging mainly because there is a 
variety of different pipelines for different cases, and none of them are considered 
optimal overall. The heat maps from the Cuffdiff (Figure 4.1) and the DESeq2 
(Figure 4.2) analysis can be compared. The similarity between the heat maps shows 
the consistency of gene expression from Cufflinks and DESeq2 packages (but not the 
consistency between differential expression). Analysis of DEGs were carried out 
using Cuffdiff (Trapnell et al., 2012) and DESeq2 (Anders and Huber, 2010; Love et 
al., 2014). The discrepancy between the Cuffdiff and the DESeq2 differential 
analysis results can be attributed to how they deal with the analysis of differential 
expression genes. In the current experiment, a major problem with Cuffdiff was that 
it modelled the length of the fragments created from each transcript across all 
replicates, therefore it normalized fragment counts by transcript length and did not 
account for differences in coverage (Trapnell et al., 2013). It has also been reported 
that Cuffdiff over controls the false positive rate of the algorithms, making the 
analysis excessively conservative (Love et al., 2014). Results for DEGs between 
Cuffdiff and DESeq2 were compared and DESeq2 seemed to be the most suitable 
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package for the discovery and analysis of DEGs. Therefore, this discussion will 
focus mainly on DESeq2 results.  
4.4.1 | Cuffdiff  
From the DEGs retrieved when comparing the 0 hours (control) transcriptome 
relative to the transcriptome cultured for 72 hours, ‘Extracellular exosome’, 
‘Cytoplasm’, ‘Nucleus’, ‘Signalling pathways’ and ‘Nucleoplasm’ were the five 
most enriched terms, suggesting that at the level of transcription in the endometrium 
the explant model was subjected to changes mostly related to cell component.  
In this study, genes were also functionally clustered in smaller groups, ranked by 
enrichment scores (Tables 4.4 and 4.5). Clustering is excellent to highlight important 
gene groups by functionality based on their annotation terms instead of on individual 
gene names. This condenses the analysis and results in a more comprehensive 
understanding of gene association, overcoming the difficulty of analysing many 
redundant/similar terms within the group (Huang et al., 2009). Between 0 hours 
(control) and 72 hours, the five most enriched gene groups were ‘Integrin’, 
‘Epidermal growth factor’, ‘Tyrosine-protein domains’, ‘Immunoglobulin-like 
domains’ and ‘Rho GTPase-activating proteins’.  
Regarding the clusters represented in Table 4.4, all biological terms retrieved from 
DAVID were related to integrins. Integrins are transmembrane receptors that regulate 
cell adhesion, usually binding extracellular matrix (ECM) glycoproteins and 
connective tissue (Hynes and Zhao, 2000). It has been demonstrated that there is an 
overexpression of genes linked to ECM in the equine endometrium during the 
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follicular phase of the oestrous cycle (Marth et al., 2015b), therefore expression of 
integrins might be expected in this study.  
Epidermal growth factors domains mediate intercellular signalling of growth and 
development (Wouters et al., 2005). Addition of EGF to the culture media may have 
contributed to the increase of significant expression genes related to the ‘Epidermal 
Growth Factor’ cluster, suggesting that this cluster may be already expected when 
analysing the transcriptome of cultured explants. Immunoglobulin-like domains are 
involved in cell-cell recognition, cell-surface receptors and the immune system, and 
are found in various protein families (Teichmann and Chothia, 2000). Tyrosine-
protein domains relate to cell cycle control regulation such as growth, proliferation, 
differentiation and transformation (Denu and Dixon, 1998). The Rho GTPase-
activating proteins regulate the Rho GTPases that are involved in cellular functions 
regulations such as gene transcription (Moon and Zheng, 2003).  
4.4.2 | DESeq2  
Over 1000 genes were observed to be differentially expressed across all time points 
(0 to 72 hours). In order to better understand these results, enrichment analysis using 
the GO categories and KEGG pathways were performed between time points. 
Normally, many gene products were associated with more than one GO category. 
Table 4.7 presented the most enriched GO terms between 0 and 24 hours, which 
included “extracellular region part”, “cellular component”, “biological process” and 
“single-organism process”. These enrichment terms are GO “cellular component” 
and “biological process” terms, which involve processes relevant to the functioning 
of cells or specific parts such as the extracellular environment, and processes 
involving only one organism. The explant tissues need to adapt and maintain their 
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homeostasis after removal from the mares’ uterus, therefore it is not surprising that 
genes related to biological processes and cell components are differentially expressed 
between 0 and 24 hours, allowing the explant tissues to remain viable even with a 
limited availability of nutrients in the culture compared to the whole mare.  
On the other hand, the aim of this study was to investigate whether the tissue culture 
system has the potential to be used for future studies into equine endometritis by 
challenging the culture with bacterial inoculation. Inflammation is an important 
portion of the innate immune system, characterizing the first line of defence against 
attacking microorganisms. Consequently, part of the analysis was focused on genes 
related to immune system and inflammatory responses (Table 4.8). It is apparent 
from Figure 4.8 that only a few genes in the network are related to immune system 
and inflammation.  
A study using RNA-Seq to target the global gene expression of the equine uterus 
under the normal effect of ovarian hormones has already been performed, in which 
over1500 genes from the immune system, cellular metabolism and extra cellular 
matrix were up-regulated during the follicular phase of the oestrous cycle (Marth et 
al., 2015b). Toll-like receptor 1 (TLR1), chemokines (CXCL6, CXCL10, CXCL16, 
CXCL17, CCL5 and CX3CL1), chemokine receptors (CXCR4, CXCR7 and DARC), 
interleukins (IL-8, IL-15 and IL-34), interleukins receptors for IL-1 and IL-17, and 
the TNF family are examples of significantly up-regulated genes during the follicular 
phase (Marth et al., 2015b). The results between 0 and 24 hours in the current study 
are comparable with the results reported in live mares by Marth et al. (2015b) in 
regards to ECM receptor-interaction (Table 4.6), immune system (Tables 4.6 and 4.8; 
Figures 4.5 and 4.6) and cell function (Table 4.7).  
116 
 
Despite this, little has changed in terms of transcriptome between 24 and 48 hours as 
shown in Table 4.9. “Legionellosis” was the most enriched KEGG pathway, but only 
the CXCL1, HSPA1A, HSPA6 and MIP-2BETA genes were related to this pathway. 
This is an unexpected pathway that is part of the bacterial infectious diseases under 
the KEGG human disease. However, the four genes can also be found in the 
“Antigen processing and presentation” KEGG pathway, as well as in the “Estrogen 
signalling pathway”. Pathways summarised in Table 4.9 were not discussed in more 
detail as the aim of this study was to focus mainly on the immune and inflammatory 
responses.  
Interestingly, MMP13 was the only down-regulated gene when analysing the 
transcriptome at 48 hours relative to 72 hours, suggesting that at 48 hours its 
expression is lower than at 72 hours. Furthermore, it did not show any significant 
enrichment analysis. MMP13 is a matrix metalloproteinases’ enzyme known to take 
part in the remodelling of connective tissue during normal or pathological conditions 
(Woessner, 1991; Murphy and Docherty, 1992). Notwithstanding, there is some 
evidence to suggest that collagenase-3 transcripts could be associated with 
malignancy since there was no significant expression of collagenase-3 reported in 
normal tissue (Freije et al., 1994). It has also been reported that expression of 
MMP13 is a possible marker of compromised uterine environment in cows (Wathes 
et al., 2011; Forde and Lonergan, 2012). This finding is somewhat surprising, and it 
indicates that relevant changes might happen in the endometrial tissue once in culture 
between 48 and 72 hours. One implication of this is that that the explant tissue might 
not be viable after 48 hours of culture, even though its colour and appearance 
continued the same.  
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4.5 | Conclusion 
The findings in this chapter indicate that there are significant differences when 
comparing the transcriptome at 0 hours to the transcriptome of cultured samples. 
Indeed, some degree of transcriptional changes was expected, considering that it is 
not possible to perfectly mimic the complex in vivo uterine system in an ex vivo 
tissue culture. Interestingly, following culture the transcriptome of explants showed 
only relatively minor variations as demonstrated in the time point analysis performed 
by DESeq2. Tissues cultured for up to 48 hours were still viable and interesting 
results can be withdrawn from studies using the explant system. It is important to 
bear in mind the possible bias in the responses after 48 hours of culture due to the 
possible interference of MMP13. 
Notwithstanding the fact that the ex vivo explant cannot perfectly mimic the 
endometrium of a live mare since there are significant transcriptomic changes 
between 0 and 24 hours, the explant model is still useful as a baseline for future 
studies. Knowing exactly which genes and pathways differ between 0 and 24 hours 
that are related to inflammation and uterine global function provides the means to set 
these changes as a baseline. Accordingly, when challenging the explant model with 
bacteria, inflammatory responses that differ from this ‘baseline’ can be determined 
and pathways truly related to endometrial inflammation can be further studied. The 
genes overlapping between the “Cytokine-cytokine receptor” KEGG pathway 
(Figure 4.6) and the GO terms in Table 4.6 are considered the baseline genes when 
utilising the explant model to modulate and study endometritis. The baseline is 
composed of the following overlapping genes: CCL2, CD40, IL1A, IL1B, IL23A, 
IL4R, IL6 and IL8 (Figure 4.8). 
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In general, this study provides the first comprehensive assessment of the pre-
breeding, non-inflammatory global gene expression analysis for the explant culture 
model, highlighting the use of abattoir-derived samples to better understand the 
physiology of the uterus to further study endometritis. It can be concluded that the 
unchallenged explants are suitable to begin modelling endometritis. The next 
chapter, therefore, moves on to discuss the differences in gene expression at the level 
of transcriptome across the different phases of the oestrous cycle. 
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CHAPTER 5 
 
 
A COMPARISON OF THE EX VIVO AND IN 
VITRO EQUINE ENDOMETRIAL 
TRANSCRIPTOMIC PROFILES AT THE 
FOLLICULAR, LUTEAL AND ANOESTROUS 
PHASES 
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5.1 | Introduction 
The 21-day equine oestrous cycle is divided into the follicular and luteal phase, 
which last approximately 4-6 days and 15-16 respectively. The anoestrous phase is 
the non-breeding season and it takes place during the winter (Watson, 1998; Aurich, 
2011). Throughout the oestrous cycle, specific physiological and behavioural events 
are controlled by particular hormones (Aurich, 2011). During the follicular phase, 
oestrogen is secreted by the developing follicles causing the mare to be sexually 
receptive to the stallion. Also, during this phase secretory and ciliary endometrial 
activities are part of the uterine clearance mechanism, enhancing the ability of the 
uterus to eliminate foreign material introduction during mating (Tunon et al., 1995; 
Aurich, 2011; Marth et al., 2015b).  
The high oestrogen and low progesterone concentrations during the follicular phase 
also provide a more resistant uterine environment against foreign material 
introduction during breeding, enhancing immunological response to infection (Marth 
et al., 2015a). Progesterone levels rise after ovulation (day 0) reaching peak levels on 
days 6-8 in mares (Ginther et al., 2006; Aurich, 2011). The combination of high 
progesterone and low oestrogen levels during the luteal phase of the oestrous cycles 
reduce the uterine oedema and diminish the uterine immune response and the 
myometrial contractility to prepare the uterine environment for the potential arrival 
of a conceptus at 5-7 days after ovulation (Evans et al., 1986a; Battut et al., 1997; 
Cannon, 1998). 
Furthermore, during the luteal phase of the oestrous cycle, if challenge occurs, 
uterine infections tend to develop more easily due to the immune suppression effect 
of high concentrations of progesterone (Hughes, 1980; Katila, 2001). A study 
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investigated the effects of steroid hormone on bacterial clearance after intra-uterine 
inoculation with bacteria, and the presence of progesterone can significantly slower 
uterine clearance (Evans et al., 1986a). Marth et al. (2015a) reviewed many studies 
(Nishikawa et al., 1984; Evans et al., 1986a; de Winter et al., 1992; Battut et al., 
1997; Ramadan et al., 1997) attesting that a higher progesterone concentration is 
indeed correlated with bacterial growth and inflammatory cell migration in the 
uterus. It has been suggested that during the follicular phase the equine uterus 
triggers a more efficient immune response than during the luteal phase of the 
oestrous cycle (Marth et al., 2015a).  
Microarray work has been carried out to explore the in vivo gene expression changes 
during the follicular and luteal phases of the equine oestrous cycle at specific days 
after ovulation (Days 0, 3, 8, 12 and 16) (Gebhardt et al., 2012). Genes with greatest 
messenger RNA (mRNA) expression during the follicular phase of the oestrous cycle 
were associated with the extracellular matrix, focal adhesion process and immune 
system functions. With regard to the luteal phase, gene expression was linked to 
protein secretion, signalling processes and metabolic processes (Gebhardt et al., 
2012).  
One study has used RNA-Sequencing (RNA-Seq) technology to investigate how the 
ovarian hormones change between the follicular phase and the luteal phase at the 
level of endometrial gene expression (Marth et al., 2015b). Consistent with the 
literature, Marth et al. (2015b) showed that during the follicular phase of the oestrous 
cycle the expression of genes related to the innate immune response was up-
regulated whereas during the luteal phase the higher expressed genes were mainly 
associated with metabolic functions.  
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Nonetheless, little is known about changes in the global gene expression in the 
equine endometrium throughout the oestrous cycle. The majority of studies have 
focused on specific genes pertinent to inflammation such as interleukins (IL1, 
IL1RN, IL6, IL8 and IL10) after uterine challenge with bacteria or semen instead of 
looking at the global endometrial gene expression during the different phases of the 
oestrous cycle (Fumuso et al., 2003; Fumuso et al., 2006; Nash et al., 2010a). 
Moreover, there is a dearth of research that has characterised global gene expression 
during the anoestrous period.  
Understanding differences between each phase of the oestrous cycle at the level of 
transcriptome will improve the understanding of physiological cyclic variation, thus 
improving the understanding of pathologies of the reproductive tract in mares such as 
endometritis. Therefore, the aim of this study was to generate transcriptomic profiles 
of unchallenged endometrial biopsies at the follicular phase, luteal phase and 
anoestrous period at three different time points (0, 24 and 48 hours). This research 
provides an innovative insight into the physiological changes across each stage of the 
equine reproductive cycle, improving the current understanding of this matter at the 
level of gene expression.  
5.2 | Materials and Methods 
5.2.1 | Animals 
Uteri from 18 native mares were collected during the follicular phase of the oestrous 
cycle (n=6), the luteal phase (n=6), and during the anoestrous period (n=6). Tissue 
collection from the abattoir were carried out between June-August for the follicular 
and luteal phases experiments, and in January for the anoestrous period. The 
123 
 
population represents a random selection of mares presented for euthanasia 
(Robertson et al., 2007). 
5.2.2 | Sample Collection  
Sample collection from native pony mares was accomplished following the 
previously described protocol (Chapter 3). Briefly, blood was collected directly from 
the jugular vein and stored at 4 
o
C for 24 hours, followed by blood serum separation 
by centrifugation. To confirm the phase of the oestrous cycle at the time of the death 
the blood serum progesterone concentration was analysed. Records of criteria used in 
the abattoir to predict the stage of the oestrous cycle and serum progesterone 
concentrations for each animal are described in Tables 5.1, 5.2 and 5.3.  
At the abattoir, cytology samples were collected with the aid of a cytobrush as 
previously described (Chapter 3). The neutrophil count for endometrium collected 
from all mares was < 2 per high power filed (400x), classifying the uterine tissue as 
normal. Blood samples and uteri were stored on ice and transported back to the 
laboratory within 7 hours. From each uterus, endometrial biopsies were taken in 
duplicate and stored in 1.5 mL of RNALater at 4 
o
C for a period of 24 hours, 
followed by RNALater removal and sample storage at -80 
o
C until RNA extraction. 
These represent the “0 hours” samples.  
At the laboratory, an additional 1x1 cm
2
 endometrial biopsy from the uterine body 
was collected and stored in 10 mL of Bouin’s fixative liquid for a period of up to 6 
months. Histology procedure was carried out as previously described (Chapter 3) and 
analysed by a Borded Pathologist for pathological and/or degenerative endometrial 
changes (Appendix 5.1). 
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5.2.3 | Endometrial Tissue Culture 
Following the protocol described in Chapter 3, biopsies were collected from each 
uterus and stored in the incubator (5% CO2, 38 °C) immersed in supplemented 
Hanks' Balanced Salt Solution (HBSS) until all biopsies were harvested for the tissue 
culture. Before initiating the tissue culture, all biopsies were washed twice in 
unsupplemented HBSS, individually weighed and individually placed into each well 
of a 6-well culture plate. During the preliminary stages of the explant tissue culture, 
there was a development in protocol regarding the volume of media added to each 
well in the 6-well plate, which is detailed in the General Material and Methods 
chapter (Chapter 3). Explants from mares 1-7 at the follicular phase of the oestrous 
cycle (Table 5.1) were collected during the preliminary stages of this project, 
therefore the tissue culture was carried out using 4.25 mL of supplemented William’s 
medium as described by Nash et al. (2008), with the aid of the wire platforms and 
lens cleaning tissue. However, biopsies taken from mares at the anoestrous phase 
(Table 5.3; Mares 13-18) were cultured in 3 mL of supplemented William’s medium 
direct in the well, excluding the use of the wire platform and the lens tissue, 
following the protocol described by Borges et al. (2012), also described in detail in 
Chapter 3. Due to the change in the protocol, mares at the luteal phase of the oestrous 
cycle (Table 5.2) were cultured in 3 mL of medium (mares 9-12) and also in 4.25 mL 
of medium (mares 7 and 8). 
All explants were cultured in triplicate for each time point and each phase of the 
oestrous cycle. The culture plates were stored in an incubator at 38 °C in 5 % CO2. 
At 24 hours and at 48 hours the explants were removed from the wells and 
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individually stored in 1.5 mL of RNALater at 4 
o
C. After a period of 24 hours the 
RNALater was removed and explants frozen at -20 
o
C until RNA extraction. 
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Table 5.1. Summary of mares sampled at the abattoir at the follicular phase of the oestrus cycle. Information regarding ovarian structures, cervical analysis 
and serum progesterone concentration.  
 
 
Mares 
Month of 
collection 
 
Ovaries
a
 
 
Cervix
b
 
Progesterone 
Concentration 
(ng/mL)
 c
 
1 July One 41 mm x 32 mm follicle on left ovary. Small follicles 
(around 7mm in diameter) on right ovary. 
Cervix pale in colour. Two fingers were passed through cervix 1.95 
2 July One small (10 mm in diameter) follicle on left ovary. One 33 
mm x 37 mm on right ovary. 
Cervix pale in colour. Three fingers were passed through 
cervix. 
0.16 
3 July One 38 mm x 45 mm follicle on left ovary. Regressing CL on 
right ovary. 
Cervix pink in colour, soft and open. Two to three fingers 
were passed through the cervical os. 
0.32 
4 July One 30 mm x 30 mm and a few small follicles on the left 
ovary. Regressing CL on left ovary. One 30mm x 25mm 
follicle on right ovary.  
Cervix becoming red. One to two fingers were passed through 
the cervical os. 
0.64 
5 July Two follicles (52 mm x 39 mm ; 50 mm x 30 mm) on left 
ovary. Regressing CL on left ovary. Small follicles (10 mm in 
diameter) on right ovary.  
Cervix pale in colour. One finger was passed through the 
cervical os.  
No blood 
6 July One 40 mm in diameter follicle on right ovary. Smaller 
follicles (around 20 mm in diameter) on left ovary. 
Cervix had a pink-pale colour and an open appearance. Three 
fingers were passed through the cervix 
0.21 
a  
Ultrasonographic measurements of ovaries. 
b  
Physical examination of cervix. 
c  
ELISA serum progesterone analysis for confirmation of stage of the oestrous cycle. 
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Table 5.2. Summary of mares sampled at the abattoir at the luteal phase of the oestrus cycle. Information regarding ovarian structures, cervical analysis and 
serum progesterone concentration. 
 
Mares 
Month of 
collection 
 
Ovaries
a 
 
Cervix
b 
Progesterone 
Concentration 
(ng/mL)
c 
7 June  One small (20 mm x 15 mm) follicle on the left ovary. One 
follicle (40 mm x 38 mm) on the right ovary. 
Cervix was pale in colour, becoming red. One and 
a half finger can be passed through the cervical os.  
8.44 
8 June One small (10 mm in diameter) follicle and a CL on left ovary. 
Two follicles (30 mm in diameter) on right follicle.  
Cervix was pale in colour, becoming red. One 
finger was passed through cervix.  
20 
9 June One follicle (30 mm in diameter) on left ovary. One follicle (also 
30 mm in diameter) on right ovary.  
Cervix pale in colour and it was closed. 4.08 
10 July One small follicle on left ovary (20 mm in diameter). One follicle 
(24 mm x 34 mm) on right ovary. 
Cervix was pale, and only one finger was passed 
through cervix.  
36.62 
11 August Small follicles on the left ovary. One follicle (40 mm in diameter) 
on the left ovary.  
Cervix was becoming red. One and a half fingers 
were passed through the cervical os. 
5.82 
12 August Small follicles (smaller than 10 mm in diameter) on left ovary. 
One follicle 40 mm x 35 mm on right ovary.  
Cervix pale in colour. One and half a finger were 
passed through the cervical os.  
5.23 
a  
Ultrasonographic measurements of ovaries. 
b  
Physical examination of cervix. 
c  
ELISA serum progesterone analysis for confirmation of stage of the oestrous cycle. 
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Table 5.3. Summary of mares sampled at the abattoir during the anoestrous period. Information regarding ovarian structures, cervical analysis and serum 
progesterone concentration. 
 
Mares 
Month of 
collection 
 
Ovaries
a 
 
Cervix
b 
Progesterone 
Concentration 
(ng/mL)
c 
13 January Small follicles smaller than 10 mm in diameter.  Cervix pale in colour and tight. One finger was 
passed through cervix. 
Undetectable  
14 January Follicles smaller than 10 mm in diameter found on both ovaries.  Cervix was pale and with a tight appearance. One 
finger was passed through the cervical os.  
0.16 
15 January Follicles smaller than 10 mm in diameter found on both ovaries. Cervix was tight and pale in colour. One finger 
was passed through the cervix.  
1.00 
16 January Follicles smaller than 10 mm in diameter found on both ovaries. Cervix was pale and closed. Only half a finger was 
passed through the cervical os.  
0.11 
17 January Small follicles smaller than 10 mm in diameter.  Cervix pale in colour. One finger was passed 
through cervix. 
0.09 
18 January Small follicles smaller than 10 mm in diameter. Cervix pale and one and a half fingers were passed 
through the cervical os.  
0.05 
a  
Ultrasonographic measurements of ovaries. 
b  
Physical examination of cervix. 
c  
ELISA serum progesterone analysis for confirmation of stage of the oestrous cycle. 
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5.2.4 | RNA Extraction and RNA-Sequencing  
As described in Chapter 3, total RNA was extracted from each technical replicate at 
the three time points resulting in a total of 144 RNA samples. The quality and 
concentration of each RNA sample were checked by Nanodrop 1000 
Spectrophotometer (Thermo Scientific, UK), and RNA integrity was assessed by 
agarose gel electrophoresis.  
Equivalent concentrations of RNA from each technical replicate (duplicates for the 
“0 hours” samples and triplicates for the cultured “24 hours” and “48 hours” 
samples) were pooled into a single library to mitigate oddities in a single replicate. 
The pooled samples had a final concentration of 1500 ng of RNA in a total volume 
of 50 µL and were used to prepare dual-indexed next-generation sequencing libraries 
via the Illumina TruSeq Stranded mRNA kit, according to the manufacturer's 
instructions (Chapter 3). Following library construction, individual libraries were 
quantified using an Epoch spectrophotometer (BioTek Ltd) and pooled at equal 
concentrations. The pooled DNA was quantified again using Qubit fluorometer 
(Thermo Fischer Ltd) and size determined via agarose gel electrophoresis, with an 
average size of 300 base pairs (bp). The pooled library was then diluted to 10 nM and 
sent to the Wales Gene Park (Institute of Medical Genetics, Cardiff University) for 
sequencing in the 2x75 bp format on an Illumina HiSeq4000 platform at a final 
dilution of 8 pM. After an initial run of one sequencing lane to determine read counts 
for each sample, the original pool was adjusted by spiking in more of any 
underperforming samples, re-quantified and diluted to 10 nM for transport to Cardiff.  
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5.2.5 | Data Processing and Gene Expression Analysis 
Following RNA-Seq, a total of 54 pair-end raw reads were generated. As previously 
described in Chapter 3, the FastQC software (version 0.11.2) was used to check the 
quality of each read, followed by the TopHat software (version 2.0.14) that was used 
to map the read to the equine reference genome (Equus caballus, EquCab2; 
GCA_000002305.1, Ensembl website). In order to summarize the number of aligned 
reads per exon, the FeatureCounts package (version 1.5.2) was used using the equine 
annotation file (Ensembl website, version EquCab2.89). Information regarding all 
RNA-Seq samples is shown in Table 5.4. Sample number 5 (Table 5.4) was excluded 
from the differential analysis due to its low sequence reads. 
To perform the differential gene expression the R/Bioconductor DESeq2 package 
was used. Pairwise analysis between the follicular, luteal and anoestrous phases were 
performed at 24 and 48 hours, while the 0 hours samples were used as a baseline for 
all comparisons. Computer codes used in this chapter are shown in Appendix 5.2. 
The Ensembl gene ID’s from the differentially expressed genes (DEGs) were 
submitted to the Search Tool for the Retrieval of Interacting Genes/Proteins 
(STRING) database (Szklarczyk et al., 2015) for retrieval of protein-protein 
interactions (PPI), network analysis and gene associations discovery. The Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways (Kanehisa and Goto, 2000) 
and the Gene Ontology (GO) terms (Ashburner et al., 2000) retrieved from STRING 
were discussed in more detail. 
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Table 5.4. Summary of the 54 RNA-sequencing samples. 
 
Sample
 
Mare
 
Time point
a 
Total sequences
b 
Mapped reads
c 
Alignment
d 
Total count
e 
1 
 
 
1 0h 
 
14732999 13093630 88.0% 8189448 
2 1 24h 14413060 12851895 88.2% 9089595 
3 1 48h 14478404 12388732 82.7% 9164680 
4 2 0h 20944446 18583416 87.8% 12011433 
5 2 24h 51908 - - - 
6 2 48h 18426338 16460869 88.5% 11751541 
7 3 0h 20676567 18713941 89.6% 11677948 
8 3 24h 17025391 15344289 89.3% 10509216 
9 3 48h 10176691 9064388 88.2% 6518790 
10 4 0h 25755178 22889123 88.0% 15379136 
 11 4 24h 13825435 12385346 88.8% 8865615 
12 4 48h 15265076 13562712 88.1% 10063029 
13 5 0h 15271868 13766764 89.3% 8800428 
14 5 24h 16545945 14801063 88.7% 10454711 
15 5 48h 21623764 19162433 87.8% 14019493 
16  6 0h 17701562 16121060 90.2% 10141641 
17 6 24h 24846417 16743308 66.8% 15154964 
18 6 48h 13704434 12424768 89.7% 9032012 
19 9 0h 15837921 14198656 88.8% 8528780 
20 9 24h 16801565 14870710 87.8% 10533817 
21 9 48h 21894316 12286341 87.7% 8717409 
22 10 0h 15640508 14114175 89.5% 8348050 
23 10 24h 14858665 13344364 89.0% 8954146 
24 10 48h 21421597 19469935 90.1% 13390511 
25 11 0h 18187487 12480734 87.3% 9552985 
26 11 24h 17030297 4560948 86.3% 9929801 
27 11 48h 16955601 4644608 87.0% 9862552 
28 12 0h 8588873 7576298 85.7% 5019375 
29 12 24h 30704205 27406716 86.8% 19331141 
30 12 48h 14546852 13012189 86.5% 9130360 
31 13 0h 17092428 15259118 85.4% 9504581 
32 13 24h 16675863 15074768 88.7% 10823555 
33 13 48h 17559191 15783230 89.2% 10835122 
34 14 0h 13009074 8965623 89.2% 6786842 
35 14 24h 14567503 13105169 89.2% 8283221 
36 14 48h 16831156 3149852 88.9% 9142764 
37 15 0h 16058695 14188031 87.6% 8202444 
38 15 24h 16822769 19736480 88.7% 13323753 
39 15 48h 19567236 17537222 88.7% 12196475 
40 16 0h 18087681 15121438 82.7% 8912819 
41 16 24h 19114852 16766789 86.9% 10986930 
42 16 48h 11933812 10568219 87.7% 7282826 
43 17 0h 13425144 11973270 88.4% 7556195 
44 17 24h 14682843 13038782 87.9% 9024019 
45 17 48h 13115579 11688883 88.3% 8131313 
46 18 0h 15593019 13905005 88.2% 8674913 
47 18 24h 14437386 12823612 87.9% 8809986 
48 18 48h 14545972 12861753 87.6% 8442258 
49 19 0h 22527362 20371381 89.6% 12732723 
50 19 24h 10566912 9542369 89.5% 6549129 
51 19 48h 16112922 14471574 88.8% 10092367 
52 20 0h 19575797 17636602 89.2% 10757896 
53 20 24h 15628899 14103747 89.5% 9640596 
54 20 48h 14577396 13294564 90.3% 8845260 
a  
Specific time-points when explants were removed from culture. 
b  
A count of the total number of sequences processed. 
c  
Number of reads mapped to the annotated equine genome. 
d 
 Percentage of reads mapped to the annotated equine genome. 
e 
Counts of reads assigned to genomic features.
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5.2.6 | Statistical analysis 
The negative binominal distribution was used to model the data for the statistical 
analysis of DEGs on the RNA-Seq data, performed by the R/Bioconductor DESeq2 
package (Love et al., 2014). The Benjamini-Hochberg (BH) false discovery rate 
(FDR) (Benjamini and Hochberg, 1995) method was used to determine differential 
gene expression with an adjusted P < 0.05 along with a log2 fold change (Log2FC) 
equal or greater than ±2. Six tests were performed in total: between the follicular and 
luteal phases at 24 and at 48 hours, between the follicular and anoestrous phases at 
24 and 48 hours and between the luteal and anoestrous phases at 24 and 48 hours, 
while the 0 hours samples were used as a baseline for all comparisons. It was tested 
whether the 24 hours or whether the 48 hours effect over the fresh 0h baseline 
transcriptome was different across the follicular and luteal phase groups, across the 
follicular and anoestrous phase groups and across the luteal and anoestrous phase 
groups while controlling for individuals. Genes featuring less than 1000 reads across 
all samples were excluded from the enrichment analysis. DEGs were analysed with 
respect to KEGG pathways and GO terms.  
The formulas indicated below express the six different comparisons performed: 
 
 
 
 
(Follicular24h – Follicular0h ) – (Luteal24h – Luteal0h) 
(Follicular48h – Follicular0h ) – (Luteal48h – Luteal0h) 
(Follicular24h – Follicular0h ) – (Anoestrous24h – Anoestrous0h) 
(Follicular48h – Follicular0h ) – (Anoestrous48h – Anoestrous0h) 
(Luteal24h – Luteal0h) – (Anoestrous24h – Anoestrous0h) 
(Luteal48h – Luteal0h) – (Anoestrous48h – Anoestrous0h) 
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5.3 | Results 
Based on PCA, the expression profile variation between and within the follicular, 
luteal and anoestrous groups was determined to allow a visual inspection of the 
samples based on their gene expression profiles. Similar expression profiles cluster 
together, as can be seen from Figure 5.1. The PCA analysis confirmed the presence 
of three subgroups; distinct clusters of follicular, luteal or anoestrous tissues. The 
clear distinction between follicular and anoestrous tissue clusters, represented by the 
green and red colours respectively, suggest that the collection of tissue at the 
follicular and anoestrous phase of the oestrous cycle was correct, taking into 
consideration that during these phases there is a low progesterone serum 
concentration in the mares’ blood. On the other hand, the cluster of luteal tissue, 
represented by the blue colour, was identified as the major component for sample 
distances. This was expected since the progesterone serum concentration at this 
phase of the oestrous cycle is much higher.  
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Figure 5.1. PCA plot of the gene expression profiles for the eighteen mares. The different colours 
show the biopsies taken at the anoestrous, follicular and luteal phases, while the different shapes 
demonstrate the different time points:  0h (), 24h () and 48h (). The analysis clearly 
demonstrates one outlier from the luteal phase. The anoestrous and follicular mares cluster together, 
as expected. The luteal mares are shown in a separate cluster, as expected, based on the difference in 
progesterone concentrations.  
 
However, it can be seen from Figure 5.1 that the luteal cluster represented by the 
blue colour has one outlier. From further analysis, mare number 7 (Table 5.2) was 
identified as the outlier. Therefore, this mare was removed from the analysis for 
DEGs to avoid biased and unreliable results. Hence, another PCA plot was produced 
to confirm that the outlier was indeed removed. Figure 5.2 shows the gene expression 
profiles for the seventeen mares used in the final differential analysis. From the PCA 
plots, it is also possible to visualise that the transcriptome profiles were not affected 
by the volume of supplemented William’s media used to culture each explant tissue 
as previously described in the Materials and Methods. 
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Figure 5.2. PCA plot of the gene expression profiles for the seventeen mares included in the 
analysis. The different colours show the biopsies taken at the anoestrous, follicular and luteal 
phases, while the different shapes demonstrate the different time points:  0h (), 24h () and 48h 
().  
 
The null hypothesis for each gene tested using DESeq2 was that there was no 
difference in its expression between the phase of the oestrous cycle groups at 24 or at 
48 hours using the 0 hours samples as a baseline. The null hypothesis was rejected 
when the observed difference in expression of a gene was greater than expected by 
random chance (using an adjusted p-value of 0.05).  
5.3.1 | Follicular vs Luteal  
At 24 hours, 12834 genes were found to be expressed, 125 of which were shown to 
be statistically significantly differentially up-regulated and 58 shown to be 
statistically significantly differentially down-regulated in the follicular relative to the 
luteal phase groups, at an FDR of 0.05 and Log2FC ≥ ±2.  
The STRING functional enrichment analysis of the DEGs identified at 24 hours was 
performed using the 12834 total expressed genes as the statistical background. The 
136 
 
protein-protein interaction (PPI) p-value was 1.0
-16
, indicating that the genes are 
biologically connected as a group since the list of genes showed more interactions 
between themselves than what was expected when a similar size of random genes is 
analysed. The predicted STRING network was composed of 181 nodes and 35 edges. 
The STRING enrichment analysis of all DEGs when comparing the follicular 
transcriptome relative to the luteal transcriptome at 24 hours returned a total of 7 
enriched KEGG pathways which are shown in more detail in Table 5.5. Furthermore, 
48 GO terms (Appendix 5.3) were enriched and the 10 most enriched terms are listed 
in Table 5.6.  
Table 5.5. Summary of the 7 enriched KEGG pathways when comparing the follicular 
transcriptome relative to the luteal transcriptome at 24 hours. Associated with Log2FC ≥ ±2 
and sorted by p-value. Table created using the STRING website. 
Pathway 
code
a
 
Description
b
 Count
c
 FDR p-value
d
 
04060 Cytokine-cytokine receptor interaction 12 1.49
-5
 
05164 Influenza A 10 0.002 
05134 Legionellosis 6 0.003 
04668 TNF signalling pathway 8 0.005 
04630 Jak-STAT signalling pathway 7 0.022 
05162 Measles 7 0.022 
05140 Leishmaniasis 5 0.035 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c
 The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
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Table 5.6. Summary of the 10 most enriched GO terms when comparing the follicular 
transcriptome relative to the luteal transcriptome at 24 hours. Associated with Log2FC ≥ ±2 
and sorted by p-value. Table created using the STRING website. 
GO Category
a
 Term name
b
 Description
c
 Count
d
 
FDR p-
value
e
 
Cellular component GO.0005575 Cellular component 13 4.10 x 10
-6
 
Biological process GO.0044707 Single-multicellular organism process 8 8.04 x 10
-5
 
Cellular component GO.0005576 Extracellular region 8 1.49 x 10
-4
 
Molecular function GO.0003674 Molecular function 11 2.37 x 10
-4
 
Molecular function GO.0005488 Binding 9 2.37 x 10
-4
 
Molecular function GO.0046914 Transition metal ion binding 5 2.37 x 10
-4
 
Biological process GO.0044699 Single-organism process 10 7.80 x 10
-4
 
Biological process GO.0050794 Regulation of cellular process 8 7.80 x 10
-4
 
Molecular function GO.0046872 Metal ion binding 6 8.51 x 10
-4
 
Biological process GO.0008150 Biological process 10 0.002 
a
 GO domain (cellular component, biological process or molecular function). 
b
 Term associated with gene ontology biological processes. 
c 
Description of each GO category. 
d 
The number of genes involved in each biological process term. 
e 
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
The “Immune system process” (GO:0002376) and the “Inflammatory response” 
(GO:0006954) biological process GO terms were also enriched (FDR = 0.005 and 
FDR = 0.009 respectively), despite not being listed in the top 10 enriched GO terms 
featured in Table 5.6. However, the DEGs part of these GO terms are illustrated in 
Figure 5.3 along with the “Cytokine-cytokine receptor interaction”, the “TNF 
signalling pathway” and the “Jak-STAT signalling pathway” KEGG pathways 
related to inflammation and immune system response (Table 5.5). With regard to 
immune gene expression, several chemokines such as CXCL1, CXCL10, CXCL14, 
interleukin (IL)-1α, IL-7 receptor (IL7R) and the NF-κB inhibitor alpha (NFKBIA) 
are examples of significantly differentially expressed genes up-regulated when 
comparing the follicular transcriptome relative to the luteal transcriptome at 24 
hours. 
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Figure 5.3. STRING predicted PPI network of the DEGs related to immune response and 
inflammation between the follicular and luteal phases at 24 hours. Red nodes represent genes 
that belong to “Cytokine-cytokine receptor interaction” (KEGG pathway), blue nodes represent 
genes that belong to the “TNF signalling pathway” (KEGG pathway), green nodes represent genes 
that belong to the “Jak-STAT signalling pathway” (KEGG pathway), yellow nodes represent genes 
that belong to the “Immune system process” (GO biological process terms) and pink nodes represent 
genes that belong to the “Inflammatory response” (GO biological process terms). The interaction 
score between nodes was set to high confidence (0.7). Disconnected nodes are hidden in the network. 
Image created using the STRING website. 
 
A total of 12834 genes were also found to be expressed at 48 hours, 401 of which 
were statistically significantly differentially up-regulated and 155 genes were shown 
to be statistically significantly differentially down-regulated in the follicular relative 
to the luteal phase groups at an FDR of 0.05 and Log2FC ≥ ±2.  
The STRING functional enrichment analysis of the DEGs identified at 48 hours was 
performed using the 12834 total expressed genes as the statistical background. The 
protein-protein interaction (PPI) p-value was 1.0
-16
, indicating that the genes are 
biologically connected as a group since the list of genes showed more interactions 
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between themselves than what was expected when a similar size of random genes is 
analysed. The predicted STRING network was composed of 547 nodes and 472 
edges. When comparing the follicular transcriptome relative to the luteal 
transcriptome, no GO terms were significantly enriched.  The “Chemical 
carcinogenesis” (05204 pathway code) was the only KEGG pathway significantly 
enriched (FDR = 0.014).  
5.3.2 | Follicular vs Anoestrous  
At 24 hours 12834 genes were found to be expressed, 14 of which were shown to be 
statistically significantly differentially up-regulated and 76 shown to be statistically 
significantly differentially down-regulated in the follicular relative to the luteal phase 
group, at an FDR of 0.05 and Log2FC ≥ ±2.   
The STRING functional enrichment analysis of DEGs at 24 hours was performed 
using the 12834 total expressed genes as the statistical background. The protein-
protein interaction (PPI) p-value was 0.008, indicating that the genes are biologically 
connected as a group since the list of genes showed more interactions between 
themselves than what was expected when a similar size of random genes is analysed. 
The predicted STRING network was composed of 88 nodes and 10 edges. 
The STRING enrichment analysis when comparing the follicular transcriptome 
relative to the anoestrous transcriptome at 24 hours returned a total of 6 enriched 
KEGG pathways which are shown in more detail in Table 5.7. Furthermore, 30 GO 
terms (Appendix 5.4) were enriched and 10 most enriched terms are listed in Table 
5.8. The “Immune response” biological process GO term (GO:0006955) was also 
enriched (FDR = 0.0235), despite no presence in the top 10 list of GO enriched 
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terms featured in Table 5.8. However, the genes related to the “immune response” 
GO term are shown in Figure 5.4 along with the “Cytokine-cytokine receptor 
interaction” and the “Complement and coagulation cascades” KEGG pathways 
related to inflammation and immune system response.  
Table 5.7. Summary of the 6 enriched KEGG pathways when comparing the follicular 
transcriptome relative to the anoestrous transcriptome at 24 hours. Associated with Log2FC ≥ 
±2 and sorted by p-value. Table created using the STRING website.  
Pathway 
code
a
 
Description
b
 Count
c
 FDR p-value
d
 
4640 Hematopoietic cell lineage 5 0.004 
5144 Malaria 4 0.008 
4060 Cytokine-cytokine receptor interaction 6 0.011 
4610 Complement and coagulation cascades 4 0.013 
5133 Pertussis 4 0.032 
5323 Rheumatoid arthritis 4 0.042 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c 
The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
 
Table 5.8. Summary of the 10 most enriched GO terms when comparing the follicular 
transcriptome relative to the anoestrous transcriptome at 24 hours. Associated with Log₂FC 
≥ ±2 and sorted by p-value. Table created using the STRING website. 
GO Category
a
 Term name
b
 Description
c
 Count
d
 
FDR p-
value
e
 
Biological process GO.0044699 Single organism process 9 5.70 x 10
-5
 
Biological process GO.0008150 Biological process 9 1.12 x 10
-4
 
Molecular function GO.0003674 Molecular function 8 2.29 x 10
-4
 
Molecular function GO.0005488 Binding 7 2.29 x 10
-4
 
Cellular component GO.0005575 Cellular component 8 4.80 x 10
-4
 
Biological process GO.0042221 Response to chemical 5 9.52 x 10
-4
 
Biological process GO.0048871 Multicellular organismal homeostasis 3 9.52 x 10
-4
 
Biological process GO.0050794 Regulation of cellular process 6 9.52 x 10
-4
 
Biological process GO.0050896 Response to stimulus 6 9.52 x 10
-4
 
Cellular component GO.0044421 Extracellular region part 5 0.001 
a
 GO domain (cellular component, biological process and molecular function). 
b
 Term associated with gene ontology biological processes. 
c 
Description of each GO category. 
d 
The number of genes involved in each biological process term.  
e 
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
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Figure 5.4. STRING predicted PPI network of the DEGs related to immune response and 
inflammation between the follicular phase and the anoestrous period at 24 hours. Red nodes 
represent genes that belong to the “Cytokine-cytokine receptor interaction” (KEGG pathway), blue 
nodes represent genes that belong to the “Complement and coagulation cascades” (KEGG pathway), 
and green nodes represent genes that belong to the “Immune response” term (GO biological process 
term). The interaction score between nodes was set to high confidence (0.7). Disconnected nodes are 
hidden in the network. Image created using the STRING website. 
 
A total of 12834 genes were also found to be expressed at 48 hours, 104 of which 
were statistically significantly differentially up-regulated and 42 shown to be 
statistically significantly differentially down-regulated in the follicular relative to the 
anoestrous phase group at an FDR of 0.05 and Log2FC ≥ ±2. 
At 48 hours, the protein-protein interaction (PPI) p-value was 3.6 x 10
-06
, indicating 
that the genes are biologically connected as a group since the predicted network has 
significantly more interactions than expected. The predicted STRING network was 
composed of 137 nodes and 23 edges composed the network. Table 5.9 provides 
information about the 7 enriched KEGG pathways and Table 5.10 shows the 5 
enriched GO terms. 
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Table 5.9. Summary of the 7 enriched KEGG pathways when comparing the follicular 
transcriptome relative to the anoestrous transcriptome at 48 hours. Associated with Log₂FC 
≥ ±2 and sorted by p-value. Table created using the STRING website. 
Pathway code
a
 Description
b
 Count
c
 FDR p-value
d
 
5133 Pertussis 6 0.008 
5162 Measles 7 0.008 
5164 Influenza A 8 0.008 
4640 Hematopoietic cell lineage 5 0.009 
4144 Endocytosis 8 0.035 
4610 Complement and coagulation cascades 4 0.045 
4974 Protein digestion and absorption 4 0.045 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c
 The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
Table 5.10. Summary of the 5 enriched GO terms when comparing the follicular 
transcriptome relative to the anoestrous transcriptome at 48 hours. Associated with Log₂FC 
≥ ±2 and sorted by p-value. Table created using the STRING website. 
GO Category
a
 Term name
b
 Description
c
 Count
d
 
FDR p-
value
e
 
Biological process GO.0006952 Defense response 5 0.010 
Biological process GO.0048871 Multicellular organismal homeostasis 3 0.010 
Biological process GO.0006955 Immune response 4 0.023 
Biological process GO.0006953 Acute-phase response 3 0.024 
Biological process GO.0001660 Fever generation 2 0.041 
a
 GO domain (cellular component, biological process and molecular function). 
b
 Term associated with gene ontology biological processes. 
c 
Description of each GO category. 
d 
The number of genes involved in each biological process term.  
e
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
5.3.3 | Luteal vs Anoestrous  
A total of 12834 genes were found to be expressed where 83 genes were shown to be 
significantly up-regulated while 103 were shown to be down-regulated in the luteal 
relative to the anoestrous phase group at an FDR of 0.05 and Log2FC ≥ ±2. The 
STRING functional enrichment analysis of differentially expressed genes at 24 hours 
was performed using the 12834 total expressed genes as the statistical background. 
According to STRING, the list of genes/proteins showed statistically more 
interactions between themselves than what was expected when a similar size of 
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random genes/proteins is analysed for both time points indicating that genes are 
biologically connected as a group (P=0.002). 
The predicted STRING network was composed of 180 nodes and 20 edges. The 
STRING enrichment analysis of all DEGs when comparing the luteal transcriptome 
relative to the anoestrous transcriptome at 24 hours returned a total of 2 enriched 
KEGG pathways which are shown in Table 5.11 while the total of 3 enriched GO 
terms is listed in table 5.12. DEGs part of the “Cytokine-cytokine receptor 
interaction” pathway are shown in Figure 5.5. 
Table 5.11. Summary of the 2 enriched KEGG pathways when comparing the luteal 
transcriptome relative to the anoestrous transcriptome at 24 hours. Associated with Log2FC ≥ 
±2 and sorted by p-value. Table created using the STRING website. 
Pathway 
code
a
 
Description
b
 Count
c
 FDR p-value
d
 
04060 Cytokine-cytokine receptor interaction 8 0.024 
04972 Pancreatic secretion 6 0.024 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c
 The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
Table 5.12. Summary of the 3 enriched GO terms when comparing the luteal transcriptome 
relative to the anoestrous transcriptome at 24 hours. Associated with Log2FC ≥ ±2 and sorted 
by p-value. Table created using the STRING website. 
GO Category
a
 Term name
b
 Description
c
 Count
d
 FDR p-value
e
 
Biological process GO.0050896 Response to stimulus 7 0.023 
Molecular function GO.0003674 Molecular function 8 0.043 
Molecular function GO.0005102 Receptor binding 3 0.043 
a
 GO domain (cellular component, biological process and molecular function). 
b
 Term associated with gene ontology biological processes. 
c 
Description of each GO category. 
d 
The number of genes involved in each biological process term.  
e
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
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Figure 5.5. STRING predicted PPI network of the DEGs related to immune response and 
inflammation between the luteal phase and the anoestrous period at 24 hours. Blue nodes 
represent genes that belong to the “Complement and coagulation cascades” (KEGG pathway). The 
interaction score between nodes was set to high confidence (0.7). Disconnected nodes are hidden in 
the network. Image created using the STRING website. 
 
At 48 hours, 12834 genes were found to be expressed, 165 of which were shown to 
be statistically significantly differentially up-regulated and 272 shown to be 
statistically significantly differentially down-regulated in the luteal relative to the 
anoestrous phase group, both at an FDR of 0.05 and Log2FC ≥ ±2. 
The STRING functional enrichment analysis of DEGs at 48 hours was performed 
using the 12834 total expressed genes as the statistical background. The STRING 
PPI p-value was < 1 x 10
-16
, indicating that the genes are biologically connected as a 
group since the predicted network has significantly more interactions than expected. 
The predicted STRING network was composed of 422 nodes and 246 edges. The 
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STRING enrichment analysis of all DEGs when comparing the luteal transcriptome 
relative to the anoestrous transcriptome at 48 hours returned a total of 2 significantly 
enriched KEGG pathways as shown in Table 5.13. Also, a total of 31 GO terms 
(Appendix 5.5) were shown to be significantly enriched at 48 hours and Table 5.14 
lists the 10 most enriched sorted by p-value.  
Table 5.13. Summary of the 2 enriched KEGG pathways when comparing the luteal 
transcriptome relative to the anoestrous transcriptome at 48 hours. Associated with Log₂FC 
≥ ±2 and sorted by p-value. Table created using the STRING website. 
Pathway 
code
a
 
Description
b
 Count
c
 FDR p-value
d
 
4974 Protein digestion and absorption 9 0.003 
4512 ECM-receptor interaction 10 0.010 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c 
The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
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Table 5.14. Summary of the 10 most enriched GO terms when comparing the luteal 
transcriptome relative to the anoestrous transcriptome at 48 hours. Associated with Log₂FC 
≥ ±2 and sorted by p-value. Table created using the STRING website. 
GO Category
a
 Term name
b
 Description
c
 Count
d
 
FDR  
p-value
e
 
Biological process GO.0051716 Cellular response to stimulus 9 0.005 
Cellular component GO.0005615 Extracellular space 7 0.005 
Cellular component GO.0012505 Endomembrane system 6 0.005 
Cellular component GO.0005576 Extracellular region 9 0.006 
Cellular component GO.0044421 Extracellular region part 8 0.006 
Biological process GO.0006508 Proteolysis 4 0.022 
Biological process GO.0009887 Organ morphogenesis 4 0.022 
Biological process GO.0009987 Cellular process 12 0.022 
Biological process GO.0032501 Multicellular organismal process 8 0.022 
Biological process GO.0044767 
Single-organism developmental 
process 
7 
0.022 
a
 GO domain (cellular component, biological process and molecular function). 
b
 Term associated with gene ontology biological processes. 
c 
Description of each GO category. 
d 
The number of genes involved in each biological process term.  
e
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
5.4 | Discussion 
In the present experiment, RNA-Seq was used to further investigate the gene 
expression profiles in the equine endometrial environment throughout the oestrous 
cycle and anoestrous period to identify the key significant changes associated with 
the different phases using the explant tissue culture. Analysis of RNA-Seq data 
generated gene expression profiles when comparing the follicular and luteal phases, 
the follicular and anoestrous phases, and the luteal and anoestrous phases. After 
performing the general KEGG/GO enrichment analysis of all DEGs, genes related to 
the immune system, to uterine function and to cellular processes were selected as 
important target genes to be discussed herein. Results from this study will improve 
the understanding of the physiological uterine changes in response to different 
pituitary and ovarian hormone concentrations and also serve as a baseline for future 
studies in mares that develop uterine pathological changes and diseases, especially 
endometrial inflammation.  
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5.4.1 | Follicular vs Luteal 
When comparing how the 24 hours effect over the fresh 0 hours transcriptome is 
different across the follicular and the luteal phase a total of 183 genes were 
significantly differentially expressed. The two biological processes retrieved from 
the enrichment analysis were the immune system and cellular processes.  
The DEGs related to the immune function were linked to the “cytokine-cytokine 
receptor interaction”, “TNF signalling pathway” and “Jak-STAT signalling pathway” 
KEGG pathways and with the GO biological processes “immune system” and 
“inflammatory response”. These categories comprised genes coding for interleukin 
family and receptors (IL1A, IL23A, IL2RB and IL7R), chemokine (C-X-C motif) 
ligand family (CXCL1, CXCL10 and CXCL14), the tumour necrosis factor (TNF) 
receptor superfamily member 4 (TNFRSF4), the NF-kB Inhibitor Alpha (NFKBIA), 
showing an Log2FC up-regulation between 2.1 and 5.3 in follicular relative to luteal 
samples. Furthermore, the LEPR gene (Log2FC = -2.4) encodes a leptin receptor that 
is known to be expressed in the uterus with higher expressions observed during the 
luteal phase of the oestrous cycle in heifers (Sosa et al., 2010). Leptin is usually 
found in adipose tissue with an important role on appetite regulation; however, its 
presence in the uterus has hypothesised its relation in reproductive function as well 
as in the metabolic status (Chilliard et al., 2001; Chelikani et al., 2003). The down-
regulation of LEPR during the follicular relative to the luteal phase agrees with these 
findings, indicating that the leptin receptor is more expressed during the luteal phase 
of the oestrous cycle also in mares.  
There is a relatively small body of literature that focuses on the equine endometrial 
gene expression profiles throughout the oestrous cycle, however the current result 
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agrees with the findings from an RNA-Seq study conducted by Marth et al. (2015b) 
when investigating the endometrial global gene expression profiles during the 
follicular and the luteal phases of the oestrous cycle. It also agrees with the first 
microarray analysis of the genes involved in the follicular and luteal phases carried 
out by Gebhardt et al. (2012), where expression profiles related to inflammatory 
responses were up-regulated during the follicular phase. Genes related to the immune 
system, when comparing the follicular transcriptome relative to the luteal 
transcriptome, were expected to be up-regulated, since the innate immune system is 
responsible for tackling the intrusion of foreign material into the uterus, specially 
pathogens, that is more likely to occur during the follicular phase when the cervix is 
open (Troedsson et al., 2001a). Furthermore, the INHBA gene and the FST genes 
coding the inhibin beta A and follistatin respectively, which are proteins linked to the 
immune system and related to hormonal changes during the oestrous cycle (Ueno et 
al., 1987; Walton et al., 2012) were up-regulated (Log2FC of 2.2 and 2.0 
respectively). It has already been described that progesterone decreases the 
expression of steroidogenic factors such as INHBA and FST in rats (Tebar et al., 
2000; Zheng et al., 2007). Therefore it is indeed expected the INHBA and FST 
expression would be up-regulated in follicular relative to luteal phase also in mares.  
The PTGS2 gene (Log2FC = 2.2) encodes a cyclooxygenase that plays a role in 
prostaglandin biosynthesis which can be induced in different tissues by cytokines, 
growth factor and inflammatory stimuli (Jones et al., 1993; Cabrera et al., 2006). In 
mammalians, the expression of PTG2S is induced by the ovulatory gonadotropin 
surge in granulosa cells, producing prostaglandins which are suggested to be 
mediators of the ovulatory process (Sirois, 1994; Sirois and Doré, 1997). It has also 
been reported that the expression of PTGS2 was upregulated in the equine 
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endometrium when luteolysis had already started (day 15-15.5) and when 
progesterone concentration declined (Atli et al., 2010). However, the up-regulation 
of PTGS2 during the follicular phase shown in the current study might be later than 
expected as PGF2α increases around day 14-16 of the oestrous cycle in mares and 
induces luteolysis, allowing the onset of another follicular phase and ovulation (Zavy 
et al., 1978; Morresey, 2011; Stout, 2011). On the other hand, if PTGS2 also 
regulates prostaglandin E (PGE) which is known to have anti-inflammatory 
properties (Harris et al., 2002; Ricciotti and FitzGerald, 2011), an up-regulation of 
PTGS2 during the follicular phase of the oestrous cycle is indeed expected. 
The ESR1 and the FGFR genes, coding an oestrogen receptor and a fibroblast growth 
factor protein respectively, were also differentially expressed when comparing the 
transcriptome across follicular and luteal phase (Log2FC of -2.0 and 4.4 
respectively). Gebhardt et al. (2012) reported the expression of ESR1 to start 
increasing at the beginning of the follicular phase with a peak during the early luteal 
phase, therefore it is expected ESR1 to be down-regulated comparing the follicular 
transcriptome relative to the luteal transcriptome in the current study. Similarly, the 
up-regulation of FGFR described in the current study agrees with Gebhardt et al. 
(2012) where it was found that a fibroblast growth factor (FGF), which acts as one of 
the mediators in the endometrial oestrogen signalling, is up-regulated during the 
early follicular phase with a peak at ovulation.  
The results at 48 hours compared the differences between the follicular and the luteal 
transcriptomes using the 0 hours transcriptome as a baseline. Since the explants have 
been in culture for a total period of 48 hours it is expected the changes in gene 
expression to be greater when comparing the 48 hours’ time point to the 0 hours 
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baseline over the 24 hours’ time point to the 0 hours baseline. Indeed, at 48 hours a 
total of 556 genes were differentially expressed, in contrast to only 183 genes at 24 
hours. However, the enrichment analysis at 48 hours only retrieved one enriched 
KEGG pathway that is not related to the immune function or with the endometrial 
environment. The “chemical carcinogenesis” KEGG pathway was the only enriched 
pathway (FDR = 0.0137). This is a rather unexpected outcome related to 
environmental chemical carcinogens that can contribute to genomic instability. This 
might be explained because the genes are overly general or because many gene sets 
participating in different pathways and processes overlapped (Simillion et al., 2017). 
However, this might be also a factor of the biases in the databases. Results that do 
not make much sense to other systems can be retrieved since many pathway studies 
have been done on diseases in humans. Therefore, this result might represent a set of 
genes that are involved in another process that is not yet annotated in horses. As 
described before, the predicted STRING protein-protein interaction network 
generated significantly more connections than expected, suggesting that the genes are 
functionally interacting units, like pathways. Therefore, it can be suggested the 
possibility of unnanonated processes that are being up or down regulated.  
Individual genes related to immune function such as CXCL14 (Log2FC = 2.7) and 
TNFRSF4 (Log2FC = 2.9) were differentially expressed, meaning that the immune 
response is also up-regulated during the follicular transcriptome relative to the luteal 
transcriptome at 48 hours. The ESR1 gene was again found to be down-regulated 
(Log2FC = -2.5) during the follicular relative to the luteal phase at 48 hours. 
However, it has been suggested that it is more reliable to concentrate on trends 
indicated by grouped genes rather than on specific isolated genes in order to interpret 
the biological changes throughout the oestrous cycle (Marth et al., 2015b).  
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5.4.2 | Follicular vs Anoestrous 
When comparing how the 24 hours effect over the fresh 0 hours transcriptome is 
different across the follicular and the anoestrous phase a total of 90 genes were 
significantly differentially expressed. The biological processes retrieved from the 
enrichment analysis were mainly related to the immune system.  
The “cytokine-cytokine receptor interaction” and the “complement and coagulation 
cascades” were the significantly enriched KEGG pathways with genes related to the 
immune function, along with the GO biological processes “immune response”. 
Enriched genes from these categories encode for IL family and receptors (IL1A, 
IL1B, IL33, IL7R and IL1RN), chemokine ligand family (CXCL6), complement 
factors and proteins (CFB, C4BPA), toll-like receptor (TLR3) showing a Log2FC up-
regulation between 2.2 and 5.9 in the follicular phase group relative to the anoestrous 
group. The hepatocyte growth factor (HGF) gene was also over expressed (Log2FC = 
2.7) and it encodes a protein that is secreted by mesenchymal cells and acts as a 
cytokine on epithelial cells (Niranjan et al., 1995). The colony stimulating factor 3 
(CSF3) gene encodes a cytokine that controls the production, differentiation and 
function of granulocytes (Raposo et al., 2006; Liu et al., 2016). As discussed before, 
genes linked to the immune response are expected to be up-regulated during the 
follicular phase, which is the period of the oestrous cycle when foreign material 
might enter the uterus and contact the endometrium during natural mating of 
artificial insemination.  
Furthermore, genes related to cellular processes were also differentially expressed. 
The tyrosine-protein kinase (KIT) is a protein coding gene that plays a role in the 
regulation of cell survival and proliferation and gametogenesis, as well as acting as a 
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cell-surface receptor for specific cytokines (Blume-Jensen et al., 1994; Roskoski, 
2005). The plasminogen activator tissue type (PLAT) gene encodes an enzyme that 
plays a role in cell migration and tissue remodelling (Green and Lund, 2005). Thus a 
higher expression of KIT and PLAT (Log2FC = 2.2 and 2.1 respectively) evident in 
the follicular phase, might be expected as this is the stage of the cycle where there is 
glandular hyperplasia and increased stromal extracellular matrix compared to the 
anoestrous phase.  
Genes related to the extracellular matrix (ECM) were also found to be up-regulated 
in the follicular transcriptome relative to the anoestrous transcriptome at 24 hours. 
The TNC gene encodes Tenascin C, an extracellular matrix protein that is known to 
be expressed in the endometrium (Midwood et al., 2011) was up regulated with a 
Log2FC of 3.1. Matrix metalloproteinases (MMPs) are proteolytic enzymes known to 
play an important role in follicular development in mammals by breaking down 
ECM and facilitating tissue remodelling (Curry and Osteen, 2003). In the present 
study, the MMP1 gene was found to be up-regulated with a Log2FC of 2.8.  
When comparing how the 48 hours effect over the fresh 0 hours transcriptome is 
different across the follicular and the anoestrous phase, 146 genes were significantly 
differentially expressed. Even though a higher number of genes were significantly 
differentially expressed at 48 hours when compared to the analysis at 24 hours, the 
DEGs were linked to a smaller number of GO categories and KEGG pathways, as 
was the case when comparing the follicular transcriptome to the luteal transcriptome 
at 48 hours. The principal biological process retrieved from the enrichment analysis 
as previously was again, the immune system. Similarly, genes involved in the 
“complement and coagulation cascades” KEGG pathway and GO biological 
153 
 
processes “defense response”, “immune response” and “acute-phase response” 
encode IL family and receptors (IL1A, IL1B and IL1RN), chemokine ligand family 
(CXCL6), and complement component/protein (C1QC and C4BPA), with a Log2FC 
up-regulation between 2.2 and 3.8 in follicular compared to anoestrous samples. 
Collagen genes (COL1A1, COL21A1 and COL3A1) were down regulated (Log2FC 
= -2.2, -3.1 and -2.4 respectively) in the follicular transcriptome compared to 
anoestrous transcriptome. However, this finding contrasts to that of others, where an 
upregulation of collagen genes occurred during the follicular phase, where it was 
hypothesised that collagen provides structural strength to help stabilise the 
oedematous uterus during the follicular phase (Marth et al., 2015b).  However, it has 
been demonstrated that collagen levels decline during the ovine follicular phase 
while MMP activity increased, and it has been suggested that cervix relaxation 
during the follicular phase might be due to collagen fibre degradation (Rodriguez-
Pinon et al., 2015). Thus, it could be proposed that collagen down-regulation during 
the follicular phase compared to the anoestrous period might be related to cervix 
relation.  
5.4.3 | Luteal vs Anoestrous 
When comparing how the 24-hour effect over the fresh 0 hours transcriptome is 
different across the luteal and the anoestrous phase, a total of 186 genes were 
significantly differentially expressed. The significant enrichments observed in the 
GO categories (Table 5.12) were “molecular function”, “receptor binding” and 
“response to stimulus”.  
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From the genes linked to the GO categories, the INHBA gene was also down-
regulated in the luteal relative to the anoestrous period, with a Log2FC of -2.1, which 
agrees with previous research demonstrating that high progesterone concentrations 
diminish its endometrial expression (Tebar et al., 2000). The PTHLH gene that 
encodes the parathyroid hormone-related protein, which is involved in the regulation 
of cellular and organ growth and development, especially in epithelial-mesenchymal 
interactions (Foley et al., 2001; Hens and Wysolmerski, 2005), was also down-
regulated with a Log2FC of -4.3. These results agree with bovine work where the 
uterine expression of both PTHLH and INHBA genes is diminished in the luteal 
phase of the oestrous cycle (Bauersachs et al., 2005). The EDNRB gene (Log2FC = 
3.1) encodes the endothelin B receptor. It has been suggested that endothelin 
participates in the luteal regression induced by prostaglandin F2α in cows (Meidan et 
al., 1999; Levy et al., 2000; Wright et al., 2001). Therefore, an up-expression of 
EDNRB during the luteal phase relative to the anoestrous phase in mares might 
suggest a stimulatory activity in luteolysis that occurs at the very end of the luteal 
phase in mares.   
Genes related to the “cytokine-cytokine receptor interaction” KEGG pathway (Table 
5.11) encode proteins for IL family and receptors (IL23A and IL12RA1), chemokine 
ligand family (CXCL10 and CXCL14), and a TNF-receptor superfamily 
(TNFRSF4), showing a Log2FC down-regulation between -2.3 and -3.6 in luteal 
relative to anoestrous samples at 24 hours. This result agrees with the hypothesis that 
high progesterone concentrations during the luteal phase reduce the efficiency of 
endometrial bacteria elimination by neutrophils, leading to a lower uterine clearance 
(Evans et al., 1986a; Watson et al., 1987; Reiswig et al., 1993). It can also be 
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deduced that the immune system during the anoestrous period is more active than 
during the luteal phase of the oestrus cycle in mares.  
When comparing how the 48 hours effect over the fresh 0 hours transcriptome is 
different across the luteal and the anoestrous phase, 437 genes were significantly 
differentially expressed. Genes related to the “protein digestion and absorption” and 
“ECM-receptor interaction” KEGG pathways encode proteins for collagen such as 
COL1A1, COL1A2, COL22A1, COL3A1 and COL5A3, with a Log2FC down-
regulation between -2.2 to -4.4. Since genes encoding collagen proteins were also 
found to be down-regulated when comparing the follicular relative to the anoestrous 
transcriptome at 48 hours, they might be associated with the anoestrous period itself 
rather than with the follicular or luteal phases. These results lead to the hypothesis 
that collagen genes are more expressed during the anoestrous period than during the 
oestrous cycle, and this might be the reason why genes encoding collagens are down-
regulated at both follicular and luteal phases relative to anoestrous. There is a lack of 
information on the collagen content of the endometrium during the anoestrous period 
in mares and in other mammals, making it difficult to theorise the reasons for the 
down-regulation of collagen coding genes when comparing the follicular and luteal 
transcriptome to the anoestrous transcriptome.  
The 10 most enriched GO terms described in Table 5.14 when comparing the luteal 
transcriptome relative to the anoestrous transcriptome at 48 hours were related to 
biological processes and cellular components. The GO terms are mostly related to the 
extracellular space/region and cellular processes and cellular responses. As 
previously mentioned, the endometrial expression of ESR1 changes throughout the 
oestrous cycle in mares, increasing at the beginning of the follicular phase and 
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reaching its peak during the early luteal phase (3 days after ovulation)  (Gebhardt et 
al., 2012). Therefore, the up-regulation of the ESR1 gene (Log2FC = 2.2) during the 
luteal relative to the anoestrous phase in the current study agrees with previous 
findings. The INHBA and PTHLH genes were again down-regulated showing 
Log2FC of -2.9 and -5.2 respectively, while the EDNRB gene was up-regulated with 
Log2FC of 3.1. These results agree with the previous discussion when comparing the 
luteal transcriptome relative to the anoestrous transcriptome at 24 hours where a 
down-regulation of INHBA and PTHLH and an up-regulation of EDNRB are 
expected during the luteal phase.  
5.5 | Conclusion 
One of the current limitations of global gene expression study during the oestrous 
cycle in mares is that all studies consider the follicular and luteal phases only, 
leading to a lack of information related to the anoestrous period. This might be 
justified if the focus on the follicular phase is in order to better understand the 
mechanisms underlying equine fertility problems. However, it is important to 
determine the global gene expression changes throughout the equine breeding season 
to improve understanding of the physiological cyclic changes by comparing and 
contrasting the findings at the follicular and luteal phases with the anoestrous period. 
This may lead to a better understanding of how pituitary and ovarian hormones shape 
the morphological and functional characteristics of the endometrium throughout the 
oestrous cycle and shed light on how uterine pathologies disrupt the endometrial 
physiological equilibria.  
The RNA-Seq data analysis provided a snapshot of gene expression levels of 
follicular phase, luteal phase and anoestrous period in the equine endometrium. At 
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the follicular phase, the gene expression is mainly related to immune pathways, 
while the gene expression at the luteal phase is mainly related to molecular functions 
and biological processes. This might be the first RNA-Seq analysis of the equine 
endometrium during the anoestrous period, suggesting the collagen genes are more 
expressed during the anoestrous period than during the oestrous cycle.  
For all comparisons (follicular relative to luteal, follicular relative to anoestrous and 
luteal relative to anoestrous) the results of the differences between the different 
transcriptomes at 48 hours using the 0 hours transcriptome as a baseline, retrieved a 
higher number of DEGs in contrast to the DEGs retrieved at 24 hours. However, the 
enrichment analysis at 48 hours did not retrieve many KEGG pathways and/or GO 
terms, or the terms were too generic. This might be due to a great number of genes 
sets taking in part in different pathways that somehow overlapped. Therefore, the 
findings at 24 hours might be the most reliable and biologically trustworthy.  
The most important limitation of this study lies in the fact that handling high 
throughput data such as RNA-Seq is still incredibly challenging. There is no gold-
standard protocol to analyse transcriptomic data and the application of rigorous 
statistical methods to target significant effects and potential candidate genes is 
complex and time-consuming. This stated bioinformatics research is still developing, 
and the biological accuracy of results is continually being improved. The data 
presented in this chapter must be interpreted with caution because the effect of 
cultivating the explants was a larger source of variation than the effect of oestrous 
cycle stage. Another point to consider is that there is a possibility of tissues collected 
at different stages of the oestrous cycle have different “sensibilities” to the tissue 
culture. In the future, more research needs to focus on which stage of the oestrous 
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cycle is the most sensitive to the culture to account for gene expression variations 
related to the culture itself. This way, it will be possible to investigate the modulation 
in gene expression based on the phase of the oestrous cycle and based on the effect 
of culture upon the explants.  
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CHAPTER 6 
 
 
EFFECTS OF LPS ON THE EQUINE 
ENDOMETRIUM TRANSCRIPTOME AT THE 
FOLLICULAR PHASE OF THE OESTROUS 
CYCLE 
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6.1 | Introduction 
It is established that uterine infections are substantial cause of low fertility in mares 
(Asbury, 1986). As a consequence, horse breeding industries are affected by 
significant financial losses (Riddle et al., 2007; Marth et al., 2015a). A normal, 
transient uterine inflammation known as mating-induced endometritis (MIE) takes 
place after breeding due to the introduction of semen, seminal plasma, debris and 
bacteria (Watson, 2000; Katila, 2001; Troedsson et al., 2001a). Nonetheless, in some 
mares the physiological inflammation develops into a persistent endometritis known 
as persistent mating-induced endometritis (PMIE), causing early embryonic loss and 
infertility (Troedsson, 1997, 2006). It has been observed that the three most common 
bacterial species isolated in uterine samples collected from mares with fertility 
problems were Escherichia coli (E. coli), Streptococcus β-haemolytic and 
Streptococcus equi subspecies zooepidemicus (S. zooepidemicus) respectively 
(Albihn et al., 2003a). E. coli has been associated with repeat breeding, while β-
haemolytic streptococci were related to clinical endometritis (Albihn et al., 2003a). 
Being the first line of defence against invading microorganisms, the innate immune 
system produces a rapid response to maintain the homeostasis of the organism. The 
most important subsystem of the innate immune system is inflammation, responsible 
for recruiting white blood cells and immune proteins to destroy  invading microbes 
and promote tissue repair (Tizard, 2013). Cytokines are important signalling proteins 
secreted by immune system cells responsible for regulating the immune reaction. 
Interleukins (IL), interferons, tumour necrosis factors (TNF) and chemokines are 
examples of cytokines that are involved in immune regulation and inflammation 
(Tizard, 2013).  
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Most studies in the field of equine endometritis have only focused on specific genes 
hypothesised to be involved in uterine inflammation. Detailed examination of mRNA 
expression of pro-inflammatory cytokines IL-1β, IL-6, TNF-α and IL-8, and the anti-
inflammatory cytokine IL-10 showed that the endometrial expression of IL-1β, IL-6, 
TNF-α was increased in both resistant and susceptible mares 24 hours after artificial 
insemination with killed sperm (Fumuso et al., 2003). Similarly, previous research 
carried out by Christoffersen et al., (2012) found that mares showed increased gene 
expression of IL-1β, IL-6, IL-8, IL-10, TNF-α, IL-1 receptor antagonist (IL-1ra) and 
serum amyloid A (SAA) after bacterial infusion. The expression levels of these 
cytokines returned to normal within a period of 12 to 24 hours after infusion in 
resistant mares, whilst susceptible mares expressed the cytokines for up to 72 hours.  
Furthermore, it has been reported that Maytenus ilicifolia (M. ilicifolia) can modulate 
a range of inflammatory responses (Souza-Formigoni et al., 1991; Jorge et al., 2004; 
Wonfor et al., 2017). M. ilicifolia, a plant of the family Celastrace, is native to the 
Tropical Atlantic Forest and it has been used in traditional medicine in South 
America in cases of inflammation and gastric ulcer due to its analgesic, anti-
inflammatory and antiulcerogenic activities (Balbach, 1980; Born, 2000; Jorge et al., 
2004). The usage of Maytenus species on inflammation and ulcers can be justified by 
the presence of metabolites such as flavonoids (Leite et al., 2001), condensed tannins 
(Gonzalez and Di Stasi, 2002), triterpenes (Itokawa et al., 1991; Shirota et al., 1994) 
and sesquiterpenes (Itokawa et al., 1991) in Maytenus leaves. It has been 
demonstrated that no apparent toxicity was induced by an acute and chronic 
administration of M. ilicifolia and M. aquifolium in rats and mice (Oliveira et al., 
1991). To date, little research has been carried out to examine the effects of 
Maytenus species in humans and animals and little is known about it. More studies 
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are still needed to confirm the effectiveness of this plant extract to treat and/or 
prevent inflammation and gastric ulcers. Based on other exploratory studies, it is 
hypothesised that they are safe for human and animal use (Oliveira et al., 1991; Jorge 
et al., 2004). Therefore, the effectiveness of M. ilicifolia plant extract as a 
preventative treatment for equine uterine inflammation was assessed in the current 
study as a preliminary pilot study. 
Studies in equine endometritis remain narrow in focus dealing only with a limited 
number of genes. In order to better understand the factors underlying endometritis at 
the level of gene expression, a more extensive transcriptomics research is required. 
Emerging transcriptomic technology offers the opportunity to investigate global gene 
expression in resistant and susceptible mares. Consequently, it will be possible to 
characterize most genes involved in PMIE.  The purpose of this investigation was to 
improve the understanding of the mechanisms underlying uterine inflammation, 
examining the development of PMIE at the level of global gene expression. 
Understanding the link between MIE and PMIE at the broadest level will contribute 
to an early identification of mares susceptible to PMIE, leading to appropriate 
breeding management. Therefore, the objectives were 1) challenge equine 
endometrial explants (n=5) with E. coli lipopolysaccharide (LPS) and 2) preliminary 
investigate the potential anti-inflammatory effect of M. ilicifolia in potentially 
abrogating these responses (n=3).  
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6.2 | Materials and Methods 
6.2.1 |Animals 
Uteri from five native mares in the follicular phase of the oestrous cycle presented 
for euthanasia at an abattoir were collected, as they are known to be resistant to 
PMIE. The age and reproductive history of each mare were unknown. Collection at 
the abattoir were carried out between June and August, which is also the period of 
the year in which mating occurs and, potentially, MIE/PMIE occurs.  
6.2.2 | Sample Collection  
Blood was collected from the jugular vein immediately after death into plain 
vacutainer tubes. Blood samples were stored at 4 
o
C for a period of 24 hours and 
blood serum was used to confirm the phase of the oestrous cycle by measuring 
progesterone concentration. Uteri were collected as soon as possible post mortem 
and stored on ice. Uteri undergoing the follicular phase of the oestrous cycle was 
initially identified by examination at the abattoir as previously described (Chapter 3). 
Briefly, the cervix was physically examined for morphology and the ovaries were 
ultrasonographically assessed for the presence of a dominant follicle and absence of 
a corpus luteum.  Records of criteria used in the abattoir to predict the stage of the 
oestrous cycle and serum progesterone concentrations are described in Table 6.1.  
Endometrial smears were collected from each uteri with the aid of a cytobrush and 
rolled onto microscope slides, following the fixation and staining protocols 
previously described. Cytology slides were prepared and assessed for neutrophil 
counts as previously described in Chapter 3. Mares demonstrated neutrophil counts < 
2 per high power filed (400x), and therefore all uteri were included in the 
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experiment. Furthermore, two endometrial biopsies were taken from the uterine horn 
bifurcation using a sterile biopsy instrument. Biopsies were stored in 1.5 mL of 
RNALater for a period of 24 hours at 4 
o
C. Thereafter, RNALater was then removed 
and the biopsies were frozen at -80 
o
C until RNA extraction.  
Blood samples and uteri were transported on ice back to the laboratory within 7 
hours of collection. At the laboratory, an additional 1x1 cm
2 
biopsy was carefully 
excised from the uterine body of each uterus and stored in 10 mL of Bouin’s fixative 
liquid for subsequent histology. The summary of the pathological and degenerative 
endometrial changes of mares providing endometrial explants for this experiment can 
be found in Appendix 6.1. All mares were kept in the study following the 
histopathological assessment.  
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Table 6.1. Characteristics of uteri from mares sampled at the abattoir used to determine the follicular phase of the oestrous cycle. Information regarding 
ovarian structures, cervical analysis and serum progesterone concentration measured retrospectively.  
 
Mares 
 
Ovaries
a
 
 
Cervix
b
 
Progesterone 
Concentration 
(ng/mL)
 c
 
1 One 40 mm in diameter follicle on right ovary. Smaller follicles 
(around 20 mm in diameter) on left ovary. 
Cervix pink-pale in colour and open appearance. 
Three fingers were passed through the cervix 
0.21 
2 One 47 mm x 37 mm follicle on left ovary. Small follicles on 
right ovary. 
Cervix red in colour, soft and open. Three fingers 
were passed through the cervix. 
0.43 
3 One 30 mm x 41 mm follicle on left ovary. Small follicles 
(around 10mm in diameter) on right ovary.  
Cervix becoming pink, but three fingers were passed 
through the cervix. 
0.54 
4 One 30 mm x 30 mm follicle on left ovary.  Cervix was becoming pink. Two to three fingers were 
passed through the cervical os. 
0.45 
5 One 25 mm in diameter follicle on left ovary.  Cervix was becoming red. Two fingers were passed 
through the cervical os. 
0.86 
a  
Ultrasonographic measurements of ovaries. 
b  
Physical examination of the cervix. 
c  
ELISA serum progesterone analysis for confirmation of stage of the oestrous cycle. 
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6.2.3 | Endometrial Tissue Culture 
At the laboratory, the uterine horns were dissected and the endometrium was 
exposed. Numerous punch biopsies were collected from each uterus, placed into 
warm supplemented Hank’s Balanced Salt Solution (HBSS) and incubated (5 % 
CO2, 38 °C) until cultured, as described in Chapter 3. Immediately after biopsies had 
been collected from all uteri, the samples were removed from the incubator, washed 
twice with unsupplemented HBSS and the tissue culture was initiated.  Before 
placing each punch biopsy into a separate well of the 6-well culture plate, biopsies 
were individually weighed in a Petri dish and the weights were recorded to allow 
prostaglandin F2α (PGF2α) production to be expressed as per mg of tissue. The hexane 
extract from dried ground M. ilicifolia leaves was prepared at Bangor University (Dr 
Vera Thoss and Dr Marc Bouillon) following methods previously described (Jorge et 
al., 2004). Briefly, pulverized M. ilicifolia leaves (1000 g) were extracted with n-
hexane (4 L) in two batches (500 g/ 2 L) via stirring at room temperature for 24 
hours. The solid leaf material was then filtered off and air-dried overnight. The green 
filtrate was concentrated under reduced pressure affording the n-hexane extract as a 
dark green brown sticky solid. The hexane extract was then diluted in absolute 
ethanol to a stock solution of 1 mg/mL.   
The tissue culture was performed in triplicate for each treatment as shown in Figure 
6.1, and plates were incubated at 38 °C in 5 % CO2 for 24 and 48 hours. To induce 
inflammation and address objective 1, E. coli LPS was added to the supplemented 
William’s medium used in the explant tissue culture. Three different concentrations 
of LPS were used: 0.3 µg/mL, 1.0 µg/mL and 3.0 µg/mL. The concentrations of LPS 
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for this experiment were chosen based on previously published explant models of 
uterine inflammation (Nash et al., 2008; Herath et al., 2009; Penrod et al., 2013).  
Explants from mares 2, 3, 4 and 5 were cultured in a total of 3 mL supplemented 
William’s medium without the wire platforms and lens cleaning tissue. As described 
in Chapter 3, some explants were cultured in 4.25 mL of supplemented William’s 
medium on top of a wire platform covered with a lens cleaning tissue during the first 
trial of the tissue culture set up. Mare 1 was one of these animals and due to the 
difficulty of finding mares at the follicular phase of the oestrous cycle, it had to be 
included in the current study. Nonetheless, the concentration of LPS per millilitre of 
medium and the proportion of supplements in William’s medium were identical to 
the cultured explants provided by mares 2, 3, 4 and 5.  
 
Figure 6.1. Tissue culture design for each mare. Samples were cultured in triplicate for 
each treatment for 24 and 48 hours. Samples were challenged with three different 
concentrations of LPS (0.3 µg/mL, 1.0 µg/mL and 3.0 µg/mL). M. ilicifolia was used as a 
pre-treatment before LPS inoculation. 
168 
 
For the objective two, a prophylactic pre-treatment using M. ilicifolia, the culture 
plates had a different time course than that of objective 1: all explants were 
immersed in supplemented William’s medium containing M. ilicifolia alone (100 
µg/mL) for a period of 24 hours. Following the pre-treatment, the medium was 
changed and replaced with fresh new medium containing M. ilicifolia (100 µg/mL) 
alone for the control group, M. ilicifolia (100 µg/mL) or LPS (1.0 µg/mL) for the M. 
ilicifolia and LPS group. The medium was assessed to investigate the endometrial 
secretion of interleukin-10 after challenge with LPS as well as after a 24 hours pre-
treatment with the plant extract M. ilicifolia to inspect its potential anti-inflammatory 
compounds. A sample volume of 200 µL of the control culture medium was 
aseptically collected at 6 hours as well as the medium from explants treated only 
with 1.0 µg/mL LPS and stored at -80 
o
C until assayed. Six hours after the end of the 
24-hour pre-treatment 200 µL of the M. ilicifolia control medium and 200 µL of the 
M. ilicifolia + LPS medium were also collected and stored at -80 
o
C (Figure 6.2). The 
culture time of 6 hours after LPS inoculation was chosen based on another study for 
the investigation of inflammatory cytokine response (Woodward et al., 2013), while 
the M. ilicifolia concentrations were chosen based on previous work (Wonfor et al., 
2017).  
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Figure 6.2. Time scale demonstrating the medium collection for the IL-10 investigation. The start 
of the culture for the control (media alone) and the LPS (1 µg/mL) groups was at 0h, as well as the 
start of the 24-hour pre-treatment with M. ilicifolia alone (100 µg/mL) in the M. ilicifolia control and 
in the M. ilicifolia + LPS wells. After 6 hours, 200 µl of media was collected from the control (media 
alone) and the LPS (1 µg/mL) culture wells. After 24h, the medium from the M. ilicifolia control and 
the M. ilicifolia + LPS wells was removed and replaced with M. ilicifolia alone (100 µg/mL)  and with 
M. ilicifolia (100 µg/mL) + LPS (1 µg/mL). At 30 hours, 200 µl of media was collected from the M. 
ilicifolia control (100 µg/mL) and from the M. ilicifolia (100 µg/mL) + LPS (1µg/mL) wells. 
 
Finally, after periods of 24 or 48 hours, the explants were removed from the tissue 
culture, individually stored in 1.5 mL of RNALater at 4 
o
C for a period of 24 hours, 
removed from the RNALater and frozen at -20 
o
C until RNA-extraction. Once the 
explants were removed, the medium was collected and stored at -20
o
C until PGF2α 
radioimmunoassays. 
6.2.4 | Prostaglandin F2α Radioimmunoassays  
Radioimmunoassays were performed to quantify the PGF2α production by explants 
after antigen challenge bacteria inoculation. Analysis compared the PGF2α 
production between control and the different concentrations of LPS to inform the 
concentration that best induced uterine inflammation thereafter taken forwards to 
RNA extraction, RNA-Sequencing (RNA-Seq) and data analysis. All medium 
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samples were brought to room temperature and 150 µL of the medium from each 
triplicate culture treatment well was pooled. The pooled samples were then diluted in 
0.05 M Tris buffer 1:200 and PGF2α antisera diluted 1:16000. Medium samples were 
run in duplicate and the standard curve was run in triplicate as previously described 
in Chapter 3 and in Appendix 3 (Cheng et al., 2001).  
Briefly, the standard curve was prepared by making up eight standard concentrations 
(5, 2.5, 1, 0.5, 0.25, 0.10, 0.05 and 0.025 ng/mL) by dissolving the stock solution in 
0.05 M Tris buffer. The standard, total binding, total count, buffer blank and test 
tubes were prepared, vortexed and incubated for 16-24 hours at 4 ˚C. The charcoal 
dextran solution (2% activated charcoal, 0.4% dextran) was added to all tubes, except 
total counts. Tubes were vortexed, incubated at 4 ˚C for 10 minutes and centrifuged 
at 1000-1500 x g. The supernatant was decanted into scintillation tubes, scintillation 
liquid was added and each tube was counted as counts per minute. The normalised 
percent bound for each sample was calculated and a standard curve was generated.  
6.2.5 | Endometrial Expression of IL-10  
Prior to performing the IL-10 ELISA, the medium samples from mares 3, 4 and 5 
were allowed to return to room temperature. The technical triplicates from each 
treatment were pooled together and then diluted 1:2 and 1:10 using the diluent 
provided in the kit (EEIL10, Invitrogen, UK). The standards and the samples were 
measured in duplicate.    
The endometrial expression of IL-10 was investigated using a commercially 
available ELISA kit following manufacturers’ instructions. The detection range was 
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90 pg/mL to 25 ng/mL, and the sensitivity of the assay was 90 pg/mL. The plate was 
read using a microliter plate reader (iMark, Bio-Rad) at an absorbance of 450 nm.  
6.2.6 | RNA Extraction and RNA-Sequencing  
LPS 3 µg/mL was the treatment chosen to be taken to RNA-Seq. From all five mares 
providing explants for this experiment, total RNA was extracted from all technical 
replicates at all time points resulting in a total of 75 RNA samples. The Nanodrop 
1000 Spectrophotometer (Thermo Scientific, UK) was used to check RNA 
concentrations and quality of each sample. The samples were also subjected to 
electrophoresis gel for RNA integrity assessment as previously described in Chapter 
3. 
Prior to constructing the libraries, equal concentrations of each technical replicate 
(duplicates for the “0 hours” samples and triplicates for the cultured “24 hours” and 
“48 hours” samples) were pooled into a single RNA sample to diminish oddities in a 
single replicate. The pooled samples had a final concentration of 1500 ng of RNA in 
a total volume of 50 µL. According to the manufacturer’s instructions, the Illumina 
TruSeq Stranded mRNA kit (20020594, Illumina) was used to prepare the dual-
indexed next-generation sequencing libraries. After library construction, each library 
was individually quantified using an Epoch spectrophotometer (BioTek Ltd) and 
finally pooled again at equal concentrations. A Qubit fluorometer (Thermo Fisher 
Ltd) was used to quantify again the pooled DNA and agarose gel electrophoresis was 
used to determine the size of each library (average size of 300bp).  
The pooled library was then diluted to 10 nM and sent to the Wales Gene Park 
(Institute of Medical Genetics, Cardiff University). Paired-ended reads in the format 
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of 2x75bp were performed on the Illumina Hiseq4000 platform at a final dilution of 
8 pM. A first run was performed and the original pool was adjusted for a few 
underperforming samples by increasing the volume, re-quantifying and diluting them 
to 10 nM for transport to Cardiff. 
6.2.7 | Data Processing and Gene Expression Analysis 
Following RNA-Seq, a total of 25 pair-end raw reads were generated. For the quality 
check the reads were analysed using the FastQC software (version 0.11.2) and then 
the TopHat software (version 2.0.14) was used to map the reads to the equine 
reference genome (Equus caballus, EquCab2; GCA_000002305.1, Ensembl 
website). The total read counts for each one of the alignment files created by TopHat 
was retrieved using the equine annotation file (Ensembl website, version 
EquCab2.89). Table 6.2 describes each RNA-Seq sample.  
The RNA-Seq analysis was carried out using the R/Bioconductor DESeq2 package. 
Pairwise analysis between the control and LPS groups were performed at 24 and at 
48 hours, as well as a pairwise analysis of explants treated with LPS between 24 and 
48 hours of treatment. Computer codes used in this chapter are shown in Appendix 
6.2. Differentially expressed genes (DEGs) were then submitted to the Search Tool 
for the Retrieval of Interacting Genes/Proteins (STRING) database (Szklarczyk et 
al., 2015) for retrieval of protein-protein interactions (PPI), network analysis and for 
the discovery of functional gene associations. The Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathways (Kanehisa and Goto, 2000) and the Protein families 
database (PFAM) (Bateman et al., 2000) retrieved from STRING were discussed in 
more detail. PFAM is a protein family database, featuring literature references, 
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functional annotation and database links for each family (Bateman et al., 2000; 
Bateman et al., 2004). 
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Table 6.2. Summary of the 25 RNA-Sequencing samples. 
Sample Mare 
Time 
point
a 
Treatment
b
 Total sequences 
Raw reads
c 
Mapped 
reads
d 
Alignment 
rate
e 
Total 
count
f 
1 1 0h  Fresh  17701562 16121060 90.2% 10141641 
2 1 24h Control   24846417 16743308 66.8% 15154964 
3 1 24h LPS  18398294 16701303 89.8% 11652793 
4 1 48h Control   13704434 12424768 89.7% 9032012 
5 1 48h LPS  19033058 17186376 89.5% 12316918 
6 2 0h  Fresh  11852707 10722543 89.6% 6944685 
7 2 24h Control   17380573 15791770 90.0% 10855899 
8 2 24h LPS  17582079 16040102 90.4% 10729403 
9 2 48h Control   17677426 16145497 90.4% 10900574 
10 2 48h LPS  22268819 20305063 90.3% 13363555 
11 3 0h  Fresh  14933482 13341562 88.4% 8412706 
12 3 24h Control   13993437 12549092 88.9% 8934190 
13 3 24h LPS  17951318 16022104 88.4% 10843436 
14 3 48h Control   18031924 16113863 88.5% 11177998 
15 3 48h LPS  20552807 18188787 87.7% 12589678 
16 4 0h  Fresh  14692121 13114096 88.3% 9142711 
17 4 24h Control   20674149 18426927 88.1% 13465046 
18 4 24h LPS  20621888 18450725 88.5% 12985243 
19 4 48h Control   15338420 13611251 87.8% 9515124 
20 4 48h LPS  15006299 13341941 88.0% 9584447 
21 5 0h  Fresh  13603818 12103539 88.2% 7724509 
22 5 24h Control   16669071 14994157 89.1% 10494651 
23 5 24h LPS  24389709 21883261 88.8% 15743688 
24 5 48h Control   18022900 16289994 89.4% 11567313 
25 5 48h LPS  17575401 15776466 88.7% 11408804 
a  
Specific time-points when explants were removed from culture. 
b 
Fresh samples were collected at the abattoir immediately after death.  
c  
Counts of the total number of sequences processed. 
d
 Number of reads mapped to the annotated equine genome. 
e  
Percentage of reads mapped to the annotated equine genome. 
f 
 Counts of reads assigned to genomic features. 
 
6.2.8 | Statistical Analysis 
The SPSS statistical package (Version 23.0, IBM, USA) was used to perform the IL-
10 data analysis. To assess IL-10 secretion between treatments a linear mixed model 
was used, with treatments (control, LPS 1 µg/mL, M. ilicifolia 100 µg/mL or M. 
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ilicifolia 100 µg/mL + LPS 1 µg/mL) set as fixed factors and horse as a random 
factor. Values were reported as the arithmetic mean ± SEM for each treatment across 
horses. The results were classified as significant where P < 0.05. 
Analysis of PGF2α secretion was also performed using SPSS. Descriptive statistics 
were expressed as the mean ± standard error of the mean (SEM). PGF2α secretion 
concentrations were corrected as ng/mL per milligram of tissue and normalized by 
square root transformation. A linear mixed model was performed to compare PGF2α 
secretion over time and between control and treated explants, where mare were fitted 
as a random effect to control for variation in PGF2α secretion from explants collected 
from different animals. Time point and treatment were fitted as the repeated 
measures. Statistical significance was assumed when P < 0.05. 
For the analysis of DEGs, a negative binomial distribution was used to perform the 
statistical analysis on the RNA-Seq data, performed by the R/Bioconductor DESeq2 
package (Love et al., 2014). The Benjamini-Hochberg (BH) false discovery rate 
(FDR) method (Benjamini and Hochberg, 1995) was used to correct the P value for 
multiple tests. Two tests were performed in total: between control (media alone) and 
LPS challenged explants at 24 hours, and from LPS challenged explants between 24 
and 48 hours. Genes that had readings across all samples lower than 1000 were 
removed from the analysis. The genes were considered differentially expressed at an 
FDR of 0.05.  
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6.3 | Results 
6.3.1 | Prostaglandin F2α Secretion by Challenged Explants 
The PGF2α secretion from control explants (media alone) and explants treated with 
LPS 0.3 µg/mL, LPS 1.0 µg/mL and LPS 3.0 µg/mL are shown in Figure 6.3. The 
statistical analysis outcome for the LPS RIA analysis is that there was no significant 
difference between treatments at either 24 or at 48 hours. However, there was a time 
effect between 24 hours and 48 hours, meaning that the overall production of PGF2α 
at 24 hours differs to the production at 48 hours.  
 
Figure 6.3. Secretion of PGF2α (Mean ± SEM) from equine endometrial explants challenged with 
LPS. Explants were cultured in supplemented William’s medium control ( ), LPS 0.3 µg/mL ( ), 
LPS 1 µg/mL ( ) and LPS 3 µg/mL ( ). After treatment, the PGF2α concentrations were measured at 
24 and 48 h. No significant difference was found between treatments at 24 h or at 48 h post-treatment. 
Values differ between 24 h and 48 h, * P < 0.001 
 
6.3.2 | Endometrial Expression of IL-10 After LPS Inoculation 
Interleukin-10 was expressed by cultured explants (Figure 6.4), however no 
significant differences in IL-10 production were found between the control, LPS 1.0 
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μg/mL treated explants, explants pre-treated with M. ilicifolia 100 µg/mL and M. 
ilicifolia (100 µg/mL) + LPS (1 µg/mL) at 6 hours.  
 
Figure 6.4. Interleukin-10 concentration (Mean ± SEM) of explants cultured in control media, 
challenged with LPS and pre-treated with M. ilicifolia. Control explants were cultured in media 
alone, treated with LPS, treated with LPS (1 µg/mL), pre-treated with M. ilicifolia (100 µg/mL) and 
M. ilicifolia (100 µg/mL) + LPS (1 µg/mL). After treatment, the IL-10 concentrations were measured 
after 6 hours. No significant difference was found between treatments.  
 
6.3.3 | Gene Expression 
The principal component analysis (PCA) plot, Figure 6.5 visually presents each 
sample in the data set, representing the effect of control (media alone) and LPS 
challenged explants over time, as well as the effect of explants collected at 0 hours 
on the count matrix. The cultured explants are clustered together separately from the 
0 hours biopsies, as shown by the first component (PC1). Mare 1 () was the only 
horse where explants for the tissue culture were cultured in 4.25 mL of media instead 
of 3 mL like the other four mares (Mares 2, 3, 4 and 5). It is apparent from the figure 
that the gene count matrix of mare 1 () clustered together with the matrixes of the 
other mares. Taking into account the expected individual differences between 
biological replicates, the plot indicates that the gene expression was not altered by 
the amount of media used in the culture.   
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Figure 6.5. PCA plot of the RNA-Seq data.  Biopsies taken at 0 hours, and explants treated with 
control (media alone) at 24 and 48 hours  or treated with LPS (3 µg/mL) at 24 and at 48 hours. 
Mares 1 (), 2 (), 3 (), 4 () and 5 (). The plot displays each sample in the dataset, 
demonstrating a cluster for samples collected at 0 hours and another cluster for the cultured samples 
(all other colours). 
 
Changes in gene expression between control (media alone) explants and LPS 
challenged explants were compared using the DESeq2 package. The null hypothesis 
for each gene tested using DESeq2 was that there was no difference in its expression 
between the control (media alone) and LPS treated groups at 24 hours. The null 
hypothesis was rejected when the observed difference in expression of a gene was 
greater than expected by random chance (using an adjusted p-value of 0.05). At 24 
hours, 11632 genes were found to be expressed, 2 of which were shown to be 
statistically significantly differentially up-regulated and 3 shown to be statistically 
significantly down regulated in the control relative to the LPS treated group, at an 
FDR of 0.05. The list of the 5 differentially expressed genes can be found in table 
6.3.  
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Table 6.3. Summary of the differentially expressed genes between control and LPS 
challenged explants cultured for 24 hours sorted by p-value.  
Mapped 
gene 
Annotation
a
 Control 24h 
Counts
b
 
LPS 24h 
Counts
c
  
Bonferroni
d
 
ENPP2 
Ectonucleotide pyrophosphatase / 
phosphodiesterase 2 
2071 636 2.11E-06 
SOX13 SRY (sex determining region Y)-box 13 3679 2986 0.025 
IRAK3 Interleukin-1 receptor-associated kinase 3 525 886 0.039 
PLVAP Plasmalemma vesicle associated protein 3832 2089 0.039 
ZC3H12C Zinc finger CCCH-type containing 12C 1377 1974 0.045 
a
 The protein coded by that specific gene. 
b
 The number of reads mapped to a specific gene from control explants. 
c
 The number of reads mapped to a specific gene from LPS-challenged explants. 
d
 Statistical correction for multiple comparisons. 
 
The STRING functional enrichment analysis of the 5 DEGs identified at 24 hours 
between LPS and control explants in culture was performed using the 11632 total 
expressed genes as the statistical background. The statistical background analysis 
was set up using the list of the 11632 genes expressed in the analysis. The protein-
protein interaction (PPI) network p-value was 1, meaning meaning that the list of 
genes was small (i.e. less than 5 or so) or that the list of 5 genes represented a 
random collection that is not well connected. As attested by STRING, this result does 
not determine that the genes are not biologically meaningful.  For this reason, the 
genes found to be differentially expressed between control and LPS at 24 hours 
(Table 6.3) were individually assessed to determine the correlation of each one of 
them to LPS and inflammation.  
The same was assumed for the analysis between 24 and 48 hours after LPS 
challenge. The null hypothesis for each gene tested using DESeq2 was that there was 
no difference in its expression between explants treated with LPS between after 24 
and 48 hours. The null hypothesis was rejected when the observed difference in 
expression of a gene was greater than expected by random chance (using an adjusted 
p-value of 0.05). A total of 11632 genes were also found to be expressed, 66 of 
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which were shown to be statistically significantly differentially up-regulated and 1 
shown to be statistically significantly down-regulated at 24 hours relative to 48 hours 
post-challenge, both at FDR of 0.05 with a Log2FC ≥ ± 2. The STRING functional 
analysis of the DEGs identified between 24 and 48 hours from the LPS challenged 
explants was performed using the 11632 total expressed genes as the statistical 
background. The PPI p-value was 1.0
-16
, indicating interaction enrichment between 
the proteins that are at least partially biologically connected as a group. The 
predicted STRING network was composed of 67 nodes and 200 edges.  
The STRING enrichment analysis of all DEGs when comparing the transcriptome of 
explants treated with LPS at 24 and 48 hours returned a total of 3 enriched PFAM 
and 1 enriched KEGG pathway which are shown in more detail in table 6.4. The 
predicted STRING PPI network is illustrated in Figure 6.6, in which the enrichments 
featured in Table 6.4 are highlighted in different colours. 
Table 6.4. Summary of the functional enrichments in the network retrieved by STRING 
between 24 and 48 hours after LPS challenge sorted by p-value. 
Enrichments
a
 Pathway code
b
 Pathway description
c
 Count
d
 FDR p-value
e
 
PFAM Protein Domains PF00225 Kinesin motor domain 8 1.11 x 10
-7
 
KEGG Pathway 04110 Cell cycle 7 9.8 x10
-4
 
PFAM Protein Domains PF02984 Cyclin, C-terminal domain 4 0.002 
PFAM Protein Domains PF00134 Cyclin, N-terminal domain 4 0.012 
a
 Enrichments from either the KEGG or the PFAM Protein Domains/Families database. 
b
 Identification code from each pathway/database. 
c
 Description of each pathway from either KEGG or PFAM. 
d
 The number of genes involved in each pathway. 
e 
Over-represented p-value with false discovery rate statistical correction for multiple comparisons.  
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Figure 6.6. STRING predicted PPI network of the DEGs between 24 and 48 hours post LPS 
challenge in the tissue culture media. Blue nodes represent genes that belong to the KEGG “Cell 
cycle” pathway, red nodes represent genes that belong to the PFAM “Kinesin motor domain”, green 
nodes represent genes that belong to the PFAM “Cyclin, C-terminal domain” and yellow nodes 
represent genes that belong to the PFAM “Cyclin, N-terminal domain”. The interaction score between 
nodes was set to high confidence (0.7). Disconnected nodes are hidden in the network. 
 
As shown in Table 6.4 the “Cell cycle” was the only significantly enriched KEGG 
pathway with an FDR p-value of 0.00098 and 7 genes involved: BUB1B (BUB1 
Mitotic Checkpoint Serine/Threonine Kinase B), CCNA2 (Cyclin-A2), CCNB1 
(Cyclin-B1), CCNB2 (Cyclin-B2), CDC20 (cell-division cycle protein 20), CDK1 
(Cyclin-dependent kinase 1), and TTK (TTK protein kinase). These genes were up-
regulated with a Log2FC between 2.8 and 3.7. This list of genes involved in the “Cell 
cycle” pathway was fed to the “KEGG Color and Pathway Search” and the pathway 
is shown in Figure 6.7.  
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Figure 6.7. DEGs in the KEGG Cell cycle pathway between 24 and 48 hours after LPS challenge in the tissue culture media. Green boxes are genes in the equine 
transcriptome, but not differentially expressed. White boxes are genes not described as horse KO terms. Yellow boxes are DEGs. Image created using the KEGG Online “Search and 
Color Pathway” tool. G1 and G2 stand for gap phases 1 and 2, respectively. S stands for DNA synthesis phase and M for mitosis phase. 
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6.4 | Discussion 
6.4.1 | Prostaglandin F2α Secretion by Challenged Explants 
There is a relatively small body of literature published on equine endometrial culture 
and biomarkers of inflammation. In vivo, neutrophils are an important process in 
inflammation and their presence in the endometrium is an indicator of inflammation 
(Katila et al., 1990; Pycock and Allen, 1990; Kotilainen et al., 1994; Zerbe et al., 
2003). The lack of peripheral circulation in the tissue culture makes it impossible to 
measure leucocyte infiltration into the endometrium. Consequently, finding other 
markers of inflammation such as prostaglandin F2α production was needed (Nash et 
al., 2010b).  
Previous research findings using radioimmunoassay to determine the PGF2α secretion 
by equine endometrial explants has already reported contrasting results between 
follicular and luteal phases and transitional season explants when challenged with 
0.03 or 3.0 µg/mL LPS and with 10, 10
3 
and 10
5 
killed whole S. zooepidemicus (Nash 
et al., 2008). Transitional season explants challenged with either LPS or S. 
zooepidemicus for 24 and 72 hours did secrete increased concentrations of PGF2α 
when compared to control explants treated with medium alone, in a concentration-
dependant manner. However, follicular and luteal explants did not significantly 
respond to treatment with LPS or S. zooepidemicus (Nash et al., 2008). On the other 
hand, a more recent study demonstrated a PGF2α response after challenging equine 
endometrial cultured explants with 3 µg/mL LPS (Nash et al., 2018), and this is why 
PGF2α was still used as a marker for explant functionality in the current study.  
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Nonetheless, the LPS RIA results of this study are similar to that first described using 
the equine endometrial culture model (Nash et al., 2008). The time difference 
between 24 and 48 hours can somehow be attributed to the great difference between 
individuals, leading to similarities within subject over-time. Also, with the 
continuous LPS stimulation considering that the LPS remained in the tissue culture 
well, a continuous production of PGF2a is expected to happen.  
Based on the concentration used in previous studies (Nash et al., 2018) and taking 
into account the concentration-dependent production of PGF2a (Nash et al., 2010b) 
the LPS 3 µg/mL was the one chosen to be taken forward to RNA extraction, RNA-
Seq and transcriptomic analysis of up and down-regulated genes. Investigation using 
transcriptomic analysis was required to determine whether or not the explants 
challenged with inflammatory inoculants express genes related to the immune system 
and to inflammation pathways. 
6.4.2 | Endometrial Expression of IL-10 After LPS Inoculation 
The potential anti-inflammatory activities of M. ilicifolia in the equine endometrium 
was investigated in vitro in this pilot study by analysing the expression of IL-10 after 
LPS inoculation and after M. ilicifolia pre-treatment followed by LPS inoculation in 
endometrial explants. IL-10 is an anti-inflammatory cytokine that prevents damage to 
the host by regulating the inflammatory immune response to pathogens during 
infection and its analysis is important for the study of persistent endometritis 
(Fumuso et al., 2006). The cultured explants expressed IL-10, however there was no 
significant difference in IL-10 expression between treatments.  
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One source of weakness in this study which could have affected the measurements of 
IL-10 was the number of horses (n=3). Further studies using more biological 
replicates might produce interesting results with a greater degree of accuracy when 
explants are challenged with LPS and pre-treated with M. ilicifolia. On the other 
hand, it appears that endometrial inflammation has not been induced properly, which 
leads to the hypothesis that LPS was not working for some reason.  E. coli LPS is 
considered a potent pathogen-associated molecular pattern that is recognized by 
innate immune cells responsible for inflammatory responses (Tizard, 2013). Thus, 
LPS has been widely used by the research community to investigate immune 
responses both in vivo and in vitro. For example, it has already been demonstrated 
that the gene expression of IL-10 is up-regulated in mares following an 
experimentally induced endometritis using E. coli (Christoffersen et al., 2012). 
However, previous studies have used either E. coli, killed spermatozoa or semen to 
induce endometritis (Fumuso et al., 2006; Christoffersen et al., 2012; Woodward and 
Troedsson, 2013). Therefore, a direct comparison between the results of the current 
study and published studies into equine endometritis are not possible.  
6.4.3 | Gene Expression           
The endometrial explant system was used to induce inflammation by LPS challenge 
in the culture medium to study the mechanisms underlying PMIE in mares at the 
level of gene expression. It is a surprising outcome that only 5 genes were shown to 
be differentially expressed when comparing the explants challenged with LPS and 
the control explants cultured in media alone for the period of 24 hours. 
This study has identified the IRAK-3 gene to be up-regulated in the tissue explants 
after LPS treatment for a period of 24 hours. The IRAK3 is part of the IL-1 receptor 
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associated kinases (IRAK) and it is mainly expressed in cells of monomyeloic origin 
(Wesche et al., 1999). Previous research findings into the IRAK family confirmed 
that their members are indeed involved in lipopolysaccharide signal transduction 
(Wesche et al., 1999). It has already been reported by numerous studies that IRAK1, 
IRAK2 and IRAK4 are involved in the IL-1R1 and TLR signalling pathways 
(Kanakaraj et al., 1998; Thomas et al., 1999; Suzuki et al., 2002; Suzuki et al., 
2003). IRAK-1 and IRAK-4 are positive TLR signal transducers and IRAK-1 and 
IRAK-2 take part in the activation of the NF-κB transcription factor (O'Neill and 
Greene, 1998; Kobayashi et al., 2002). IRAK-3 is induced by TLR stimulation, 
however, it negatively regulates the TLR signalling, being involved in the initiation 
of endotoxin tolerance. After persistent LPS stimulation, it has been demonstrated 
that IRAK-3 is indeed a key component in inducing LPS tolerance, maintaining the 
innate immune system homeostasis by negative regulating the TLR signalling 
(Kobayashi et al., 2002).  
Another study looked at the IRAK-3 expression after LPS stimulation in 
macrophages in cell culture (Lyroni et al., 2017). It also supports the idea that IRAK-
3 is involved in the mechanisms of endotoxin tolerance. It demonstrated that in the 
case of acute inflammation induced by LPS, IRAK-3 is induced within 24 hours of 
culture. However, during continuous LPS stimulation that occurred in that cell 
culture study, considering that the LPS stayed continuously in the cell culture 
medium, the transcriptional activation of IRAK-3 has been silenced after 24 hours to 
enable the cells to return to homeostasis and to be responsive (Lyroni et al., 2017).  It 
is suggested that this also happened in the current study as LPS was maintained in 
the medium where explants were cultured. IRAK might be induced by the LPS 
challenge, which in turn is dampening down the TLR pathway response so that a 
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large inflammatory response in healthy mares does not happen and therefore 
persistent inflammation is avoided to allow fertilisation to occur. Perhaps in 
susceptible mares the IRAK response does not lead to a dampening down of the TLR 
pathway and inflammation is free to persist. Nonetheless, not much is known about 
the transcriptional regulation of IRAK-3, therefore future studies are needed to 
determine how IRAK-3 interacts with other IRAK molecules and to better 
understand its role in inflammation (Zhou et al., 2013; Lyroni et al., 2017). Another 
hypothesis is that, as indicated by PGF2α, the cultured explants did not respond to 
LPS challenge. This might explain why other members of the TLR pathway were not 
differentially expressed in this study.   
The second up-regulated gene after LPS challenge at 24 hours was the ZC3H12C 
gene that encodes the Zinc Finger CCCH-Type containing 12C protein. To date, a 
study has demonstrated that the CCCH-zinc finger protein family participates in the 
macrophage activation (Liang et al., 2008). A previous in vitro study showed that the 
inflammatory cytokine TNFα induces the expression of ZC3H12C in cultured 
endothelial cells. When overexpressed, ZC3H12C significantly inhibits the 
endothelial cell inflammatory response by attenuating the expression of chemokines 
such as MCP-1 (Monocyte chemoattractant protein-1), IL-8, VCAM-1 (Vascular cell 
adhesion protein 1), ICAM-1 (Intercellular adhesion molecule 1) and E-selectin 
(selectin cell adhesion molecule) as well as inhibiting the NF-κB signalling pathway 
(Liu et al., 2013).  
It is established that organisms do not benefit from uncontrolled inflammation and 
that it leads to tissue impairment, therefore negative feedback mechanisms usually 
take place to control inflammatory responses caused by pathogens (Liang et al., 
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2008). IL-8 is a key chemokine in endometritis, attracting neutrophils to the uterus, 
which are the main effector cells of inflammation in endometritis (Fumuso et al., 
2006). Based on the previous research findings discussed above, if expression of 
ZC3H12C attenuated IL-8 in the healthy mares used in this study, it could mean that 
susceptible mares that do not upregulate this gene have a high IL-8 response and 
therefore neutrophil influx to the uterus, resulting in a massive persistent uterine 
inflammation. It is possible that ZC3H12C plays an anti-inflammatory role in the 
vascular endothelial cells in vitro (Liu et al., 2013), however further research is 
needed to elucidate the mechanisms in which they regulate inflammation in vivo and 
in vitro for endometrial explants.   
The ENPP2, also known as autotaxin, was down-regulated after the 24 hours LPS 
inoculation. It is responsible to convert extracellular lysophosphatidylcholine to 
lysophosphatidate (LPA), where the latter is linked to inflammatory pathways 
(Brindley et al., 2013; Benesch et al., 2014; Benesch et al., 2015a). Injury and 
inflammation cause autotaxin to be produced, and its levels decrease with the 
resolution of tissue repair (Benesch et al., 2014; Benesch et al., 2015b). It is known 
that the healing cycle is disrupted by prolonged inflammation and a high autotaxin 
concentration leads to various inflammatory pathological conditions (Nikitopoulou et 
al., 2012; Hozumi et al., 2013; Benesch et al., 2014; Benesch et al., 2015a).  
Therefore, a down-expression of autotaxin in healthy mares in this study suggests 
that the inflammation has already been resolved. It can then be hypothesised that 
mares susceptible to PMIE who do not down-regulate this gene have an intense and 
prolonged inflammatory response, leading to persistent uterine inflammation. 
Nonetheless, more research into the mechanism of autotoxin is needed, since it is 
189 
 
also involved in numerous metabolic pathways. It is important to understand whether 
a down-regulation of autotaxin is linked to metabolism or immunity (Knowlden and 
Georas, 2014). 
The SOX13 gene was down-regulated after the 24 hours LPS inoculation. It is one of 
the members of the SOX family transcription factors that are related to development 
processes such as sex determination, cell proliferation, survival, differentiation and 
maturation in different cell lineages and also related to human genetic diseases 
(Wegner, 1999; Wang et al., 2006; Lefebvre, 2010). It has been reported that SOX13 
is linked with the emergence of gammadelta T cells in the thymus (Lefebvre, 2010). 
Gammadelta T cells can secrete pro-inflammatory cytokines such as IL-17, which 
plays a role in host defense against microorganisms and takes part during infection 
(Papotto et al., 2017; Veldhoen, 2017). Therefore, a down-regulation of SOX13 in 
healthy mares means a lower emergency of gammadelta T cells and consequently a 
decrease in cytokine secretion. This happening at 24 hours after LPS challenge can 
suggest that inflammation has already been resolved by this time. On the other hand, 
PMIE susceptible mares might have an up-regulation of SOX13, leading to a higher 
emergency of gammadelta T cells and a consequent greater production of cytokines 
to tackle inflammation.  
The PLVAP gene, also called PV-1, was also down-regulated after LPS challenge. It 
encodes the Plasmalemma Vesicle Associated Protein, which is a cell-specific 
protein related to transport across the endothelium. Therefore PLVAP is expressed 
by a subset of normal microvascular endothelial cells (ECs) creating trans-
endothelial channels and fenestrae (Stan et al., 2004; Niemela et al., 2005). It has 
been suggested that PLPVAP might have a role in inflammation, specifically in the 
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leukocyte transendothelial migration (Keuschnigg et al., 2009; Rantakari et al., 
2015). In vitro capillary flow assays demonstrated that PLPVAP contributes to the 
transcellular migration of leukocytes by diminishing the resistance through 
membrane fusion. Indeed, in vivo studies also showed that blockage of PLPVAP in a 
peritoneal inflammation reduced by approximately 85 % the migration of leukocytes 
overall, in special the neutrophil invasion was inhibited by 65 % (Keuschnigg et al., 
2009). A down-regulation of PLVAP in healthy mares in this study might suggest 
that susceptible mares who do not down-regulate this gene have an aggravated 
inflammatory response in the uterus by increasing leukocyte trafficking.  
Between 24 and 48 hours after LPS inoculation, the differential expression analysis 
demonstrated an up-regulation of the cell cycle KEGG pathway (Table 6.4). The cell 
cycle is divided in DNA synthesis (S) and mitosis (M) phases, with two gap phases 
(G1 and G2) in the order G1/S/G2/M (Nurse, 2000; Rhind and Russell, 2012) as 
demonstrated in Figure 6.7. The progression through the cell cycle, in most cell 
types, is run by the interaction of numerous molecules such as cyclins, cyclin-
activating kinases (CAKs), cyclin-dependent kinases (CDKs) and cyclin-dependent 
kinase inhibitors (CDKIs) (Sherr and Roberts, 1995; Tusell et al., 2005). Within the 
cell cycle progression, cyclins and the CDKs classes of protein determine whether 
cells proceed through the cells cycles of cells endure in a state of arrest (Sherr, 1996; 
Meijer et al., 1997; Tian et al., 2007). Therefore, the enriched PFAM domains are 
also linked to the cell cycle KEGG pathway. 
It has been demonstrated in a preliminary study that a selective cyclin-dependent 
kinase inhibitor significantly suppressed the expression of proinflammatory 
cytokines (Tian et al., 2007), while another showed that cell cycle inhibition reduces 
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inflammatory responses after traumatic brain injury (Skovira et al., 2016). The 
healthy pony mares used in the current study, known to be resistant to persistent 
uterine inflammation, were in the follicular phase of the oestrous cycle when immune 
responses are up-regulated. Therefore, it is thought that between 0 and 24 hours after 
LPS challenged the response was mounted, tackled inflammation and returned to 
normal by 24 hours. On the other hand, it is surprising that no immune genes were 
changed between 24 and 48 hours of LPS challenge, since it is known that most 
mares take up 48 hours after challenge to clear the uterine inflammation induced by 
semen and/or sperm. Therefore, it is also hypothesised that LPS was not working 
properly.   
6.5 | Conclusion 
In conclusion, this study provided preliminary information on the endometrial 
transcriptome modulation when explants are challenged with E. coli LPS in vitro. 
Surprisingly, there was no significant production of PGF2α as a marker of 
inflammation following LPS challenge and explants showed very little difference in 
expression of genes related to inflammation when compared to the baseline set in 
Chapter 4. 
Considering that the mares providing explants to this experiment were free of 
inflammation and thought to be resistant to persistent endometritis, the up-regulation 
of IRAK-3 suggests that during the first 24 hours of LPS inoculation, the 
endometrium was already resolving the inflammation and maintaining the innate 
immune system homeostasis by maybe producing tolerance to LPS. However, 
IRAK-3 was not up-regulated after 24 hours, agreeing with the result from previous 
in vitro research where LPS was maintained in the culture medium, that the 
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expression of IRAK-3 stops after 24 hours to allow the cells to be responsive again in 
case of a chronic explosion to LPS (Lyroni et al., 2017). Similarly, the up-regulation 
of the ZC3H12C gene and the down-regulation of the ENPP2, SOX13 and PLPVAP 
genes after 24 hours of LPS inoculation lends further evidence to the hypothesis that 
by the end of the 24 hours the explants were already resolving the inflammation 
induced by LPS. The gene expression analysis between 24 and 48 hours after LPS 
inoculation retrieved a list of up-regulated genes related to the cell cycle. There is 
still limited knowledge regarding the linkage of cell cycle pathways, inflammation 
and endotoxin. However, this study suggests that by this time the inflammation 
caused by LPS was already resolved and that the cultured explants were again in 
homeostasis, therefore the only significant differentiated pathways were the ones 
related to the cell cycle.  
These findings agree with the literature, where mares are considered resistant to 
PMIE when they clear the uterus of the normal transient inflammatory response 
within 48 hours after mating, sometimes at around 12-24 hours (LeBlanc et al., 1994; 
Troedsson, 1999, 2006; Christoffersen et al., 2012). Nonetheless, further research 
could focus on how the equine endometrial transcriptome is modulated after LPS 
challenge at earlier time points of inflammation such as 6 and 12 hours using the 
explant culture model described in this study. Using an earlier and broader range of 
time points after inflammation starts might shed more light on the inflammatory 
pathways expressed during endometritis before the inflammation is resolved. Further 
research could also study how the response is different in explants collected from 
susceptible mares. The five genes found to be over-expressed in this study, IRAK-3, 
ZC3H12C, ENPP2, SOX13 and PLPVAP might be interesting candidates to focus 
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upon when conducting future studies into LPS-induced persistent endometritis in 
mares.  
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CHAPTER 7 
 
 
CHARACTERIZATION OF TRANSCRIPTOMIC 
PROFILES OF MARES RESISTANT AND 
SUSCEPTIBLE TO PMIE IN VIVO AND EX VIVO 
 
  
195 
 
7.1 | Introduction 
A normal, transient uterine inflammation occurs in mares after natural mating or 
artificial insemination caused by many factors such as spermatozoa, seminal 
components, debris and bacteria (Troedsson et al., 1999; Watson, 2000; Katila, 2001; 
Troedsson et al., 2001a). This normal inflammation, known as mating-induced 
endometritis (MIE), is needed to cleanse the uterine environment and allow embryo 
survival (Troedsson, 2006; Troedsson and Woodward, 2016; Christoffersen and 
Troedsson, 2017).  However, some mares fail to clear the MIE and it consequently 
becomes a persistent inflammation called persistent mating-induced endometritis 
(PMIE), causing subfertility in mares (Watson, 2000; Troedsson, 2006). Lower 
pregnancy rate in mares suffering from PMIE causes expensive losses to the horse 
breeding industry (Riddle et al., 2007). 
Based on their ability to clear uterine inflammation and infection, mares are 
classified as resistant or susceptible to PMIE. Mares are considered resistant to PMIE 
when they clear the uterus off the normal transient MIE within 36-48 hours post-
challenge, while susceptible mares fail to clear inflammation and remain with 
intrauterine fluid after this period of time (Katila, 1995; Troedsson, 1999). 
Traditionally, endometritis has been diagnosed based on mare’s history, evidence of 
fluid within the uterine lumen during physical examination of cervix and vagina and 
laboratory diagnostic aids such as uterine culture, cytology and biopsy (LeBlanc and 
Causey, 2009). The uterine biopsy grading system (Kenney, 1978; Kenney and Doig, 
1986) has been regularly used and proved to be an effective method to indicate the 
presence or absence of MIE and PMIE in mares (Troedsson et al., 1993a; Fumuso et 
al., 2003; Woodward et al., 2012). However, these methods of diagnosis can only be 
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used after mating, when the inflammation is already present and may lead to 
infertility.  
The endometrium is a mucous membrane, and the innate immune response is the 
main immunological response to inflammation along with myometrial contractions to 
mechanically clear the uterine environment (Troedsson, 2006; Christoffersen and 
Troedsson, 2017). Research has focused on the factors associated with resistance and 
susceptibility to PMIE in mares, demonstrating that cytokines contribute to the 
pathogenesis of persistent endometritis induced by mating or by bacterial inoculation 
(Fumuso et al., 2003; Christoffersen et al., 2010; Christoffersen et al., 2012; 
Woodward et al., 2013). It is also known that seminal plasma proteins modulate the 
innate immune response by up-regulating the expression of interleukin (IL) 8 and IL-
1β in susceptible mares, while this regulation does not happen in resistant mares 
(Fedorka et al., 2016; Fedorka et al., 2017).  
However, the global gene expression underlying resistance before bacteria or semen 
reach the endometrium is still unclear. Therefore, the aim of this study was to 
identify differentially expressed genes (DEGs) between mares resistant and 
susceptible to PMIE before mating occurs, acting as a baseline for global 
transcriptome profile before a challenge has been applied to underlie the mechanisms 
involved in resistance and susceptibility.  
7.2 | Materials and Methods 
7.2.1 | Animals 
Uteri from resistant native mares (n=3) in the follicular phase of the oestrous cycle 
were collected at an abattoir immediately after death. The age and reproductive 
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history of each mare were unknown. Biopsies from Finnhorse mares (n=3) thought to 
be susceptible to PMIE were collected during the follicular phase of the oestrous 
cycle. This procedure was performed at the Field Station for Equine Research, 
Resources Institute Finland approved by the National Animal Experiment Board 
Finland (Approval no. ESAVI/4961/04.10.06/2015). 
7.2.2 | Sample Collection  
Resistant (ex vivo) mares 
Sample collection from native pony mares was performed following the protocol 
described in Chapter 3. Briefly, blood was collected directly from the jugular vein 
immediately post-mortem and stored at 4 
o
C for 24 hours, followed by blood serum 
separation by centrifugation and serum progesterone analysis to confirm the phase of 
the oestrous cycle at the time of the death. Records of criteria used in the abattoir to 
predict the stage of the oestrous cycle and serum progesterone concentrations for 
each animal are described in Table 7.1. 
At the abattoir, cytology samples were collected with the aid of a cytobrush as 
previously described (Chapter 3), and all mares were free of uterine inflammation 
(neutrophil count < 2 per high power filed). Immediately after death, biopsies were 
collected in duplicate from each uterus and stored in 1.5 mL of RNALater at 4 
o
C for 
a period of 24 hours, followed by RNALater removal and sample storage at -80 
o
C 
until RNA extraction. At the laboratory, a 1x1 cm
2
 biopsy from the uterine body was 
taken and stored in 10 mL of Bouin’s fixative liquid for a period of up to 6 months. 
Histology procedure was carried out as previously described (Chapter 3) and 
analysed by a Boarded Pathologist for pathological and/or degenerative endometrial 
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changes. Native pony mares were used as an example of PMIE resistant mares. The 
evidence is anecdotal, but in practice PMIE is very rarely observed in ponies; 
therefore, they are known to be resistant. Furthermore, all mares in this group were 
classified as Category I in the biopsy grading system (Appendix 7.1).  
Susceptible (in vivo) mares 
Paired endometrial biopsies were obtained from Finnhorse mares with a history of 
chronic endometritis and fluid accumulation but free of active inflammation the time 
of collection, from the Natural Resources Institute Finland, using a sterile biopsy 
instrument. Mares were classified as susceptible to PMIE based on their clinical 
history (Table 7.2).  
Biopsies for RNA-Sequencing (RNA-Seq) were placed into 1.5 mL of RNALater 
immediately after collection for a period of 24 hours at 4 
o
C followed by RNALater 
removal and sample storage at -80 
o
C. Samples were posted to Aberystwyth 
University (Wales, United Kingdom) by airmail while frozen in dry ice. Biopsies for 
histopathologic analysis to confirm the susceptibility of mares collected at the same 
time were placed in formalin immediately after collection for a period of 2-4 weeks 
and then replaced by 70 % ethanol. Samples intended for histopathology analysis 
were sent to Aberystwyth University (Wales, United Kingdom) at room temperature 
via airmail. Histology procedure was performed as previously described (Chapter 3) 
and the pathological endometrial changes were analysed by a Boarded Pathologist 
(Appendix 7.1). 
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Table 7.1. Summary of resistant mares sampled at the abattoir. Information regarding ovarian structures, cervical analysis and serum progesterone 
concentration.  
 
Mares 
 
Ovaries
a
 
 
Cervix
b
 
Progesterone 
Concentration 
(ng/mL)
 c
 
1  One 41 mm x 32 mm follicle on left ovary. Small follicles 
(around 7 mm in diameter) on right ovary. 
Cervix is pale in colour. Two fingers were passed through 
cervix 
1.95 
2  One small (10 mm in diameter) follicle on left ovary. One 
33mm x 37 mm on right ovary. 
Cervix is pale in colour. Three fingers were passed through 
cervix. 
0.16 
3  One 40mm in diameter follicle on right ovary. Smaller 
follicles (around 20 mm in diameter) on left ovary. 
Cervix had a pink-pale colour and had an open appearance. 
Three fingers were passed through the cervix 
0.21 
a  
Ultrasonographic measurements of ovaries. 
b  
Physical examination of cervix. 
c 
 Serum progesterone analysis for confirmation of stage of the oestrous cycle. 
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Table 7.2. Clinical history of susceptible mares.  
 
Mares 
 
Clinical history 
4  Born in 1999. Foaled 2009 and 2010 but did not conceive in 2006 and in 2010. Presence of cloudy uterine fluid during the follicular phase on 3 
occasions in 2013. In 2014, presence of clear fluid (30 x 30 mm) during 3 follicular phases. In 2015, one occasion of cloudy fluid (15 x 70 mm) 
but no samples were taken for further analysis. Nothing remarkable in 2016 and 2017. 
5 Born in 2000. Foaled 2010 and 2011. Did not conceive in 2014 (inseminated in 5 follicular phases, followed by 41 examinations). In 2014 there 
was the presence of cloudy fluid accumulations after artificial insemination (AI) in the second to fourth follicular phases. Uterine lavage and 
administration of oxytocin were performed in 3 follicular phases, but no swabs or cultures were done. Seven examinations and 2 AI were 
performed in 2015, with no accumulation of fluid. A total of 9 examinations were carried out in March 2017, followed by 3 AI in one follicular 
phase followed by increasing amounts and echogenicity of fluid. However, in August 2017 there was no fluid accumulation.  
6  Born in 2003, but not used for breeding. Twenty-five examinations were carried out in 2011, where cervical bleeding was caused by a student 
and then cloudy fluid (60 x 80 mm) was present on one occasion after that. Six examinations were carried out in 2012, revealing a very tight 
cervix and clear fluid accumulations (25 x 30 mm) during one follicular phase. An intrauterine saline infusion in March 2013 led to cloudy fluid 
accumulation. Uterine lavage performed in April found neutrophils. Another uterine lavage with penicillin was performed in May and the content 
was clean, however, the cervix was extremely tight during the follicular phase. In 2014, an episode of endometritis was induced by a deep AI. No 
treatment was performed and no fluid accumulations happened from March to August. Six examinations were carried out in 2017 and fluid 
accumulation (maximum of 35 x 50 mm) was present once during one follicular phase and twice during the early luteal phase. 
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7.2.3 | RNA Extraction and RNA-Sequencing  
Following the methods described in Chapter 3, total RNA was extracted from tissue 
harvested from all mares, resulting in a total of 6 RNA samples. The quality and 
concentration of each RNA sample were checked by Nanodrop spectrophotometer 
and RNA integrity was assessed by agarose gel electrophoresis as previously 
described. Each RNA sample was diluted in DNAse/RNAse-free water to a final 
concentration of 1500 ng of RNA in a total volume of 50 µL.  
RNA samples were processed and sent to RNA-Seq. Briefly, dual-indexed next-
generation sequencing libraries were prepared, quantified using an Epoch 
spectrophotometer and pooled at equal concentrations. Pooled libraries were 
quantified a second time using Qubit fluorometer and size determined via agarose gel 
electrophoresis, with an average of 300 base pairs (bp). Following a dilution to 10 
nM, pooled libraries were sent to RNA-Seq in Wales Gene Park (Institute of Medical 
Genetics, Cardiff University). Pooled samples were paired-end sequenced in 2 x 75 
bp format on an Illumina HiSeq4000 platform at a final dilution of 8 pM.  
7.2.4 | Data Processing and Gene Expression Analysis 
A total of 6 pair-ended raw reads were generated after RNA-Seq, shown in Table 7.3. 
As previously described in Chapter 3, the quality of the reads was checked using the 
FastQC software (version 0.11.2), followed by the use of the TopHat software 
(version 0.11.2) to map the reads to the equine reference genome (Equus caballus, 
EquCab2; GCA_000002305.1, Ensembl website). The equine annotation file 
(Ensembl website, version EquCab2.89) was used along with the FeatureCounts 
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package (version 1.5.2) to summarize the number of aligned reads per exon for each 
sample.  
The R/Bioconductor DESeq2 package was used to perform the differential gene 
expression analysis between resistant and susceptible mares. Computer codes used in 
this chapter are shown in Appendix 7.2. The Ensembl gene ID’s from the 
differentially expressed genes (DEGs) were submitted to the Search Tool for the 
Retrieval of Interacting Genes/Proteins (STRING) data base (Szklarczyk et al., 2015) 
to retrieve the predicted protein-protein interactions (PPI) network analysis and 
enrichment discovery of Gene Ontology (GO) terms (Ashburner et al., 2000) and 
Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa and Goto, 2000) 
pathways. 
Table 7.3. Summary of the 6 RNA-Sequencing samples.  
Mare
 
Total sequences raw reads
a 
Mapped reads
b 
Alignment rate
c 
Total count
d 
1  
 
 
14732999 13093630 88.0% 8189448 
2  20944446 18583416 87.8% 12011433 
3  17701562 16121060 90.2% 10141641 
4  21859635 19667469 89% 13089310 
5  16730252 15179851 90% 10096188 
6  19196009 17395595 89.7% 12114955 
a  
A count of the total number of sequences processed. 
b  
Number of reads mapped to the annotated equine genome. 
c  
Percentage of concordant reads mapped to the annotated equine genome.
 
d 
 Counts of reads assigned to genomic features. 
 
 
7.2.5 | Statistical Analysis 
The analysis of DEGs was performed using the negative binominal distribution 
performed by the DESeq2 package (Love et al., 2014). The differential gene 
expression between the resistant ex vivo relative to the susceptible in vivo samples 
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was performed. Differential expression was determined using the Benjamini-
Hochgerg (BH) false discovery rate (FDR) (Benjamini and Hochberg, 1995) method 
with an adjusted P < 0.05. Genes featuring less than 1000 reads across all samples 
were excluded from the enrichment analysis. DEGs were analysed with respect to 
KEGG pathways and GO terms.  
7.3 | Results 
The gene expression variation between samples was visually inspected based on 
principal component analysis (PCA) as shown in Figure 7.1. The PCA analysis 
confirmed that resistant mares cluster together, represented by the red colour. 
Susceptible mares are represented by the blue colour. Mares 4 and 5 cluster together 
while mare 6 shows a bigger variance. Mares 4 and 6 had their susceptibility to 
endometritis confirmed by the biopsy category III (Appendix 7.1), while mare 5 was 
classified in Category I.  
 
Figure 7.1. PCA plot of the gene expression profiles for the six mares analysed. The two 
colours represent biopsies from susceptible mares and resistant mares. Mares 1 (●), 2 (▲), 
3 (■), 4 (), 5 () and 6 (). 
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The null hypothesis for each gene tested using DESeq2 was that there was no 
difference in its expression between PMIE resistant and susceptible groups before 
breeding. The null hypothesis was rejected when the difference in gene expression of 
a gene was greater than expected by random chance (using an adjusted p-value of 
0.05).  
A total of 17042 genes were found to be expressed, 56 of which were statistically 
significantly differentially up-regulated, and 122 genes were shown to be statistically 
significantly differentially down-regulated in the resistant relative to the susceptible 
group, at an FDR of 0.05. The STRING functional enrichment analysis of DEGs was 
performed using the 17042 total expressed genes as the statistical background. The 
PPI p-value was 1.4 x 10
-4
, indicating that the genes are biologically connected as a 
group since the predicted network has significantly more interactions than expected 
when a similar size of random genes is analysed. The predicted STRING network 
was composed of 175 nodes and 159 edges. 
The STRING enrichment analysis of all DEGs when comparing the transcriptome of 
resistant relative to the susceptible mares returned a total of 31 significantly enriched 
pathways were observed for the “molecular function” and “cellular component” GO 
categories (Appendix 7.3). The 10 most enriched GO terms are shown in more detail 
in Table 7.4. Also, a total of 6 significantly enriched KEGG pathways were 
observed, which are described in Table 7.5.  
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Table 7.4. Summary of the 10 most enriched GO terms. Comparing the transcriptome of 
resistant mares relative to the transcriptome of susceptible mares sorted by p-value. Table 
created using the STRING website. 
GO Category
a
 Term name
b
 Description
c
 Count
d
 
FDR p-
value
e
 
Cellular component GO.0005737 Cytoplasm 10 8.86 x 10
-6
 
Cellular component GO.0044464 Cell part 11 8.86 x 10
-6
 
Cellular component GO.0005623 Cell 11 9.38 x 10
-6
 
Cellular component GO.0005622 Intracellular 10 1.08 x 10
-5
 
Cellular component GO.0005575 Cellular component 11 3.48 x 10
-5
 
Cellular component GO.0016020 Membrane 8 6.80 x 10
-5
 
Cellular component GO.0043226 Organelle 8 1.35 x 10
-4 
 
Molecular function GO.0003674 Molecular function 11 1.37 x 10
-4
 
Cellular component GO.0044444 Cytoplasmic part 7 3.27 x 10
-4
 
Cellular component GO.0043227 Membrane-bounded organelle 7 4.83 x 10
-4
 
a
 GO domain (cellular component, biological process or molecular function). 
b
 Term associated with gene ontology biological processes. 
c 
Description of each GO category. 
d 
The number of genes involved in each biological process term. 
e 
Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
Table 7.5. Summary of the 6 enriched KEGG pathways. Comparing the transcriptome of 
resistant mares relative to the transcriptome of susceptible mares sorted by p-value. Table 
created using the STRING website. 
Pathway code
a
 Description
b
 Count
c
 FDR p-value
d
 
05323 Rheumatoid arthritis 8 0.000 
05168 Herpes simplex infection 10 0.002 
01100 Metabolic pathways 26 0.006 
05164 Influenza A 8 0.012 
04145 Phagosome 7 0.029 
05140 Leishmaniasis 5 0.029 
a
 KEGG pathway identification code. 
b
 Description of each KEGG pathway. 
c
 The number of genes involved in each pathway. 
d
 Over-represented p-value with false discovery rate statistical correction for multiple comparisons. 
 
Although no enrichment of pathways related to pathogen recognition receptors, 
chemokines or antimicrobial peptides were observed, in isolation, genes related to 
the immune system were differentially expressed when comparing the transcriptome 
of resistant mares relative to susceptible mares. Genes coding for toll-like receptor 
(TLR4), chemokine (C-C) ligand family (CCL5), interferon regulatory factor (IRF7) 
and transcription factor (AP-1) were up-regulated in resistant mares in relation to 
susceptible mares, showing Log2 fold changes (Log2FC) between 1.3 and 2.9.  
206 
 
7.4 | Discussion 
By analysing the gene expression profiles of each mare in the PCA plot (Figure 7.1), 
not all susceptible mares demonstrated expression profiles that could be clustered 
together. Mare 6 showed a considerable variation when compared to mares 4 and 5. 
Mare 6 has a clinical history of endometritis and showed a biopsy category III, 
confirming its susceptibility to PMIE. Mare 5 also has a clinical history of 
endometritis; however, it had a category I biopsy score. Kenney (1978) attests that 
improvement in the inflammatory status of the endometrium can happen as 
demonstrated by repeated biopsies. It is therefore hypothesised that the endometrium 
of mare 5 was classified as category I even though its clinical history attested its 
susceptibility to PMIE due to episodes of prolonged fluid accumulation after 
artificial insemination.   
When comparing the transcriptome of resistant mares relative to the transcriptome of 
susceptible mares, a total of 179 genes were shown to be statistically significant 
differentially expressed. Cellular components and metabolic pathways were the two 
biological niches mostly retrieved from the enrichment analysis as previously shown 
in Tables 7.4 and 7.5. Nonetheless, this study aimed to understand how the gene 
expression modulates resistance and susceptibility to PMIE. Thus, each one of the 
four up-regulated DEGs related to the immune function was discussed in more detail.  
The AP-1 is a family of transcript factors that participate in cell proliferation control, 
survival and death (Shaulian and Karin, 2001). However, many other stimuli such as 
serum, growth factor, tumour necrosis factor (TNF-α) and interleukin (IL) 1 can 
potently induce AP-1 activity (Lamph et al., 1988; Ryder and Nathans, 1988; 
Brenner et al., 1989; Muegge et al., 1989). The AP-1 response to proinflammatory 
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cytokines such as TNF-α and IL-1 and toll-like receptors such as TLR4 suggest its 
involvement in inflammation and innate immune response (Grimm and Baeuerle, 
1993; Chang and Karin, 2001; Shaulian and Karin, 2001). It is hypothesised that 
during an episode of MIE in resistant mares proinflammatory cytokines will induce 
AP-1 activity, which will then produce transcription factors and regulate gene 
expression related to inflammation to help them resolve MIE before it turns into 
PMIE. 
Chemokines are involved in leukocyte chemotaxis and activation during 
inflammation (Tizard, 2013). However, besides acting during pathological 
conditions, chemokines are also involved in physiological conditions (Rossi and 
Zlotnik, 2000; Ning et al., 2011). Therefore, it can be suggested that a physiological 
up-regulation of CCL5 in resistant mares compared to susceptible ones makes them 
more resistant to a persistent inflammatory response caused by semen and/or bacteria 
entering the uterus during breeding.  
To date, there appears to exist only one study comparing the gene expression 
between resistant and susceptible mares before breeding but focusing on specific 
genes previously identified to be associated with acute endometritis (Marth et al., 
2018). It showed a higher expression of CCL2 in susceptible mares compared to 
resistant, but they did attest that presence of bacteria in some of the samples from 
PMIE susceptible mares might have increased the expression of some genes. Both 
CCL2 and CCL5 act in the immune context through their monocyte recruiting 
activities (Soria and Ben-Baruch, 2008). However, it has been shown that regulation 
of CCL5 expression is complex, involving a stimulus and also a tissue specific 
activation of transcription factors (Fessele et al., 2001). Therefore, it is hypothesised 
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that a higher expression of CCL5 in the resistant compared to susceptible mares’ 
endometrium makes them more resistant to a persistent inflammatory response, while 
the endometrium of susceptible mares is not able to express enough CCL5.  
Toll-like receptors are pattern recognition receptors (TLRs), taking part in pathogen 
detection acting as the first step in the host’s defence (Tizard, 2013). 
Lipopolysaccharides (LPS) from gram-negative bacteria such as Escherichia coli (E. 
coli) are recognized by TLR4, a transmembrane molecule (Chow et al., 1999; 
Takeuchi et al., 1999). Taking into account that E. coli is one of the most common 
microorganisms isolated from PMIE cases (Hughes and Loy, 1975), it can be 
hypothesised that resistant mares have a higher basal expression of TLR4 in order to 
quickly suppress the inflammation after breeding caused by invading gram-negative 
bacteria that can be deposited into the uterus during natural mating and in some 
cases, artificial insemination (Troedsson, 1999; Watson, 2000; Katila, 2001).  
The current results are again in contrast with the recent findings of Marth et al. 
(2018) which found an up-regulation of TLR4 in susceptible mares compared to 
resistant mares. However, it included mares at different phases of the oestrous cycle 
in the analyses, and some of the susceptible mares showed bacteria in the uterus 
(Marth et al., 2018). Instead of analysing the global gene expression in the equine 
endometrium, this study used quantitative real-time polymerase chain reaction to 
analyse specific genes previously identified to be linked to endometritis (Marth et al., 
2018). For experimental purposes, it is important to have similar methodologies to 
make comparisons and draw conclusions across studies. Therefore, the results of the 
current study might not be similar to those published due to different methodologies.  
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Interferon regulatory factors are involved in processes such as regulation of immune 
response, host defence, cytokine signalling and regulation of cell growth, specially 
regulation of immune cell differentiation and activation (Taniguchi et al., 2001; Ning 
et al., 2011). Interferon regulatory form 7 (IRF7), along with IRF3, is a key regulator 
of the type I interferon (IFN) comprised of IFN-α and –β, that play a role in both 
innate and adaptive immunity (Honda et al., 2005). An inactive form of IRF7 is 
present in uninfected cells that, after being stimulated by different factors such as 
viral infections and TLRs, become phosphorylated and positively regulate other 
interferon-stimulated genes, participating in innate immunity (Honda et al., 2005).  
Therefore, an up-regulation of IRF7 in resistant mares in relation to susceptible 
mares might contribute to homeostasis by preparing the uterine environment to resist 
infection and facilitate the healing process in case inflammation occurs.  
 
7.5 | Conclusion  
The biggest limitation of this study is the number of biological replicates for the 
susceptible group. The legislation in the United Kingdom is severely restricted and 
collecting biopsies from live mares in practice is difficult to obtain permissions for 
(both that of the mare owner and Home Office permissions). Thus, samples from 
Finland were used in this study where a population of research mares was available.  
Unfortunately, only three horses were available for sample collection. Moreover, it is 
difficult finding susceptible mares at the abattoir, since no information about their 
reproductive history is available.  
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Despite the enrichment analysis retrieving mostly metabolic and cellular pathways, 
specifically AP-1, CCL5, IRF7 and TLR4 genes provide an indication of immune 
responses when comparing resistant relative to susceptible mares. All samples used 
in the current study were collected before breeding. Therefore, all gene expression 
related to immunity is not a response to contamination and should represent the 
underlying endometrial immune homeostasis of resistant and susceptible mares. 
Thus, it is hypothesised that an over expression of immune genes by resistant mares 
means that they are able to physiologically prepare the uterus ahead of mating to 
tackle MIE caused by the introduction of foreign material in the uterus after breeding 
more efficiently than susceptible mares.  
It is important to highlight that two different breeds of mares were used in this 
experiment, and genetic characterization is important to assign individuals to correct 
populations in order to assure breed integrity (Glowatzki-Mullis et al., 2006). 
Therefore, the different genetic backgrounds of these two groups of mares could be 
the cause of the differences in gene expression seen when performing transcriptomic 
analysis. If further investigations in different populations with a bigger sample size 
using only one breed of mares retrieve the similar results, these genes can be used in 
the future as markers of resistance in mares before breeding.  
In conclusion, the present study provides preliminary insights into measuring 
expression levels of genes linked to the immune system to better understand the 
mechanisms associated with resistance and susceptibility to PMIE in mares before 
breeding. An understanding of which genes regulate the delicate balance of 
resistance and susceptibility to PMIE is a promising approach for improved 
reproductive management. In future, understanding which genes are linked to PMIE 
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resistance and susceptibility will allow the appropriate classification of mares based 
on gene expression analysis of endometrial biopsies at the pre-breeding examination.  
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CHAPTER 8 
 
 
GENERAL DISCUSSION 
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This thesis explored the use of an endometrial tissue culture system as a model to 
study the equine endometrium in combination with global gene expression analysis. 
The global endometrial gene expression throughout the oestrous cycle and 
anoestrous period, as well as the gene expression related to the innate immune 
system after bacterial challenge was analysed from in vitro cultured explants and ex 
vivo samples. This work also studied the ex vivo and the in vivo basal gene 
expression of resistant and susceptible mares before breeding. 
One of the primary aims of this research project was to apply state-of-the-art RNA-
Sequencing (RNA-Seq) technology to study the transcriptome of cultured 
endometrial explants to better understand the tissue culture system, which might be 
used in the future as a model to study the equine endometrium and more specifically, 
equine endometritis. RNA-Seq allows the quantification and identification of gene 
expression changes during different conditions, making it possible to classify normal 
developmental changes as well as illness and disease states (Wang et al., 2009). 
RNA assessments have the potential to be used in the clinical diagnosis of different 
conditions (Wang et al., 2009; Ozsolak and Milos, 2011).  
Regarding the bioinformatics analysis, it is critical to choose the appropriate tool for 
the analysis of differentially expressed genes (DEGs) to ensure valid conclusions are 
drawn from a data set. Nonetheless, there is no optimal pipeline for the analysis of 
RNA-Seq data since there are many different applications and analysis scenarios in 
which this high-throughput technology can be used (Conesa et al., 2016). The 
DESeq2 package (Love et al., 2014) for the analysis of DEGs was chosen to be used 
for all RNA-Seq data created in this thesis as it can perform more complex analysis 
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such as multiple comparisons and analysis of time-series data (Conesa et al., 2016). 
DESeq2 uses modelling to improve model performance under the negative binominal 
assumption of statistical analysis (Huang et al., 2009; Love et al., 2014). When 
compared to other software used for differential gene expression analysis such as 
edgeR, voom, SAMseq and Cuffdiff, DESeq2 showed a higher sensitivity, especially 
for small fold changes such as 2 or 3 (Love et al., 2014; Zhou et al., 2014). 
All endometria from which explants were collected were carefully analysed, as 
previously described in Chapter 3, to ensure they were free of inflammation, both 
acute and chronic. The endometrial tissue culture was performed as previously 
described by Nash et al. (2008), but adopting the collection of intact explants using 
sterile punch biopsies according to Borges et al. (2012). Consistent with previous 
findings, the explants cultured in this piece of work appeared to be viable throughout 
the whole experimentation period since there was no alteration of their colour and 
appearance throughout the culture period of 72 hours (Nash et al., 2008). It was 
decided to use the punch biopsy to collect intact explants rather than the mechanical 
tissue chopper to reduce releasing damage-associated molecular patterns (DAMPs) 
molecules after tissue disruption that happens when the tissue is mechanically 
chopped. The innate immune system can be modulated by DAMPs, thus triggering 
inflammation due to tissue damage (Borges et al., 2012).  
The first aim of the current work was to further investigate the explant tissue culture 
system by determining how the transcriptome of cultured explants is modulated once 
in culture and whether the transcriptome of cultured explants represents the 
transcriptome of a whole mare, to then use the culture system for future studies into 
equine endometritis. This work appears to be the first in the literature to sequence the 
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transcriptome of equine cultured endometrial explants at different time points and to 
investigate how the gene expression is modified once the explants are placed in 
culture. It was  observed that there is an expected variation between the 0 hours ex 
vivo biopsies (collected at 0 hours, or as soon post-mortem as possible) compared to 
the in vitro explants cultured for a period of 24 hours (Chapter 4). The focus when 
studying the explant tissue culture at the global gene expression level was the innate 
immune genes’ expression. This was done by comparing the 0 hours biopsies with 
the in vitro cultured explants at 24 hours followed by gene expression analysis 
between 24, 48 and 72 hours of culture. 
The study established that the CCL2, CD40, IL1A, IL1B, IL23A, IL4R, IL6 and IL8 
genes linked to the innate immunity were shown to be down-regulated (LogFC 
between -2.7 and -6) when comparing the transcriptome of the ex vivo 0 hours 
samples to the transcriptome of explants cultured for 24 hours. These genes were set 
as a baseline for future work involving inflammation of the endometrium when using 
the explant tissue culture system. The most likely explanation for this down-
regulation in the ex vivo samples is that once the punch biopsies are collected from 
the endometrium and placed in the culture plate, there is a higher expression of 
inflammatory genes in the biopsies in relation to the whole mare. Even though intact 
explants were used in the current work, it is thought that impact to the innate 
immunity was caused to some extent when excising the biopsy from the tissue. The 
inflammatory responses from bovine cultured intact and chopped endometrium have 
already been compared, using control medium and medium challenged with 
Escherichia coli (E. coli) lipopolysaccharide (LPS) (Siegmund et al., 2001; Borges et 
al., 2012). Indeed, both intact explants and chopped endometrium showed an 
accumulation of interleukins, yet chopped tissue accumulated more IL-6, IL-8 and 
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IL-1β than intact explants both in control medium and when challenged with LPS. It 
is expected that even intact explants might modulate the innate immunity; however, 
they have already been utilised in other research, ex vivo in rodents and in vitro in 
cows for the investigation of immunity and inflammation (Siegmund et al., 2001; 
Borges et al., 2012). Therefore, even though genes related to the innate immune 
system are expressed in cultured intact explants, the tissue culture system can still be 
validated in the future following further research and used as a model to study 
endometritis. If, after challenging with inflammatory stimulants, the expression of 
genes classified as the baseline is found to be higher, they may be indicative of a 
genuine innate immunity response to the inflammatory challenge itself, instead of a 
normally expected expression due to the removal of tissue from the intact 
endometrium. Indeed, after challenging explants with LPS (Chapter 5), expressed 
genes did not overlap with the ones set as a baseline here. This matter was discussed 
in more detail throughout the general discussion.  
Between 24 hours and 48 hours of culture, there was a minimal change in gene 
expression (Chapter 4), which does not seem to interfere with the innate immunity. 
Nevertheless, based on the gene expression analysis, the explants showed altered 
transcriptomic profiles after 48 hours in culture. The greater expression of MMP13 at 
72 hours of culture compared to 48 hours might be related to a compromised uterine 
environment as already reported in cows (Wathes et al., 2011; Forde and Lonergan, 
2012). Therefore, the transcriptomic analysis at 72 hours can bias the results of 
DEGs. This is in line with the findings of Borges et. al. (2012), who found necrotic 
fragmentation of glands and stroma in bovine intact explants cultured after 48 hours. 
Thus, the explants for the subsequent experiments were only cultured for 24 and 48 
hours.  
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The second aim of the thesis was to compare the global endometrial transcriptomic 
changes throughout the oestrous cycle and the anoestrous period from pony mares 
known to be resistant to persistent-mating induced endometritis (PMIE). The equine 
oestrous cycle takes place during the spring and summer and early autumn, and lasts 
an average of 21 days, comprising 5-7 days of follicular phase. The anoestrous phase 
takes place during the winter months and is characterized by a lack of ovarian 
activity (Aurich, 2011). Changes in ovarian hormones drive the morphology and 
molecular biology of reproductive organs throughout the oestrous cycle (Aurich, 
2011; Marth et al., 2015b). A better understanding of the cyclical physiological 
changes that happen in the equine endometrium during the different phases of the 
oestrous cycle might improve the understanding of inflammatory conditions and 
pathologies of the mare’s reproductive tract. 
The seasonal variability of gene expression throughout the oestrous cycles in mares 
(Chapter 5) supports previous findings that hormones change the physiological 
uterine environment (Gebhardt et al., 2012; Marth et al., 2015b). Based on the 
findings of the current work, it is possible to make a clear distinction between genes 
that are regulated during the follicular and luteal phases of the oestrous cycle. After 
24 hours of culture, follicular phase explant gene expression related mainly to 
immune pathways when compared to the luteal phase of the oestrous cycle, with an 
up regulation of genes coding for interleukins (IL1A, IL23A, IL2RB and IL7R), 
chemokines (CXCL1, CXCL10 and CXCL14), tumour necrosis factor receptor 
(TNFRSF4), NF-kB Inhibitor Alpha, an inhibin (INHABA) and follistatin (FST). 
During the follicular phase, when breeding occurs, the cervix is open enabling semen 
and often accompanying bacteria to enter the uterus. Thus, an up-regulation of innate 
immune genes will help tackle the intrusion of foreign material into the uterus 
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During the luteal phase, DEGs were mainly linked to molecular functions, biological 
processes and uterine functions, with an up-regulation of genes such as EDNRB, 
ESR1 and LEPR. Additionally, this research suggests the expression of genes linked 
to the innate immune system during the anoestrous period is higher when compared 
to the luteal phase, yet lower when compared to the follicular phase. This agrees with 
the hypothesis that during the luteal phase, high progesterone concentrations 
diminish the endometrial elimination of bacteria and/or semen, resulting in a lower 
uterine clearance (Evans et al., 1986a; Watson et al., 1987). It can be concluded that 
the expression of genes related to the innate immune system is greater during the 
follicular phase, followed by the anoestrous period and it is lowest during the luteal 
phase of the oestrous cycle during progesterone dominance.  
The current study also showed an up-regulation of collagen genes during the 
anoestrous phase compared to the follicular and luteal phases. This contradicts recent 
findings where collagen genes were up-regulated during the follicular phase of the 
oestrous cycle in mares compared to the luteal phase (Marth et al., 2015b). However, 
it is hard to compare results since the work from Marth et al. (2015b) did not study 
the gene expression during the anoestrous period.  The higher collagen expression is 
a rather unexpected finding when studying the endometrial response during the 
anoestrous phase, and the current lack of information on the collagen content in the 
equine endometrium and also in other mammals make it difficult to theorise this 
finding.  
Further research needs to be done to elucidate what the situation really is during the 
anoestrous period specifically, at the level of global gene expression using RNA-Seq. 
By collecting biopsies from susceptible and resistant mares during the anoestrous 
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period and comparing their transcriptomes might help finding the true picture about 
the anoestrous period in mares.  
Unexpected outcomes, such as the “chemical carcinogenesis” KEGG pathway shown 
to be the only enriched pathway when comparing across the follicular and luteal 
phases at 48 hours, or the lower number of enriched pathways retrieved at 48 hours 
overall, might be linked to biases in the databases. Many pathways studies were 
based on human diseases, and they are included as results in other systems. 
Therefore, some retrieved pathways do not make much sense. Instead, the DEGs may 
be involved in another process not yet annotated. It has also been hypothesized that 
the analysis at 48 hours did not retrieve many enriched pathways, or the pathways 
were not related to the immune function or to the endometrial environment because 
the DEGs were taking part in pathways and processes that somehow overlapped, or 
because the list of genes was to general (Simillion et al., 2017). 
Moreover, the third aim of the thesis was to utilise the explant tissue culture to study 
equine endometrial inflammation, which can be mainly caused by bacterial infection 
and PMIE (Zent et al., 1998; Troedsson, 1999; Causey, 2006; Woodward and 
Troedsson, 2013). The field of equine uterine inflammation is many years old, but 
little focus has been given to the global gene expression and most studies had used 
quantitative polymerase chain reaction (qPCR) to study a pre-selected, but limited 
number of genes thought to be related to endometritis (Fumuso et al., 2003; Fumuso 
et al., 2007; Nash et al., 2010b; Christoffersen et al., 2012; Woodward et al., 2013). 
Only recently has there been a study using the RNA-Seq technology to investigate 
the endometrial gene expression related to inflammation after infecting mares with E. 
coli. The main up-regulated genes 3 hours after inoculation included toll-like 
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receptors 2 and 4, pro-inflammatory cytokines, chemokines and equine β-defensin 1 
(Marth et al., 2015a). The work conducted by Marth et al. (2015a) has only 
investigated the global gene expression during acute endometritis, at 6 hours post    
E. coli inoculation. However, it is already known that mating-induced endometritis 
(MIE) might take up to 36-48 hours to be cleared from the uterus. Therefore, by 
using the explant tissue culture, this thesis expanded the mentioned published work 
by looking at the global gene expression from explants after 24 and 48 hours of LPS 
challenge to better understand the mechanisms underlying the progression of MIE to 
PMIE.  
Explants were cultured in control medium and in medium challenged with different 
concentrations of LPS (0.3 µg/mL, 1.0 µg/mL or 3.0 µg/mL). Radioimmunoassays 
(RIA) were performed to quantify the prostaglandin F2α (PGF2α) production by 
explants as a marker of inflammation to check whether the LPS was causing a 
response and to help refine the number of samples sent for transcriptomic analysis. 
However, no statistically significant difference was seen in PGF2α production 
between treatments at either 24 or 48 hours. This result agrees with previous studies 
using the explant tissue culture, where explants at the follicular phase of the oestrous 
cycle did not significantly produce PGF2α in response to challenge with LPS or 
Streptococcus zooepidemicus (Nash et al., 2008). On the other hand, a more recent 
study using the same explant tissue culture has shown a PGF2α response following 
challenge with 3 µg/mL LPS in follicular stage explants, and this is why PGF2α is 
still used as a marker for explant functionality (Nash et al., 2018). Thus, since the 
main goal of the current work was to better understand the transcriptome of equine 
endometrium after antigen challenge, explants cultured in medium challenged with 
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LPS 3 µg/mL (instead of 0.3 or 1 µg/mL) were the ones chosen to be taken forward 
to RNA extraction, RNA-Seq and transcriptomic analysis (Chapter 6).  
The enrichment analysis for DEGs did not retrieve many pathways related to the 
immune system after LPS challenge. A few isolated genes such as IRAK and 
ZC3H12C were shown to be up-regulated in cultured explants challenged with LPS 
for 24 hours when compared to explants cultured in media alone. On the other hand, 
the ENPP2, SOX13 and PLVAP genes were shown to be down-regulated after LPS 
challenge at 24 hours. None of these genes overlaped with the genes set as the 
baseline in Chapter 4, suggesting that the gene expression might be indeed related to 
the LPS challenge. Nonetheless, more genes related to immune responses were 
expected to be up-regulated after LPS challenge, which might suggest that the LPS 
was not working properly, in accordance with the lack of PGF2a response. All uteri 
used in this experiment were collected from mares thought to be resistant to PMIE at 
the follicular phase of the oestrous cycle, when immune responses are up-regulated. 
Therefore, another hypothesis for this outcome is that between 0 and 24 hours the 
immune response was mounted and it was tackling inflammation induced by the 
LPS. Since the mares did not present acute or chronic endometritis, it is suggested 
that by the end of the 24 hours of challenge, the uterine immune system had already 
resolved most of the inflammation and it was bringing the uterine environment back 
to homeostasis. In the future, adding more time points to the explant tissue culture 
during challenge with LPS, such as 6 and 12 hours, might help shed light into the 
immune responses occurring in the endometrium before 24 hours.  It would also be 
interesting to test explants from mares with active endometritis to study the global 
gene expression at different time points of the inflammation.  
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Finally, the fourth aim of the current work was to use RNA-Seq technology to study 
the transcriptome of PMIE resistant and susceptible mares before breeding, to better 
understand the innate differences in gene expression even before the endometrial 
environment is challenged with semen or bacteria. The majority of research 
conducted into MIE and PMIE focuses on immune changes after uterine challenge 
with semen and/or bacteria (Troedsson et al., 1993c; Katila, 1995; Troedsson, 1999; 
Fumuso et al., 2003; Christoffersen et al., 2012; Marth et al., 2015a). 
Notwithstanding this, this approach does not address the dearth of knowledge 
regarding any putative changes to endometrial homeostasis in susceptible or resistant 
mares before breeding. Advances in the understanding of how these two categories 
of mares differ in their uterine gene expression might shed light into the link between 
MIE and PMIE.   
In the body of work detailed here, four genes have been identified as having the 
potential to distinguish mares between resistant and susceptible to PMIE before the 
uterine environment faces a challenge. PMIE resistant mares showed an up-
regulation of TLR4, CCL5, IRF7 and AP-1 genes in relation to susceptible mares, 
which are genes linked to the immune response (Chapter 7).   
The ability to distinguish between resistant and susceptible mares can have 
significant clinical implications in the breeding industry worldwide. This is the first 
study to look at the global gene expression between resistant and susceptible mares 
before breeding. Further transcriptomic analysis with a larger number of mares 
would be required to confirm the gene expression changes reported in this study. 
Nonetheless, in a field application technique, biopsies collected from broodmares as 
is routine during the pre-breeding period and can be utilised for RNA-Seq analysis; 
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there is thus potential for endometrial RNA-Seq analysis to be used as a screening 
method to classify mares likely to be resistant or susceptible to PMIE based on up or 
down-regulation of certain genes.  
The utilisation of transcriptomics to better understand the equine endometrium and to 
identify potential genes for the identification of PMIE resistant and susceptible mares 
is novel and promising. However, there are a few limitations to this portion of work. 
Perhaps the most serious disadvantage of this study is that samples were collected 
from mares presented for euthanasia at a commercial abattoir and no background 
information about the animals was available. Since no metadata were available for 
each one of the mares used in this piece of work, it was not possible to divide them 
into homogeneous groups such as age, presence and/or absence of illness, type of 
management, etc. For this reason, a substantial variability in the specified outcome is 
expected. Thus, even though the results in gene expression might represent true 
differences, they can also be biased because of sampling variability. To balance this 
variability, a larger sample size is required (Biau et al., 2008). Due to the difficulty in 
sample collection, the number of mares used in this study might be too small to 
account for all the variability in the data. Therefore, this study could be 
underpowered when it comes to statistical analysis. In statistics, the type II error is 
considered a “false negative”, when a null hypothesis that is false gets rejected, 
meaning that there is a fail to assert what is present (Steidl et al., 1997; Akobeng, 
2016). The risk of type II error increases as the power of a study decreases, which 
then also reduces the chances of detecting a difference when it exists (Biau et al., 
2008). For this reason, this study might have missed real results due to its high risk 
of type II errors.  
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Another point to consider is that accounting for the duration of sample collection 
plus the transportation of samples back to the laboratory a period of 7 hours elapsed. 
In addition, once in the laboratory uteri were dissected and punch biopsies were then 
collected, adding another hour until the tissue culture was set and running. There is a 
lack of research regarding the effects of time between collection and use of tissue 
samples derived from abattoirs. However, it has been demonstrated that the bacterial 
composition of sputum samples collected from human adults with respiratory 
infections changed after storage at room temperature for different intervals of time 
before samples were frozen (Cuthbertson et al., 2014). It was showed that within the 
first hour of collection is the best window for sample storage/transportation at room 
temperature before freezing at -80 
o
C. However, the authors suggest that a window of 
12 hours of collection is acceptable without significant differences in the bacterial 
composition in the case of sputum samples (Cuthbertson et al., 2014). As regards this 
current study it is impossible to attest what could have occurred to the tissue at the 
level of gene expression in the period between sample collection and culture set up 
and how this could influence the results. These could be significant as after the uterus 
removal from the mare’s body a cascade of reactions might occur due to many 
reasons such as the lack of blood circulation, differences in the mare’s internal 
temperature compared to the outside room temperature and contact with the external 
environment. Taking this into consideration, specific gene expression patterns 
observed between the 0 hours’ samples and the samples culture for up to 24 hours 
might be related not only to the effect of the culture itself, but also related to 
transcriptomic changes as a result of the long transportation time between uteri 
collection and the start of the tissue culture.  
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Another issue related to the methodology of the experiments in this thesis is that 
intact endometrial explants were used to set up a tissue culture. The tissue culture 
was chosen over alternative model systems such as epithelial and stromal cell 
cultures because the latter is one step behind in representing the uterus of a whole 
mare as it disrupts the endometrial architecture (Borges et al., 2012). As previously 
described, the equine endometrial explants are composed of both epithelial and 
stromal cells (Nash et al., 2008), however the proportion of these type of cells in 
each explant is unknown. For this reason, the heterogeneity of explants in terms of 
cell composition could not be assessed. It is known that the basal gene expression is 
different in cell types, as assessed by single-cell RNA-Seq analysis (Saliba et al., 
2014). Therefore, results in gene expression could have been modulated depending 
on the ratio between stromal and epithelial cells in the explants used in this thesis. 
For future studies it would be interesting to look at the gene expression of stromal 
and epithelial endometrial cells and perhaps compare the results with the results of 
the current thesis.  
Handling RNA-Seq data is also challenging since there are many available tools 
available for each step of the analysis, but there is no standard protocol when it 
comes to data processing, differential analysis and functional pathway analysis. 
RNA-Seq is being used in many laboratories and tools for the analysis of such data 
are constantly being developed and improved (Williams et al., 2014). Standardizing 
methods for experiment design, sample collection and RNA-Seq data analysis will 
provide the research community with powerful instruments to understand the 
biological implications of RNA-Seq results, as well as facilitate the comparison 
across different studies.  
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Furthermore, there is also the factor of biases in databases for the study of equine 
pathways which is a severe limitation when working with RNA-Seq data, which 
complicates the biological interpretation of sequence data. After analysing RNA-Seq 
data, the next step is to identify statistically enriched biological processes in the data 
through the analysis of biological pathways (Khatri et al., 2012). Annotation 
inequality is a problem that is increasing over time (Haynes et al., 2018). Good 
annotations are available for well-known processes; however, there is much to be 
discovered. For example, the protein-protein interaction networks in this thesis 
retrieved from the Search Tool for the Retrieval of Interacting Genes/Proteins 
(STRING) (Szklarczyk et al., 2015) website reported genes with generally 
significant more connection than expected by random chance, suggesting that they 
are functional interacting units. However, not always the enrichment analysis linked 
these genes to known pathways, suggesting the possibility of unannotated processes 
that are being up or down-regulated. Nevertheless, the power of using transcriptomic 
analysis to comprehensively investigate the explant tissue culture and to better 
understand the global gene expression in the equine endometrium before and after 
challenge has been shown.  
Conclusion 
This work appears to be one of the firsts to use high-throughput analysis to study the 
equine endometrial environment before semen or bacterial inoculation, at the 
different stages of the oestrous cycle and after LPS inoculation. In studies of equine 
endometritis, the choice of sample is important. In fact, during the last 15 years, 
studies investigating the innate immune pathways in the equine endometrium after 
challenge with semen and bacteria used different protocols and different time points 
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for sampling (Fumuso et al., 2003; Fumuso et al., 2007; Christoffersen et al., 2010; 
Nash et al., 2010a; Nash et al., 2010b; Christoffersen et al., 2012; Woodward et al., 
2013). Thus, the comparison of results across studies is difficult and likely to be 
limited. There is a serious need for model systems where the main characteristics of 
the endometrium are preserved, to better understand the equine uterine function and 
innate immunity.   
Despite its exploratory nature, this work investigated the use of the explant tissue 
culture system as a future model for studies of the equine endometrium at the level of 
the transcriptome as a standardized method to study endometritis in the mare.  This 
study emphasized the complexity of interactions in the innate immune response in 
the equine endometrium under the effect of different hormones throughout the 
oestrous cycle, where innate immune genes exhibited increased expression during the 
follicular phase of the oestrous cycle when compared to the luteal phase and the 
anoestrous period. Also, a number of genes of potential interest were identified 
during bacterial challenge and also between resistant and susceptible mares before 
breeding. 
The present thesis contributes to the knowledge in the field of in vitro research as 
well as in the field of equine endometritis, by providing evidence that the equine 
endometrial explant tissue culture can be used for further research into endometritis 
at the level of global gene expression and therefore, has important implications to 
help understanding fertility problems in mares.  This study also provided important 
insights into gene expression to better understand the mechanisms linked to 
resistance and susceptibility to PMIE. This has a future application to clinical 
practice when the genes underlying resistance and susceptibility are fully elucidated, 
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by analysing the global gene expression of endometrial biopsies in order to classify 
mares into PMIE resistant and susceptible at the pre-breeding examination before 
challenge occurs.   
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Appendix 3.1 
Progesterone ELISA 
The progesterone ELISA kit (EIA 1561, DRG Diagnostics) determined the 
progesterone concentration in blood serum. The kit contained one pre-treated 96 
wells plate coated with anti-progesterone antibody, 7 standard vials ready to use in 
concentrations of 0; 0.3; 1.25; 2.5; 5; 15; 40 ng/mL, enzyme conjugate ready to use, 
substrate solution ready to use, stop solution ready to use and a 40 x concentrated 
wash solution. Thirty millilitres of 40x concentrated wash solution was diluted in 
1170 mL deionized water. Reagents were allowed to reach room temperature before 
use and were mixed without foaming. Pregnant mare serum was used as a positive 
control, and male horse serum was used as a negative control.  
The plate was snapped to the number of wells needed and secured in the holder. In 
duplicate, 25 µL of standards, 25 µL of samples and 25 µL of controls were 
dispensed into wells and incubated for 5 minutes at room temperature. Two hundred 
microliters of enzyme conjugate were dispensed into each well and the plate was 
covered using a plate sealer cover. The plate was incubated on a rocker (Scientific 
Gyro rocker Stuart, Z316520, Sigma, UK) for 60 minutes at room temperature. 
Contents were shaken out, wells were washed with 400 µL of diluted wash solution 
three times and wells were stroke sharply on absorbent paper. A volume of 200 µL of 
substrate solution was dispensed into each well and the plate was covered again. The 
plate was incubated on a rocker for 15 minutes at room temperature in the dark. The 
reaction was stopped by adding 100 µL of stop solution to each well.  
Within 10 minutes of adding the stop solution, the plate was read. The absorbance of 
each well at 450+/-10 nm was determined using a plate reader (iMark Microplate 
Absorbance Reader, Bio-Rad, UK). The concentration (ng/mL) values for each 
standard, controls and samples were exported.  
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Appendix 3.2 
Buffers and Reagents for Histology and Tissue Culture  
 
Haematoxylin and Eosin for Histology  
Harris Haematoxylin was made up by adding 1 g of haematoxylin (H9627, Sigma, 
UK) in 10 mL of absolute ethanol, and was then added to a previously dissolved 20 g 
of aluminium potassium sulphate (11443713, Fisher, UK) in 200 mL of warm 
distilled water. The mixture was brought to boil and 0.5 g of mercuric oxide (203793, 
Sigma, UK) was added. The solution was rapidly cooled and 4 mL of acetic acid was 
added to improve nuclear selectivity. Alcoholic Eosin was made up by adding 1 g of 
eosin (E4009, Sigma, UK) in 100 mL 70 % ethanol.  
Epidermal Growth Factor Stock  
A vial of 50 µg Epidermal Growth Factor (10605-HNAE-250, Life Technologies, 
UK) was reconstituted by adding 1000 µL of sterile water, resulting in a final 
concentration of 50 µg/mL. The solution was stored in 100 µL aliquots at -20 °C. 
Neomycin and Streptomycin Stock 
A 10 mg/mL stock solution of neomycin trisulfate salt hydrate (N6386, Sigma, UK) 
and streptomycin sulfate salt (S6501, Sigma, UK) was prepared. By using a high 
precision balance, 1 g of neomycin and 1 g of streptomycin were weighed into a 
beaker.  Distilled water was added to the beaker until the final weight was 100 g. The 
solution was stirred until the powder was completely dissolved and then filtered 
through a 0,22 µg filter. The solution was stored in 5 mL aliquots at -20°C. 
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Appendix 3.3 
Prostaglandin F2α Radioimmunoassay 
 
Chemicals and Reagents 
Tris Buffer (0.05M) 
One gram of gelatin (440454B, BDH) was dissolved in 200 mL distilled water by 
stirring at 50 ˚C. To this 0.2 g sodium azide (S-8032, Sigma, UK), 6.61 g Tris HCl 
(T-3253, Sigma, UK), 0.97 g Tris base (T-1503, Sigma, UK) were added and 
solution was made up to 1 L with distilled water. The pH was adjusted to 7.4 by 
adding 1 M HCl or 10 % NaOH when necessary. 
Dextran-coated charcoal suspension 
In 190 mL distilled water 0.8 g dextran (3190, Sigma, UK) was dissolved and stirred 
for 20 minutes. To this, 4.0 g of activated charcoal (C404053, Fisher, UK) was added 
and the suspension was stirred for approximately 20 minutes.  The suspension was 
made up to 200 mL with distilled water and stored at 4 ˚C for up to 14 days. The 
suspension was thoroughly stirred before each use. 
Tracer 
To achieve the working concentration of 10000-12000 counts per minute (cpm) per 
mL, 10 µL PGF2α tracer (NET433250UC, Perkin Elmer, UK) was added into 1990 
µL Tris buffer. The tracer solution was read as cpm to find the final concentration. If 
the concentration was lower than the 10000-12000 cpm expected, more tracer was 
added to it until the solution reached the final working concentration.  
Antiserum 
A standard dilution of antiserum was performed to discover which solution produces 
30 % binding of tracer when non-radioactive PGF2α is present. Firstly, a 1:100 
dilution of antiserum was made up by adding 100 µL antiserum to 9900 µL Tris 
buffer and aliquots were stored at -20 ˚C. A 1:2 serial dilution of the 1:100 diluted 
antiserum was then performed. Five hundred microliters of tris buffer were added to 
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8 different tubes. From the 1:100 diluted antiserum, 500 µL was taken and added to 
the next tube and mixed by pipetting, giving a 1:2000 dilution. This procedure was 
repeated for each tube in sequence, by removing 500 µL each time to perform a 
serial dilution. The final concentrations of antiserum were: 1:1000, 1:2000, 1:8000, 
1:16000, 1:32000, 1:64000, 1:128000, 1:256000. Antisera were a kind gift from 
Professor N Poyser (University of Edinburgh, Edinburgh, Scotland, UK) and 
Professor Claire Wathes (Royal Veterinary College, London, UK). 
PGF2α Standards 
A 1 mg/mL stock solution was made up by adding 1 mL absolute ethanol to a 1 mg 
vial of PGF2α (P0314-1MG, Sigma, UK). A 1 µg/mL standard solution was made up 
by adding 100 adding 100 µL of 1 mg/mL solution to 99.9 mL tris buffer and 
aliquots were stored at -20 ˚C until needed. A 2 mL of 10 ng/mL standard solution 
was performed by adding 20 µL of 1 µg/mL solution to 1980 µL tris buffer (1:100 
dilution). The standards were made up in tubes as per table and were kept at 4 ˚C for 
up to 15 days. One standard curve was needed for each centrifugation. 
Standard Concentration    
(ng/mL) 
Volume of 10 ng/mL standard 
(µL) 
Volume of Tris Buffer 
(µL) 
5 (1:2) 500 500 
2.50 (1:4) 250 750 
1.00 (1:10) 100 900 
0.50 (1:20) 50 950 
0.25 (1:40) 25 975 
0.10 (1:100) 10 990 
0.05 (1:200) 5 995 
0.025 (1:400) 2.5 997.5 
Assay Procedure 
Each standard/sample was run in triplicate. Tubes (11778908, Fisher, UK) were TC 
(total count), NSB (Buffer blank), TB (total binding), Std (standard), QC (quality 
check) and Tests (sample), and volumes of each reagent were added as per crib sheet.   
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Reagents TC NSB TB Std QC Tests 
Standards - - - 100 µl - - 
Sample - - - - 100 µl 100 µl 
Buffer 500 µl 300 µl 200 µl 100 µl 100 µl 100 µl 
Antiserum - - 100 µl 100 µl 100 µl 100 µl 
Tracer 100 µl 100 µl 100 µl 100 µl 100 µl 100 µl 
Tubes were vortexed and incubated at 4 ˚C for 16-24 hours. Two hundred microliters 
of charcoal dextran solution were added to each tube except total count. Tubes were 
vortexed, incubated for 10 mins at 4 ˚C and centrifuged at 1000-1500 g at 4 ˚C. 
Supernatant was decanted into labelled 6 mL scintillation tubes (E1412-7000, Star 
Lab, UK), 4 mL of scintillantion liquid (1200-436, Optiphase HiSafe, Perkin Elmer, 
UK) was added to each tube and tubes were shaken to mix throughout. Count as 
counts per minute (cpm) for 2 mins was performed for each tube. 
Calculation 
Normalised percent bound for each standard/sample was gained with the following 
equation: 
%𝐵/𝐵0 =
(𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑜𝑟 𝑠𝑎𝑚𝑝𝑙𝑒 𝑐𝑝𝑚 − 𝑁𝑆𝐵 𝑐𝑝𝑚)
(𝐵0 𝑐𝑝𝑚 − 𝑁𝑆𝐵 𝑐𝑝𝑚)
𝑥 100% 
A standard curve was generated by plotting the normalised percent bound as a 
function of the log10 PGF2α concentrations.  
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Appendix 3.4 
RNA Extraction  
The GeneJET RNA purification kit (K0731, GeneJET RNA Purification Kit, Thermo 
Scientific, UK) was used to purify total RNA cultured tissue. The kit contained 
Protainase K, Lysis buffer, Wash buffer 1 concentrated, wash buffer 2 concentrated, 
nuclease-free water, GeneJET RNA purification columns pre-assembled with 
collection tubes, 2 mL collection tubes and 1.5 mL collection tubes. Components 
were stored at room temperature and proteinase K was stored at -20 
o
C after being 
opened. 
Fifty millilitres of 96-100 % ethanol was added to Wash Buffer 1, and 170 mL of 
ethanol was added to Wash Buffer 2. The required amount of Lysis buffer was 
supplemented with 20 µl β-mercaptoethanol (M6250, Sigma, UK) for each 1 mL 
volume of Lysis buffer. Proteinase K was diluted by adding 10 µl to 590 µL of TE 
buffer (10 mM Tris HCl, pH 8.0, 1 mM EDTA).  
Up to 30 mg of fresh or frozen tissue was placed in a safe lock tube (0030123328, 
Fisher, UK) containing 300 µL of supplemented lysis buffer and a stainless steel 
bead (69989, 5mm, Qiagen, UK). The tissue was immediately disrupted using a 
rotor-stator homogenizer (TissueLyser LT, 85600, Qiagen, UK) until the suspension 
was uniform. Tubes containing the lysate and the beads were centrifuged for 2 
minutes at 12000 x g to pellet any cell debris. Supernatant was transferred to another 
RNA/DNAse free tube (11598252, Fisher, UK). Six hundred microliters of diluted 
Proteinase K was added to each tube, vortexed and incubated at 15-25 °C for 10 
minutes. After incubation, tubes were centrifuged for 10 min at ≥12000 x g and 
supernatant was transferred into a new RNAse-free microcentrifuge tube. Four 
hundred and fifty microliters of ethanol (96-100%) were added to each tubed and 
mixed by pipetting.  
Up to 700 µL of lysate was transferred to the GeneJET RNA Purification Column 
inserted in a collection tube. The column was centrifuged for 1 min at 12000 x g. The 
flow-through was discarded and the purification column was placed back in the 
collection tube. This procedure was repeated until all lysate was transferred into the 
column and centrifuged, then he collection tube containing the flow-through solution 
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was discarded. The RNA purification column was placed into a new 2 mL collection 
tube. Seven hundred microliters of wash buffer 1 (supplemented with ethanol) were 
added to the RNA purification column and centrifuged for 1 min at 12000 x g. The 
flow-through was discarded and the purification column was placed back into the 
collection tube. Six hundred microliters of wash buffer 2 (supplemented with 
ethanol) were added into the RNA purification column and centrifuged for 1 min at 
12000 x g. The flow-through was discarded and the purification column was placed 
back into the collection tube. Two hundred and fifty microliters of wash buffer 2 
(supplemented with ethanol) were added to the purification column and centrifuged 
for 2 min at 12000 x g. If residual solution was seen in the purification column, the 
collection tube was emptied and the column was centrifuged again for 1 min at 
maximum speed. Finally, the collection tube containing the flow-through solution 
was discarded and the purification column was transferred to a sterile 1.5 mL RNa-se 
free micro centrifuge tube. A hundred microliter of nuclease/rnase-free water was 
added to the centre of the RNA purification column membrane and centrifuged for 1 
min at 12000 x g to elute RNA. The purification column was discarded and the 
extracted RNA was stored at -80
 o
C until use. 
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Appendix 3.5  
Computer code  
 Quality check, mapping the reads to the reference genome and total counts of 
RNA-Sequencing data  
 
Quality control of raw reads 
> module load fastqc/0.11.2 
 
> fastqc –o ../output_folder –t 4 –-extract <rawfastq_forward_read>.fq 
> fastqc –o ../output_folder –t 4 –-extract <rawfastq_reverse_read>.fq 
 
 
 
 
Map reads to the reference genome 
 
# TopHat requires Bowtie to map the reads to the reference genome 
#Bowtie needs the genome to be indexed 
 
> module load bowtie/2.2.3 
 
# -f specifies that the genome is in fasta format file 
# INDEX is the prefix chosen to all files that will be written by 
Bowtie 
 
> bowtie2-build –f <genome>.fa <genome>.INDEX 
 
 
 
> module load tophat/2.0.14 
> module load samtools/0.1.19 
# tophat –p 8 –G <annotationfile>.gtf -0 ../output_directory 
<genome.INDEX> <rawfastq_forward_read>.fq <rawfastq_reverse_read>.fq  
> tophat –p 8 –G annotationfile.gtf -0 ../output_directory genome.INDEX 
sample1_R1.fastq sample2_R2.fastq  
 
 
 
 
FeatureCounts 
  
> module load subread/1.5.2 
# featureCounts -p <for paired reads> -t <specifies feature in 
annotation file> -g <specifies attribute type in annotation file>  
-a <annotation_file> -o <output_file> input_file1 [input_file2] ... 
 
> featureCounts -p -t exon -g gene_id –a annotationfile.gtf –o outputfile 
sample1.bam sample2.bam sample3.bam ... 
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Appendix 4.1  
Kenney Classification of Mares Providing Endometrial Explants in Chapter 4 
 
Mares Histology report
b
 
Kenney 
classification 
1  Medium epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed difuse grade 1 fibrosis. I 
2  Medium epithelium. Stratum compactum showed lymphocyte focal infiltration grade 1. Stratum spongiosum examined, no pathologic 
findings noted. 
I 
3  Medium epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed focal cystic glands grade 
1. 
I 
4 Tall epithelium. Stratum compactum showed diffuse gland atrophy grade 1. Stratum spongiosum showed diffuse gland atrophy grade 2, 
multifocal cystic glands grade 3 with inspissated contents, fibrosis periglandular grade 3 and lymphocyte infiltration grade 1.  
II 
5  Tall epithelium. Stratum compactum showed lymphocyte infiltration grade 1. Stratum spongiosum showed focal cystic glands grade 1.  I 
6  Medium epithelium. Stratum compactum showed lymphocyte infiltration grade 1, macrophage and erythrophagocytes infiltration grade 
2. Stratum spongiosum showed lymphocyte infiltration grade 1, macrophage and erythrophagocytes infiltration grade 2 and siderocyte 
infiltration grade 1.  
I 
7 Tall epithelium. Stratum compactum showed focal lymphocyte infiltration grade 1. Stratum spongiosum examined, no pathologic 
findings noted. 
I 
8 Stratum compactum showed infiltration of macrophages and erythrophagocytes grade 3. Stratum spoingiosum showed focal cystic glands 
grade 1, focal periglandular fibrosis grade 1 and infiltration of macrophages and erythrophagocytes grade 1.  
I 
 a
 Grade 1 = minimal/very few/very small. Grade 2 = slight/few/small. Grade 3 =  moderate/moderate number/moderate size. Grade 4 = marked/many/large. 
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Appendix 4.2  
Computer Codes used in Chapter 4 
 
Trimmomatic script for each sample 
 
> module load java/jdk1.7.0_40 
 
# java -jar <path to trimmomatic jar> paired-end PE [-threads 
<threads>] [-phred33 | -phred64] <input_forward _read>.fq 
<input_reverse_read>.fq <output_forward_paired>.fq 
<output_forward_unpaired>.fq <output_reverse_paired>.fq 
<output_reverse_unpaired>.fq 
 
> java –jar ../trimmomatic/0.33/trimmomatic-0.33.jar PE –threads 2  
–phred33 sample1_R1.fastq sample1_R2.fastq sample1_R1_trim.p.fastq 
sample1_R1_trim.unp.fastq sample1_R2_trim.p.fastq 
sample1_R2_trim.unp.fastq ILLUMINACLIP:/cm/shared/apps/trimmomatic/ 
0.33/adapters/TruSeq3-PE-2.fa:2:30:10 LEADING:30 TRAILING:30 
SLIDINGWINDOW:4:30 MINLEN:100  HEADCROP:10  
 
 
 
 
Tuxedo analysis 
 
 Cufflinks  
 
 
> module load cufflinks/2.2.1 
 
# for each sample 
# -p -o <output_directory> <sample_accepted_hits>.bam 
> cufflinks -p 6 –o ../sample1_output_directory sample1_accepted_hits.bam 
> cufflinks -p 6 –o ../sample2_output_directory sample2_accepted_hits.bam 
... 
> cufflinks -p 6 –o ../sample2_output_directory 
sample32_accepted_hits.bam 
 
# create a file called assemblies.txt that lists the assembly file 
created by TopHat for each sample. The file should contain the following 
lines: 
../sample1/transcripts.gtf 
../sample2/transcripts.gtf 
../sample3/transcripts.gtf 
... 
../sample32/transcripts.gtf 
 
# run cuffmerge on all assemblies to create a single merged 
transcriptome annotation 
 
> cuffmerge –o ../output_folder_merged –g annotation.gtf –s genome.fasta 
–p 8 assemblies.txt 
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Cuffdiff sample to sample analysis 
 
> module load cufflinks/2.2.1 
# -o <output_directory> -b <genome>.fa -L <labels> -u <cuffmerge>.gtf 
<sample1_acceptedhits>.bam <sample2_acceptedhits>.bam ... 
> cuffdiff -o ../output_directory -b genome.fasta -p 8 –L \ 
M1_0h,M1_24h,M1_48h,M1_72h,M2_0h,M2_24h,M2_48h,M2_72h,M3_0h,M3_24h,M3_4
8h,M3_72h,M4_0h,M4_24h,M4_48h,M4_72h,M5_0h,M5_24h,M5_48h,M5_72h,M6_0h,M
6_24h,M6_48h,M6_72h,M7_0h,M7_24h,M7_48h,M7_72h,M8_0h,M8_24h,M8_48h,M8_7
2h –u merged.gtf sample1_accepted_hits.bam \  
sample2_accepted_hits.bam sample3_accepted_hits.bam ... \ 
sample32_accepted_hits.bam 
 
Cuffdiff time-point analysis 
> module load cufflinks/2.2.1 
# -o <output_directory> -b <genome>.fa -L <labels> -u <cuffmerge>.gtf 
> cuffdiff –o ../output_directory –b genome.fasta –p 8 –L 
Time0h,Time24h,Time48h,Time72h –u merged.gtf  \ 
sample1_accepted_hits.bam,sample5_accepted_hits.bam,sample9_accepted_hi
ts.bam,sample13_accepted_hits.bam,sample21_accepted_hits.bam,sample29_a
ccepted_hits.bam \ 
sample2_accepted_hits.bam,sample6_accepted_hits.bam,sample10_accepted_h
its.bam,sample14_accepted_hits.bam,sample22_accepted_hits.bam,sample30_
accepted_hits.bam \ 
sample3_accepted_hits.bam,sample7_accepted_hits.bam,sample11_accepted_h
its.bam,sample15_accepted_hits.bam,sample23_accepted_hits.bam,sample31_
accepted_hits.bam \ 
sample3_accepted_hits.bam,sample7_accepted_hits.bam,sample11_accepted_h
its.bam,sample15_accepted_hits.bam,sample23_accepted_hits.bam,sample31_
accepted_hits.bam \ 
 
DESeq2 analysis 
# load package to summarize bam files 
> library(GenomicAlignments) 
 
# put bam files together in a list 
bamfilelist <-c("sample1.bam", "sample2.bam", "sample3.bam, ... 
sample28.bam”)  
 
#BamFileList from Rsamtools provides an R interface to BAM files 
> library(Rsamtools) 
> bamfiles <- BamFileList(bamfilelist)  
 
# use annotation file with the function makeTxDbFromGFF from 
GenomicFeatures  
# list of exons grouped by gene for couting read/fragments 
> library(GenomicFeatures) 
> txdb <- makeTxDbFromGFF("annotationfile.gtf", format="gtf")  
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# produce a GRangesList of all the exons grouped by gene  
> ebg <- exonsBy(txdb, by="gene") 
 
# summarizeOverlaps from GenomicAlignment counts the fragments/reads 
and produces a SummarizedExperiment object`'se' 
> se <- summarizeOverlaps(features=ebg, reads=bamfiles, 
                        mode="Union", 
                        singleEnd=FALSE, 
                        ignore.strand=TRUE, 
                        fragments=TRUE )  
# metadata file created in excel (info about the experiment) 
> sampleTable <- read.csv("exp1_metadata.csv") 
 
# assign the sampleTable as the colData of the summarized experiment by 
converting it into a DataFrame 
> colData(se) <- DataFrame(sampleTable) 
> colData(se) 
DataFrame with 28 rows and 3 columns 
        sample  timepoint horse 
         <factor>    <factor> <factor> 
1  sample1.bam,control0h,1 
2  sample2.bam,time24h,1 
3  sample3.bam,time48h,1 
4  sample4.bam,time72h,1 
5  sample5.bam,control0h,2 
6  sample6.bam,time24h,2 
7  sample7.bam,time48h,2 
8  sample8.bam,time72h,2 
9  sample9.bam,control0h,3 
10 sample10.bam,time24h,3 
11 sample11.bam,time48h,3 
12 sample12.bam,time72h,3 
13 sample13.bam,control0h,4 
14 sample14.bam,time24h,4 
15 sample15.bam,time48h,4 
16 sample16.bam,time72h,4 
17 sample17.bam,control0h,5 
18 sample18.bam,time24h,5 
19 sample19.bam,time48h,5 
20 sample20.bam,time72h,5 
21 sample21.bam,control0h,6 
22 sample22.bam,time24h,6 
23 sample23.bam,time48h,6 
24 sample24.bam,time72h,6 
25 sample25.bam,control0h,7 
26 sample26.bam,time24h,7 
27 sample27.bam,time48h,7 
28 sample28.bam,time72h,7 
 
# DESeq2 - differential analysis  
# SummarizedExperiment 'se' created before will be used for DESeq2 
# nbinomLRT() function to test for the significance of multiple 
coefficients at once 
> library(DESeq2) 
> ddsLRT <- DESeqDataSet(se, design = ~ horse + timepoint) 
> ddsLRT <- estimateSizeFactors(ddsLRT) 
> ddsLRT <- estimateDispersions(ddsLRT) 
> ddsLRT <- nbinomLRT(ddsLRT, reduced = ~ horse) 
> resLRTA <- results(ddsLRT) 
> summary(resLRT) 
> write.csv(resLRT, "resLRTexp1.csv") 
 
 
# dispersion-mean plot 
> plotDispEsts(ddsLRT, main="Estimation of dispersion", sub="For 
Likelihood ratio test object") 
 
# calc of size factors 
> sizeFactors(dds) 
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# normalize data to produce PCA plot 
> rld <- rlog(ddsLRT, blind=FALSE)  
> pcaData <- plotPCA(rld, intgroup = c("timepoint", "horse"), 
returnData = TRUE) 
> percentVar <- round(100 * attr(pcaData, "percentVar")) 
> library("ggplot2") 
> ggplot(pcaData, aes(x = PC1, y = PC2, color = timepoint, shape = 
horse)) + geom_point(size =3) + xlab(paste0("PC1: ", percentVar[1], "% 
variance")) + ylab(paste0("PC2: ", percentVar[2], "%variance")) + 
coord_fixed() + scale_shape_manual(values=seq(0, 8)) 
 
#DESeq2 analysis of normal data 
 
> dds <- DESeqDataSet(se, design = ~ horse + timepoint) 
> dds <- DESeq(dds) 
> resultsNames(dds) 
> plotDispEsts(dds, main="Estimation of dispersion", sub="For DESeq2 
object") 
 
#'contrast' argument to extract comparisons of different levels  
# contrast = c('factorName','numeratorLevel','denominatorLevel') 
> res_0hand24h <- results(dds, contrast=c("timepoint", "control0h", 
"time24h")) 
> res_24hand48h <- results(dds, contrast=c("timepoint", "time24h", 
"time48h")) 
> res_48hand72h <- results(dds, contrast=c("timepoint", "time48h", 
"time72h")) 
 
# save and export  
> write.csv(res_0hand24h, "resWH5A_0hand24h.csv") 
> write.csv(res_24hand48h, "resWH5A_24hand48h.csv") 
> write.csv(res_48hand72h, "resWH5A_48hand72h.csv") 
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Appendix 4.3 
List of all significantly enriched GO terms in Chapter 4 between 0 
hours (control) and 72 hours – Cuffdiff results 
 
Enrichment term Term name Gene 
count 
FDR p-value 
GOTERM_CC_DIRECT GO:0070062~extracellular exosome 644 4.17 x 10
-41
 
GOTERM_CC_DIRECT GO:0005925~focal adhesion 130 2.71 x 10
-19
 
GOTERM_CC_DIRECT GO:0005737~cytoplasm 598 9.30 x 10
-12
 
GOTERM_CC_DIRECT GO:0009897~external side of plasma 
membrane 
68 3.73 x 10
-10
 
GOTERM_BP_DIRECT GO:0007229~integrin-mediated signaling 
pathway 
36 2.00 x 10
-8
 
GOTERM_BP_DIRECT GO:0007155~cell adhesion 56 1.12 x 10
-7
 
GOTERM_BP_DIRECT GO:0030335~positive regulation of cell 
migration 
52 1.10 x10
-6
 
GOTERM_CC_DIRECT GO:0009986~cell surface 101 2.54 x 10
-6
 
GOTERM_CC_DIRECT GO:0008305~integrin complex 16 9.44 x 10
-6
 
GOTERM_BP_DIRECT GO:0001525~angiogenesis 44 4.70 x10
-5
 
GOTERM_CC_DIRECT GO:0045121~membrane raft 40 8.66 x 10
-5
 
GOTERM_MF_DIRECT GO:0005524~ATP binding 276 9.12 x 10
-5
 
GOTERM_MF_DIRECT GO:0005509~calcium ion binding 148 1.49 x 10
-4
 
GOTERM_BP_DIRECT GO:0008284~positive regulation of cell 
proliferation 
73 5.32 x 10
-4
 
GOTERM_CC_DIRECT GO:0005829~cytosol 218 5.99 x 10
-4
 
GOTERM_CC_DIRECT GO:0005783~endoplasmic reticulum 120 8.15 x 10
-4
 
GOTERM_CC_DIRECT GO:0030027~lamellipodium 41 8.26 x 10
-4
 
GOTERM_BP_DIRECT GO:0008285~negative regulation of cell 
proliferation 
70 8.81 x10
-4
 
GOTERM_BP_DIRECT GO:0030198~extracellular matrix organization 31 0.001 
GOTERM_CC_DIRECT GO:0005634~nucleus 486 0.002 
GOTERM_CC_DIRECT GO:0005615~extracellular space 210 0.002 
GOTERM_BP_DIRECT GO:0008360~regulation of cell shape 40 0.003 
GOTERM_BP_DIRECT GO:0010628~positive regulation of gene 
expression 
48 
0.004 
GOTERM_CC_DIRECT GO:0005911~cell-cell junction 40 0.004 
GOTERM_CC_DIRECT GO:0005604~basement membrane 23 0.008 
GOTERM_BP_DIRECT GO:0034446~substrate adhesion-dependent cell 
spreading 
19 
0.009 
GOTERM_BP_DIRECT GO:0007160~cell-matrix adhesion 27 0.010 
GOTERM_BP_DIRECT GO:0033138~positive regulation of peptidyl-
serine phosphorylation 
27 
0.010 
GOTERM_BP_DIRECT GO:0045766~positive regulation of 
angiogenesis 
31 
0.010 
GOTERM_BP_DIRECT GO:0048146~positive regulation of fibroblast 
proliferation 
20 
0.010 
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GOTERM_BP_DIRECT GO:0043066~negative regulation of apoptotic 
process 
66 
0.011 
GOTERM_MF_DIRECT GO:0008201~heparin binding 35 0.013 
GOTERM_BP_DIRECT GO:0030155~regulation of cell adhesion 18 0.015 
GOTERM_BP_DIRECT GO:0043065~positive regulation of apoptotic 
process 
45 
0.018 
GOTERM_BP_DIRECT GO:0006954~inflammatory response 60 0.024 
GOTERM_CC_DIRECT GO:0048471~perinuclear region of cytoplasm 86 0.026 
GOTERM_MF_DIRECT GO:0046872~metal ion binding 186 0.027 
GOTERM_MF_DIRECT GO:0005178~integrin binding 12 0.029 
GOTERM_BP_DIRECT GO:0030154~cell differentiation 43 0.032 
GOTERM_CC_DIRECT GO:0005578~proteinaceous extracellular 
matrix 
51 
0.032 
GOTERM_CC_DIRECT GO:0043209~myelin sheath 46 0.036 
GOTERM_BP_DIRECT GO:0043123~positive regulation of I-kappaB 
kinase/NF-kappaB signaling 
45 
0.037 
GOTERM_CC_DIRECT GO:0001772~immunological synapse 17 0.038 
GOTERM_BP_DIRECT GO:0032496~response to lipopolysaccharide 30 0.043 
GOTERM_CC_DIRECT GO:0031012~extracellular matrix 33 0.046 
GOTERM_BP_DIRECT GO:0048008~platelet-derived growth factor 
receptor signaling pathway 
14 
0.049 
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Appendix 4.4  
Clusters between 0 hours (control) and 72 hours 
 
Annotation Cluster 1 - Enrichment Score: 5.99 
Category Term Count PValue FDR 
UP_KEYWORDS Integrin 19 9.93 x 10
-9
 0.000 
INTERPRO IPR013649:Integrin alpha-2 14 7.54 x 10
-7
 0.001 
INTERPRO IPR000413:Integrin alpha chain 14 7.54 x10
-7
 0.001 
INTERPRO IPR018184:Integrin alpha chain, C-terminal 
cytoplasmic region, conserved site 
13 1.07 x10
-6
 0.002 
INTERPRO IPR013519:Integrin alpha beta-propellor 14 1.99 x10
-6
 0.004 
INTERPRO IPR013517:FG-GAP repeat 13 7.60 x 10
-6
 0.014 
SMART SM00191:Int_alpha 14 1.38 x 10
-5
 0.020 
 
Annotation Cluster 2 - Enrichment Score: 4.06 
Category Term Count PValue FDR 
UP_KEYWORDS EGF-like domain 38 1.97E-05 0.026 
INTERPRO IPR001881:EGF-like calcium-binding 37 4.17E-05 0.075 
INTERPRO IPR000152:EGF-type aspartate/asparagine 
hydroxylation site 
31 5.53E-05 0.099 
SMART SM00179:EGF_CA 37 0.002 1.731 
 
Annotation Cluster 3- Enrichment Score: 3.66 
Category Term Count PValue FDR 
INTERPRO IPR008266:Tyrosine-protein kinase, active site 32 3.44E-05 0.062 
INTERPRO IPR020635:Tyrosine-protein kinase, catalytic 
domain 
29 4.83E-05 0.087 
INTERPRO IPR001245:Serine-threonine/tyrosine-protein 
kinase catalytic domain 
39 4.63E-04 0.830 
UP_KEYWORDS Tyrosine-protein kinase 25 7.85E-04 1.042 
SMART SM00219:TyrKc 29 8.74E-04 1.256 
 
Annotation Cluster 4 - Enrichment Score: 3.49 
Category Term Count PValue FDR 
INTERPRO IPR003599:Immunoglobulin subtype 76 2.64E-05 0.047 
INTERPRO IPR007110:Immunoglobulin-like domain 95 3.03E-04 0.543 
SMART SM00409:IG 76 0.004119 5.790 
 
Annotation Cluster 5 - Enrichment Score: 3.26 
Category Term Count PValue FDR 
INTERPRO IPR008936:Rho GTPase activation protein 29 8.39E-05 0.151 
INTERPRO IPR000198:Rho GTPase-activating protein domain 22 6.25E-04 1.118 
SMART SM00324:RhoGAP 22 0.003 4.630 
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Annotation Cluster 6 - Enrichment Score: 2.64 
Category Term Count PValue FDR 
INTERPRO IPR000387:Protein-tyrosine/Dual specificity 
phosphatase 
26 4.42E-04 0.793 
INTERPRO IPR003595:Protein-tyrosine phosphatase, catalytic 21 0.00 2.326 
INTERPRO IPR016130:Protein-tyrosine phosphatase, active 
site 
21 0.005 8.797 
SMART SM00404:PTPc_motif 21 0.009 12.949 
 
 
 
Annotation Cluster 7 - Enrichment Score: 2.48 
Category Term Count PValue FDR 
INTERPRO IPR002172:Low-density lipoprotein (LDL) 
receptor class A repeat 
17 0.001 2.374 
INTERPRO IPR023415:Low-density lipoprotein (LDL) 
receptor class A, conserved site 
14 0.002 4.291 
SMART SM00192:LDLa 16 0.011 15.034 
 
 
 
Annotation Cluster 8 - Enrichment Score: 2.34 
Category Term Count PValue FDR 
UP_KEYWORDS ANK repeat 48 0.002 2.343 
INTERPRO IPR002110:Ankyrin repeat 49 0.005 8.346 
INTERPRO IPR020683:Ankyrin repeat-containing domain 49 0.011 18.191 
 
 
 
Annotation Cluster 9 - Enrichment Score: 2.25 
Category Term Count PValue FDR 
INTERPRO IPR002073:3'5'-cyclic nucleotide 
phosphodiesterase, catalytic domain 
11 0.002 3.307 
INTERPRO IPR023088:3'5'-cyclic nucleotide 
phosphodiesterase 
10 0.003 5.775 
INTERPRO IPR023174:3'5'-cyclic nucleotide 
phosphodiesterase, conserved site 
10 0.005 8.702 
INTERPRO IPR003607:HD/PDEase domain 9 0.033 45.393 
 
 
 
Annotation Cluster 10 - Enrichment Score: 1.96 
Category Term Count PValue FDR 
INTERPRO IPR025660:Cysteine peptidase, histidine active site 7 0.004 6.572 
INTERPRO IPR000668:Peptidase C1A, papain C-terminal 7 0.012 19.418 
INTERPRO IPR013128:Peptidase C1A, papain 7 0.012 19.418 
SMART SM00645:Pept_C1 7 0.027 32.254 
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Annotation Cluster 11 - Enrichment Score: 1.94 
Category Term Count PValue FDR 
INTERPRO IPR020728:Apoptosis regulator, Bcl-2, BH3 
motif, conserved site 
5 0.005 7.938 
INTERPRO IPR020717:Apoptosis regulator, Bcl-2, BH1 
motif, conserved site 
5 0.012 19.203 
INTERPRO IPR026298:Blc2 family 6 0.013 20.667 
GOTERM_MF GO:0046982~protein heterodimerization 
activity 
8 0.013 19.247 
INTERPRO IPR002475:Bcl2-like 6 0.022 32.737 
 
Annotation Cluster 12 - Enrichment Score: 1.61 
Category Term Count PValue FDR 
GOTERM_BP GO:0048846~axon extension involved in axon 
guidance 
5 0.016 26.309 
GOTERM_BP GO:0097490~sympathetic neuron projection extension 4 0.026 39.350 
GOTERM_BP GO:0097491~sympathetic neuron projection guidance 4 0.026 39.350 
GOTERM_BP GO:0036486~ventral trunk neural crest cell migration 4 0.026 39.350 
GOTERM_BP GO:0061549~sympathetic ganglion development 5 0.031 45.511 
 
Annotation Cluster 13 - Enrichment Score: 1.50 
Category Term Count PValue FDR 
INTERPRO IPR016161:Aldehyde/histidinol dehydrogenase 8 0.031 43.672 
INTERPRO IPR015590:Aldehyde dehydrogenase domain 8 0.031 43.672 
INTERPRO IPR016162:Aldehyde dehydrogenase, N-terminal 8 0.031 43.672 
INTERPRO IPR016163:Aldehyde dehydrogenase, C-terminal 8 0.031 43.672 
 
Annotation Cluster 14 - Enrichment Score: 1.49 
Category Term Count PValue FDR 
INTERPRO IPR000426:Proteasome, alpha-subunit, N-terminal 
domain 
5 0.024 34.894 
GOTERM_CC GO:0019773~proteasome core complex, alpha-subunit 
complex 
5 0.027 34.494 
INTERPRO IPR023332:Proteasome A-type subunit 5 0.040 52.444 
SMART SM00948:SM00948 5 0.042 46.103 
 
 Annotation Cluster 15 - Enrichment Score: 1.48 
Category Term Count PValue FDR 
GOTERM_MF GO:0004740~pyruvate dehydrogenase (acetyl-
transferring) kinase activity 
4 0.023 31.537 
GOTERM_BP GO:0010510~regulation of acetyl-CoA biosynthetic 
process from pyruvate 
4 0.026 39.350 
INTERPRO IPR005467:Signal transduction histidine kinase, core 4 0.044 55.796 
INTERPRO IPR018955:Branched-chain alpha-ketoacid 
dehydrogenase kinase/Pyruvate dehydrogenase kinase, 
N-terminal 
4 0.044 55.796 
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Annotation Cluster 16 - Enrichment Score: 1.47 
Category Term Count PValue FDR 
INTERPRO IPR012896:Integrin beta subunit, tail 5 0.024 34.894 
INTERPRO IPR002369:Integrin beta subunit, N-terminal 5 0.040 52.444 
SMART SM01242:SM01242 5 0.042 46.103 
 
Annotation Cluster 17 - Enrichment Score: 1.46 
Category Term Count PValue FDR 
INTERPRO IPR020422:Dual specificity phosphatase, subgroup, 
catalytic domain 
11 0.026 38.217 
INTERPRO IPR024950:Dual specificity phosphatase 10 0.034 45.921 
INTERPRO IPR000340:Dual specificity phosphatase, catalytic 
domain 
12 0.049 59.184 
 
Annotation Cluster 18 - Enrichment Score: 1.43 
Category Term Count PValue FDR 
GOTERM_MF GO:0008865~fructokinase activity 4 0.023 31.537 
GOTERM_MF GO:0019158~mannokinase activity 4 0.023 31.537 
INTERPRO IPR019807:Hexokinase, conserved site 4 0.044 55.796 
INTERPRO IPR022672:Hexokinase, N-terminal 4 0.044 55.796 
INTERPRO IPR001312:Hexokinase 4 0.044 55.796 
INTERPRO IPR022673:Hexokinase, C-terminal 4 0.044 55.796 
 
Annotation Cluster 19 - Enrichment Score: 1.39 
Category Term Count PValue FDR 
INTERPRO IPR026791:Dedicator of cytokinesis 5 0.040 52.444 
INTERPRO IPR027007:DHR-1 domain 5 0.040 52.444 
INTERPRO IPR027357:DHR-2 domain 5 0.040 52.444 
INTERPRO IPR010703:Dedicator of cytokinesis C-terminal 5 0.040 52.444 
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Appendix 4.5 
List of all significantly enriched KEGG pathways and GO terms in Chapter 4 
when comparing the 0 hours (control) relative to 24 hours associated with 
Log2FC ≥2 at an FDR of 0.05 sorted by p-value – DESeq2 results 
 
Enrichment term Term name Description Gene 
count 
FDR p-value 
KEGG pathway 4610 Complement and coagulation cascades 24 6.92 x 10-15 
Cell component GO.0005576 extracellular region 24 5.94 x 10-11 
KEGG pathway 4640 Hematopoietic cell lineage 19 7.03 x 10-11 
Cell component GO.0044421 extracellular region part 20 1.33E x 10-11 
KEGG pathway 4060 Cytokine-cytokine receptor interaction 29 1.69 x 10-9 
Cell component GO.0005575 cellular_component 33 2.65 x 10-9 
KEGG pathway 4151 PI3K-Akt signaling pathway 49 1.92 x 10-8 
Biological Process GO.0008150 biological_process 33 2.10 x 10-8 
KEGG pathway 4512 ECM-receptor interaction 22 6.55 x 10-8 
Biological Process GO.0044699 single-organism process 29 6.84 x 10-8 
Biological Process GO.0006950 response to stress 18 6.84 x 10-8 
Biological Process GO.0006952 defense response 15 6.84 x 10-8 
Cell component GO.0005615 extracellular space 14 3.32 x 10-7 
KEGG pathway 10 Glycolysis / Gluconeogenesis 17 3.62 x 10-7 
KEGG pathway 4066 HIF-1 signaling pathway 23 9.44 x 10-7 
Biological Process GO.0050896 response to stimulus 19 2.04 x 10-7 
Biological Process GO.0006954 inflammatory response 11 2.04 x 10-7 
KEGG pathway 5020 Prion diseases 12 6.34 x 10-7 
KEGG pathway 4668 TNF signaling pathway 24 6.72 x 10-6 
Molecular Function GO.0003674 molecular_function 27 9.18 x 10-6 
Molecular Function GO.0043167 ion binding 18 9.18 x 10-6 
Molecular Function GO.0005488 binding 21 1.01 x 10-5 
KEGG pathway 4510 Focal adhesion 33 1.06 x 10-5 
KEGG pathway 5200 Pathways in cancer 42 2.71 x 10-5 
Molecular Function GO.0070011 peptidase activity, acting on L-amino acid 
peptides 
6 
2.96 x 10-5 
KEGG pathway 5206 MicroRNAs in cancer 25 3.38 x 10-5 
Biological Process GO.0009987 cellular process 24 4.86 x 10-5 
KEGG pathway 5144 Malaria 11 6.12 x 10-5 
Biological Process GO.0044763 single-organism cellular process 21 0.000 
Biological Process GO.0050789 regulation of biological process 18 0.000 
Biological Process GO.0044707 single-multicellular organism process 14 0.000 
Biological Process GO.0065008 regulation of biological quality 13 0.000 
Molecular Function GO.0046872 metal ion binding 12 0.000 
KEGG pathway 5222 Small cell lung cancer 18 0.000 
KEGG pathway 4630 Jak-STAT signaling pathway 20 0.000 
KEGG pathway 5202 Transcriptional misregulation in cancer 24 0.000 
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Biological Process GO.0002376 immune system process 11 0.000 
Biological Process GO.0044238 primary metabolic process 18 0.000 
Biological Process GO.0065007 biological regulation 18 0.000 
Biological Process GO.0006953 acute-phase response 6 0.000 
KEGG pathway 1120 Microbial metabolism in diverse 
environments 
24 
0.000 
Biological Process GO.0006629 lipid metabolic process 7 0.000 
KEGG pathway 1230 Biosynthesis of amino acids 15 0.000 
KEGG pathway 5323 Rheumatoid arthritis 15 0.000 
Biological Process GO.0044710 single-organism metabolic process 15 0.000 
Biological Process GO.0071704 organic substance metabolic process 18 0.000 
KEGG pathway 5150 Staphylococcus aureus infection 9 0.000 
Biological Process GO.0006508 proteolysis 6 0.001 
KEGG pathway 5146 Amoebiasis 17 0.001 
KEGG pathway 5219 Bladder cancer 10 0.002 
KEGG pathway 5322 Systemic lupus erythematosus 10 0.002 
Biological Process GO.0008152 metabolic process 19 0.002 
Biological Process GO.0051239 regulation of multicellular organismal 
process 
10 
0.002 
Biological Process GO.0006955 immune response 8 0.002 
KEGG pathway 5133 Pertussis 13 0.002 
Molecular Function GO.0004175 endopeptidase activity 4 0.003 
KEGG pathway 5414 Dilated cardiomyopathy 12 0.003 
Cell component GO.0005623 cell 20 0.003 
Molecular Function GO.0003824 catalytic activity 14 0.003 
Molecular Function GO.0005509 calcium ion binding 5 0.003 
Cell component GO.0005622 intracellular 18 0.003 
Biological Process GO.0050794 regulation of cellular process 14 0.003 
KEGG pathway 140 Steroid hormone biosynthesis 6 0.004 
Molecular Function GO.0046914 transition metal ion binding 7 0.004 
Cell component GO.0044464 cell part 19 0.004 
KEGG pathway 4015 Rap1 signaling pathway 25 0.004 
KEGG pathway 5134 Legionellosis 11 0.004 
KEGG pathway 5410 Hypertrophic cardiomyopathy (HCM) 11 0.004 
KEGG pathway 5205 Proteoglycans in cancer 26 0.005 
Biological Process GO.0051716 cellular response to stimulus 11 0.005 
KEGG pathway 51 Fructose and mannose metabolism 8 0.005 
KEGG pathway 4064 NF-kappa B signaling pathway 14 0.005 
KEGG pathway 4976 Bile secretion 10 0.005 
Biological Process GO.0048518 positive regulation of biological process 11 0.007 
Cell component GO.0044424 intracellular part 17 0.007 
Biological Process GO.0048522 positive regulation of cellular process 10 0.008 
Biological Process GO.0032787 monocarboxylic acid metabolic process 5 0.008 
Cell component GO.0005737 cytoplasm 16 0.008 
Molecular Function GO.1901681 sulfur compound binding 4 0.009 
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Biological Process GO.0042221 response to chemical 10 0.009 
Biological Process GO.0044767 single-organism developmental process 10 0.009 
KEGG pathway 5142 Chagas disease (American 
trypanosomiasis) 
15 
0.010 
KEGG pathway 5143 African trypanosomiasis 6 0.010 
KEGG pathway 1200 Carbon metabolism 16 0.010 
Biological Process GO.0042592 homeostatic process 8 0.010 
Molecular Function GO.0008270 zinc ion binding 5 0.013 
Biological Process GO.0048856 anatomical structure development 9 0.014 
KEGG pathway 4080 Neuroactive ligand-receptor interaction 11 0.017 
Biological Process GO.0043436 oxoacid metabolic process 6 0.017 
Molecular Function GO.0004222 metalloendopeptidase activity 3 0.018 
KEGG pathway 4014 Ras signaling pathway 23 0.019 
KEGG pathway 4913 Ovarian steroidogenesis 7 0.019 
Biological Process GO.0009056 catabolic process 7 0.021 
KEGG pathway 4380 Osteoclast differentiation 15 0.021 
Cell component GO.0012505 endomembrane system 7 0.022 
Biological Process GO.0048731 system development 8 0.031 
Biological Process GO.0070887 cellular response to chemical stimulus 8 0.031 
Biological Process GO.0001516 prostaglandin biosynthetic process 3 0.031 
Biological Process GO.0030574 collagen catabolic process 3 0.031 
Biological Process GO.0051781 positive regulation of cell division 4 0.032 
KEGG pathway 4115 p53 signaling pathway 11 0.033 
Biological Process GO.0048583 regulation of response to stimulus 8 0.033 
Cell component GO.0044425 membrane part 11 0.034 
Biological Process GO.0051336 regulation of hydrolase activity 5 0.034 
Biological Process GO.0098542 defense response to other organism 5 0.034 
Biological Process GO.0009605 response to external stimulus 7 0.037 
Biological Process GO.0048513 organ development 7 0.037 
Molecular Function GO.0005539 glycosaminoglycan binding 4 0.039 
KEGG pathway 5145 Toxoplasmosis 15 0.040 
Biological Process GO.0007275 multicellular organismal development 8 0.041 
KEGG pathway 5412 Arrhythmogenic right ventricular 
cardiomyopathy (ARVC) 
9 
0.042 
KEGG pathway 524 Butirosin and neomycin biosynthesis 2 0.044 
KEGG pathway 4672 Intestinal immune network for IgA 
production 
6 
0.047 
Cell component GO.0043226 organelle 13 0.050 
Cell component GO.0016020 membrane 12 0.050 
Cell component GO.0071944 cell periphery 8 0.05 
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Appendix 5.1 
Kenney Classification of Mares Providing Endometrial Explants in Chapter 5 
 
Mares Histology report
b
 
Kenney 
classification 
1  Medium epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed diffuse grade 1 fibrosis. I 
2  Medium epithelium. Stratum compactum showed lymphocyte focal infiltration grade 1. Stratum spongiosum examined, no pathologic 
findings noted. 
I 
3  Tall epithelium. Stratum compactum showed diffuse gland atrophy grade 1. Stratum spongiosum showed diffuse gland atrophy grade 2, 
multifocal cystic glands grade 3 with inspissated contents, fibrosis periglandular grade 3 and lymphocyte infiltration grade 1.  
II 
4 Medium epithelium. Stratum compactum showed lymphocyte infiltration grade 1, macrophage and erythrophagocytes infiltration grade 
2. Stratum spongiosum showed lymphocyte infiltration grade 1, macrophage and erythrophagocytes infiltration grade 2 and siderocyte 
infiltration grade 1.  
I 
5 Tall epithelium. Stratum compactum showed focal lymphocyte infiltration grade 1. Stratum spongiosum examined, no pathologic 
findings noted. 
I 
6  Tall epithelium. Stratum compactum showed focal lymphocyte infiltration grade 1. Stratum spongiosum showed focal cystic glands 
grade 1 and local lymphocyte infiltration grade 1.  
I 
7 Medium epithelium. Stratum compactum examined, no pathological findings noted. Stratum spongiosum showed multifocal cystic 
glands with inspissated contents grade 1. 
I 
8 Low epithelium. Stratum compactum showed siderocyte infiltration grade 1. Stratum spongiosum examined, no pathologic findings 
noted.  
I 
9 Low epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed focal cystic glands grade 1 I 
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with inspissated contents and epithelial hyperplasia and cystic glands grade 1. 
10 Low epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed focal cystic glands grade 1 
with inspissated contents and epithelial hyperplasia. 
I 
11 No tissue available for examination.  - 
12 Low epithelium. Stratum compactum showed lymphocyte infiltration grade 1. Stratum spongiosum showed focal cystic glands grade 1. I 
13  Low epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed multifocal cystic glands 
grade 2 with inspissated contents, epithelial hyperplasia and focal cystic glands grade 1. 
I 
14 Low epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed multifocal cystic glands 
grade 1 with inspissated contents and lymphocyte infiltration grade 1. 
I 
15 No tissue available for examination.  - 
16 Low epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed multifocal cystic glands 
grade 2 with inspissated contents and periglandular fibrosis grade 2.  
II 
17 Low epithelium. No pathologic findings. I 
18 Low epithelium. Stratum compactum showed siderocyte infiltration grade 1. Stratum spongiosum showed multifocal cystic glands grade 
2 with inspissated contents and infiltration of siderocytes grade 2. 
I 
 a
 Grade 1 = minimal/very few/very small. Grade 2 = slight/few/small. Grade 3 =  moderate/moderate number/moderate size. Grade 4 = marked/many/large.
269 
 
Appendix 5.2  
Computer Code used in Chapter 5  
DESeq2 analysis 
 
 
# load package to summarize bam files 
> library(GenomicAlignments) 
 
# put bam files together in a list 
bamfilelist <-c("sample1.bam", "sample2.bam", "sample3.bam, ... 
sample50.bam”)  
 
#BamFileList from Rsamtools provides an R interface to BAM files 
> library(Rsamtools) 
> bamfiles <- BamFileList(bamfilelist)  
 
# use annotation file with the function makeTxDbFromGFF from 
GenomicFeatures  
# list of exons grouped by gene for couting read/fragments 
> library(GenomicFeatures) 
> txdb <- makeTxDbFromGFF("annotationfile.gtf", format="gtf")  
 
# produce a GRangesList of all the exons grouped by gene  
> ebg <- exonsBy(txdb, by="gene") 
 
# summarizeOverlaps from GenomicAlignment counts the fragments/reads 
and produces a SummarizedExperiment object`'se' 
> se <- summarizeOverlaps(features=ebg, reads=bamfiles, 
                        mode="Union", 
                        singleEnd=FALSE, 
                        ignore.strand=TRUE, 
                        fragments=TRUE )  
# metadata file created in excel (info about the experiment) 
> sampleTable <- read.csv("exp2_metadata.csv") 
 
# assign the sampleTable as the colData of the summarized experiment by 
converting it into a DataFrame 
> colData(se) <- DataFrame(sampleTable) 
> colData(se) 
DataFrame with 50 rows and 5 columns 
sample,phase,horse,timepoint,horse.n 
1  sample_1.bam,follicular,1,0h,1 
2  sample_2.bam,follicular,1,24h,1 
3  sample_3.bam,follicular,1,48h,1 
4  sample_4.bam,follicular,2,0h,2 
5  sample_6.bam,follicular,2,48h,2 
6  sample_10.bam,follicular,3,0h,3 
7  sample_11.bam,follicular,3,24h,3 
8  sample_12.bam,follicular,3,48h,3 
9  sample_13.bam,follicular,4,0h,4 
10 sample_14.bam,follicular,4,24h,4 
11 sample_15.bam,follicular,4,48h,4 
12 sample_16.bam,follicular,5,0h,5 
13 sample_17.bam,follicular,5,24h,5 
14 sample_18.bam,follicular,5,48h,5 
15 sample_55.bam,follicular,6,0h,6 
16 sample_56.bam,follicular,6,24h,6 
17 sample_58.bam,follicular,6,48h,6 
18 sample_22.bam,luteal,8,0h,1 
19 sample_23.bam,luteal,8,24h,1 
20 sample_24.bam,luteal,8,48h,1 
21 sample_25.bam,luteal,9,0h,2 
22 sample_26.bam,luteal,9,24h,2 
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23 sample_27.bam,luteal,9,48h,2 
24 sample_28.bam,luteal,10,0h,3 
25 sample_29.bam,luteal,10,24h,3 
26 sample_30.bam,luteal,10,48h,3 
27 sample_31.bam,luteal,11,0h,4 
28 sample_32.bam,luteal,11,24h,4 
29 sample_33.bam,luteal,11,48h,4 
30 sample_34.bam,luteal,12,0h,5 
31 sample_35.bam,luteal,12,24h,5 
32 sample_36.bam,luteal,121D,48h,5 
33 sample_37.bam,anoestrous,13,0h,1 
34 sample_38.bam,anoestrous,13,24h,1 
35 sample_39.bam,anoestrous,13,48h,1 
36 sample_40.bam,anoestrous,14,0h,2 
37 sample_41.bam,anoestrous,14,24h,2 
38 sample_42.bam,anoestrous,14,48h,2 
39 sample_43.bam,anoestrous,15,0h,3 
40 sample_44.bam,anoestrous,15,24h,3 
41 sample_45.bam,anoestrous,15,48h,3 
42 sample_46.bam,anoestrous,16,0h,4 
43 sample_47.bam,anoestrous,16,24h,4 
44 sample_48.bam,anoestrous,16,48h,4 
45 sample_49.bam,anoestrous,17,0h,5 
46 sample_50.bam,anoestrous,17,24h,5 
47 sample_51.bam,anoestrous,17,48h,5 
48 sample_52.bam,anoestrous,18,0h,6 
49 sample_53.bam,anoestrous,18,24h,6 
50 sample_54.bam,anoestrous,18,48h,6 
 
# DESeq2 - differential analysis  
# SummarizedExperiment 'se' created before will be used for DESeq2 
> library(DESeq2) 
> dds_matrix <- DESeqDataSet(se, design = ~ phase + timepoint + 
phase:timepoint) 
> dds_matrix <- DESeq(dds_matrix) 
> resultsNames(dds_matrix) 
 
# reassign DESeqDataSet a design of  ~ grp + grp:ind.n + grp:cnd 
# this new design will result in the following model matrix  
# exp2_matrix2 <- model.matrix(~ phase + phase:horse.n + 
phase:timepoint, colData) 
> exp2_matrix2 <- model.matrix(~ phase + phase:horse.n + 
phase:timepoint, colData) 
> dds_matrix2 <- DESeq(dds_matrix, full=exp2_matrix2, betaPrior=F) 
 
#'contrast' argument to extract comparisons of different levels  
# contrast = c('factorName','numeratorLevel','denominatorLevel') 
> res_follicular_luteal_24h_matrix2 <- results(dds_matrix2, 
contrast=list("phasefollicular.timepoint24h","phaseluteal.timepoint24h"
)) 
 
> res_follicular_luteal_48h_matrix2 <- results(dds_matrix2, 
contrast=list("phasefollicular.timepoint48h","phaseluteal.timepoint48h"
)) 
 
> res_follicular_anoestrous_24h_matrix2 <- results(dds_matrix2, 
contrast=list("phasefollicular.timepoint24h","phaseanoestrous.timepoint
24h")) 
> res_follicular_anoestrous_48h_matrix2 <- results(dds_matrix2, 
contrast=list("phasefollicular.timepoint48h","phaseanoestrous.timepoint
48h")) 
 
 
> res_luteal_anoestrous_24h_matrix2 <- results(dds_matrix2, 
contrast=list("phaseluteal.timepoint24h","phaseanoestrous.timepoint24h"
)) 
> res_luteal_anoestrous_48h_matrix2 <- results(dds_matrix2, 
contrast=list("phaseluteal.timepoint48h","phaseanoestrous.timepoint48h"
)) 
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#writing files for results 
> write.csv(res_follicular_luteal_24h_matrix2, 
"res_follicular_luteal_24h_matrix2.csv") 
> write.csv(res_follicular_luteal_48h_matrix2, 
"res_follicular_luteal_48h_matrix2.csv") 
 
> write.csv(res_follicular_anoestrous_24h_matrix2, 
"res_follicular_anoestrous_24h_matrix2.csv") 
> write.csv(res_follicular_anoestrous_48h_matrix2, 
"res_follicular_anoestrous_48h_matrix2.csv") 
 
> write.csv(res_luteal_anoestrous_24h_matrix2, 
"res_luteal_anoestrous_24h_matrix2.csv") 
> write.csv(res_luteal_anoestrous_48h_matrix2, 
"res_luteal_anoestrous_48h_matrix2.csv") 
 
# dispersion-mean plots 
> plotDispEsts(dds_matrix2, main="Estimation of dispersion for 
dds_matrix2", sub="For DESeq2 object") 
 
# calc of size factors 
> sizeFactors(dds_matrix2) 
 
# normalize data to produce PCA plot 
> rld_matrix2 <- rlog(dds_matrix2, blind=FALSE) 
 
> pcaData_rld_matrix2 <- plotPCA(rld_matrix2, intgroup = c("timepoint", 
"horse", "phase"), returnData = TRUE) 
percentVar <- round(100 * attr(pcaData_rld_matrix2, "percentVar")) 
 
> library("ggplot2") 
> ggplot(pcaData_rld_matrix2, aes(x = PC1, y = PC2, color = phase, 
shape = timepoint)) + geom_point(size =3) + xlab(paste0("PC1: ", 
percentVar[1], "% variance")) + ylab(paste0("PC2: ", percentVar[2], 
"%variance")) + coord_fixed() + scale_shape_manual(values=seq(0, 20)) 
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Appendix 5.3 
List of all significantly enriched GO terms in Chapter 5 when comparing the 
follicular and luteal phase groups at 24 hours associated with Log2FC ≥2 at an 
FDR of 0.05 sorted by p-value  
GO Category Term name Description Count 
FDR p-
value 
Cellular component GO.0005575 Cellular component 13 4.10 x 10
-6
 
Biological process GO.0044707 Single-multicellular organism process 8 8.04 x 10
-5
 
Cellular component GO.0005576 Extracellular region 8 1.49 x 10
-4
 
Molecular function GO.0003674 Molecular function 11 2.37 x 10
-4
 
Molecular function GO.0005488 Binding 9 2.37 x 10
-4
 
Molecular function GO.0046914 Transition metal ion binding 5 2.37 x 10
-4
 
Biological process GO.0044699 Single-organism process 10 7.80 x 10
-4
 
Biological process GO.0050794 Regulation of cellular process 8 7.80 x 10
-4
 
Molecular function GO.0046872 Metal ion binding 6 8.51 x 10
-4
 
Biological process GO.0008150 Biological process 10 0.002 
Biological process GO.0044767 single-organism developmental process 6 0.002 
Biological process GO.0065008 regulation of biological quality 6 0.002 
Biological process GO.0050896 response to stimulus 7 0.002 
Biological process GO.0048518 positive regulation of biological process 6 0.002 
Biological process GO.0051716 cellular response to stimulus 6 0.002 
Cellular component GO.0044421 extracellular region part 6 0.003 
Biological process GO.0002376 immune system process 5 0.005 
Biological process GO.0048731 system development 5 0.005 
Biological process GO.0006357 regulation of transcription from RNA 
polymerase II promoter 
4 0.006 
Biological process GO.0007275 multicellular organismal development 5 0.007 
Molecular function GO.0038023 signaling receptor activity 3 0.008 
Biological process GO.0009987 cellular process 8 0.008 
Biological process GO.0048522 positive regulation of cellular process 5 0.008 
Biological process GO.0065007 biological regulation 7 0.008 
Biological process GO.0042221 response to chemical 5 0.009 
Biological process GO.0006954 inflammatory response 4 0.009 
Molecular function GO.0008270 zinc ion binding 3 0.011 
Biological process GO.0003008 system process 3 0.013 
Biological process GO.0044763 single-organism cellular process 7 0.016 
Biological process GO.0001660 fever generation 2 0.018 
Biological process GO.0006950 response to stress 5 0.018 
Biological process GO.0008217 regulation of blood pressure 2 0.018 
Biological process GO.0033554 cellular response to stress 3 0.018 
Biological process GO.0048513 organ development 4 0.018 
Molecular function GO.0004222 metalloendopeptidase activity 2 0.020 
Molecular function GO.0016209 antioxidant activity 2 0.020 
Molecular function GO.0005515 protein binding 3 0.029 
Biological process GO.0045893 positive regulation of transcription, DNA-
templated 
3 0.030 
Biological process GO.0051094 positive regulation of developmental process 3 0.030 
Biological process GO.0048583 regulation of response to stimulus 4 0.031 
Biological process GO.0002244 hematopoietic progenitor cell differentiation 2 0.034 
Biological process GO.0030574 collagen catabolic process 2 0.034 
Biological process GO.0045639 positive regulation of myeloid cell 
differentiation 
2 0.034 
Cellular component GO.0005623 cell 7 0.037 
Cellular component GO.0005615 extracellular space 4 0.037 
Biological process GO.0008152 metabolic process 6 0.049 
Cellular component GO.0005886 plasma membrane 4 0.050 
Cellular component GO.0071944 cell periphery 4 0.050 
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Appendix 5.4 
List of all significantly enriched GO terms in Chapter 5 when comparing the 
follicular and anoestrous phase groups at 24 hours associated with Log2FC ≥2 at 
an FDR of 0.05 sorted by p-value  
 
GO Category Term name Description Count 
FDR p-
value 
Biological process GO.0044699 Single-organism process 9 5.71 x 10
-5
 
Biological process GO.0008150 Biological process 9 1.12 x 10
-4
 
Molecular function GO.0003674 Molecular function 8 2.29 x 10
-4
 
Molecular function GO.0005488 Binding  7 2.29 x 10
-4
 
Cellular component GO.0005575 Cellular component 8 4.8 x 10
-4
 
Biological process GO.0042221 Response to chemical 5 9.52 x 10
-4
 
Biological process GO.0048871 Multicellular organismal homeostasis 3 9.52 x 10
-4
 
Biological process GO.0050794 Regulation of cellular process 6 9.52 x 10
-4
 
Biological process GO.0050896 Response  to stimulus 6 9.52 x 10
-4
 
Cellular component GO.0044421 Extracellular region part 5 0.001 
Biological process GO.0009987 Cellular process 7 0.002 
Biological process GO.0051716 Cellular response to stimulus 5 0.002 
Biological process GO.0006950 Response to stress 5 0.002 
Biological process GO.0006953 Acute-phase response 3 0.003 
Cellular component GO.0005576 Extracellular region 5 0.003 
Cellular component GO.0005615 Extracellular space 4 0.003 
Cellular component GO.0005623 Cell  6 0.003 
Biological process GO.0044763 Single-organism cellular process 6 0.004 
Biological process GO.0006952 Defense response 4 0.005 
Molecular function GO.0043167 Ion binding 5 0.006 
Biological process GO.0001660 Fever generation 2 0.008 
Biological process GO.0065008 Regulation of biological quality 4 0.011 
Molecular function GO.0046914 Transition metal ion binding 3 0.016 
Biological process GO.0044707 Single-multicellular organism process 4 0.019 
Biological process GO.0006955 Immune response 3 0.024 
Cellular component GO.0044464 Cell part 5 0.024 
Biological process GO.0008152 Metabolic process 5 0.029 
Biological process GO.0044700 Single organism signaling 3 0.036 
Biological process GO.0044710 Single-organism metabolic process 4 0.037 
Biological process GO.0007154 Cell communication 3 0.043 
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Appendix 5.5  
List of all significantly enriched GO terms in Chapter 5 when comparing the 
luteal and anoestrous phase groups at 48 hours associated with Log2FC ≥2 at an 
FDR of 0.05 sorted by p-value  
 
GO Category Term name Description Count 
FDR  
p-
value 
Biological process GO.0051716 Cellular response to stimulus 9 0.005 
Cellular component GO.0005615 Extracellular space 7 0.005 
Cellular component GO.0012505 Endomembrane system 6 0.005 
Cellular component GO.0005576 Extracellular region 9 0.006 
Cellular component GO.0044421 Extracellular region part 8 0.006 
Biological process GO.0006508 Proteolysis 4 0.022 
Biological process GO.0009887 Organ morphogenesis 4 0.022 
Biological process GO.0009987 Cellular process 12 0.022 
Biological process GO.0032501 Multicellular organismal process 8 0.022 
Biological process GO.0044767 Single-organism developmental process 7 0.022 
Biological process GO.0048705 Skeletal  system morphogenesis 3 0.022 
Biological process GO.0048856 Anatomical structure development 7 0.022 
Biological process GO.0060349 Bone  orphogenesis 3 0.022 
Biological process GO.0065008 Regulation of biological quality 7 0.022 
Cellular component  GO.0005623 Cell  11 0.024 
Cellular component  GO.0005575 Cellular component 12 0.025 
Cellular component  GO.0005886 Plasma membrane 6 0.025 
Cellular component  GO.0071944 Cell periphery 6 0.025 
Biological process GO.0002376 Immune system process 6 0.027 
Biological process GO.0022412 Cellular process involved in reproduction 
in multicellular organism 
3 0.027 
Biological process GO.0045637 Regulation of myeloid cell differentiation 3 0.027 
Biological process GO.0048731 System development 6 0.027 
Biological process GO.0060348 Bone development 3 0.027 
Biological process GO.0044707 Single-multicellular organism process 7 0.033 
Biological process GO.0007275 Multicellular organismal development 6 0.036 
Cellular component  GO.0044464 Cell part 10 0.037 
Biological process GO.0050896 Response to stimulus 8 0.041 
Biological process GO.0008150 Biological process 12 0.045 
Biological process GO.0044699 Single-organism process 11 0.045 
Biological process GO.0048522 Positive regulation of cellular process 6 0.045 
Biological process GO.0001501 Skeletal system development 3 0.046 
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Appendix 6.1  
Kenney Classification of Mares Providing Endometrial Explants in Chapter 6 
 
Mares Histology report
b
 
Kenney 
classification 
1 Tall epithelium. Stratum compactum showed focal lymphocyte infiltrate grade 1. Stratum spongiosum showed focal cystic glands grade 1 
and local lymphocyte infiltration grade 1. 
I 
2 Medium epithelium. Stratum compactum showed lymphocyte and siderocyte infiltrate grade I. Stratum spongiosum showed focal cystic 
glands grade 1, epithelial hyperplasia grade 1, periglandular fibrosis grade 1 and siderocyte grade 2. 
I 
3 Medium epithelium. Stratum compactum examined, no pathologic findings noted. Stratum spongiosum showed focal cystic glands grade 
1 with inspissated contents.  
I 
4 Tall epithelium. Stratum compactum showed lymphocyte infiltration grade 1. Stratum spongiosum examined, no pathologic findings 
noted.  
I 
5 Tall epithelium. Stratum compactum showed multifocal cystic glands grade 2 with inspissated contents. Stratum spongiosum showed 
periglandurar fibrosis grade 2. 
II 
 a
 Grade 1 = minimal/very few/very small. Grade 2 = slight/few/small. Grade 3 =  moderate/moderate number/moderate size. Grade 4 = marked/many/large.
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Appendix 6.2  
Computer Code used in Chapter 6 
 
# load package to summarize bam files 
> library(GenomicAlignments) 
 
# put bam files together in a list 
bamfilelist <-c("sample1.bam", "sample2.bam", "sample3.bam, ... 
sample25.bam”)  
 
#BamFileList from Rsamtools provides an R interface to BAM files 
> library(Rsamtools) 
> bamfiles <- BamFileList(bamfilelist)  
 
# use annotation file with the function makeTxDbFromGFF from 
GenomicFeatures  
# list of exons grouped by gene for couting read/fragments 
> library(GenomicFeatures) 
> txdb <- makeTxDbFromGFF("annotationfile.gtf", format="gtf")  
 
 
# produce a GRangesList of all the exons grouped by gene  
> ebg <- exonsBy(txdb, by="gene") 
 
# summarizeOverlaps from GenomicAlignment counts the fragments/reads 
and produces a SummarizedExperiment object`'se' 
> se <- summarizeOverlaps(features=ebg, reads=bamfiles, 
                        mode="Union", 
                        singleEnd=FALSE, 
                        ignore.strand=TRUE, 
                        fragments=TRUE )  
# metadata file created in excel (info about the experiment) 
> sampleTable <- read.csv("exp3_metadata.csv") 
 
# assign the sampleTable as the colData of the summarized experiment by 
converting it into a DataFrame 
> colData(se) <- DataFrame(sampleTable) 
> colData(se) 
DataFrame with 25 rows and 3 columns 
        sample_id   treatment horse_id 
         <factor>    <factor> <factor> 
1  sample1.bam,alive_0h,1 
2  sample_2.bam,control_24h,1 
3  sample_3.bam,LPS_24h,1 
4  sample_4.bam,control_48h,1 
5  sample_5.bam,LPS_48h,1 
6  sample_6.bam,alive_0h,2 
7  sample_7.bam,control_24h,2 
8  sample_8.bam,LPS_24h,2 
9  sample_9.bam,control_48h,2 
10 sample_10.bam,LPS_48h,2 
11 sample_11.bam,alive_0h,3 
12 sample_12.bam,control_24h,3 
13 sample_13.bam,LPS_24h,3 
14 sample_14.bam,control_48h,3 
15 sample_15.bam,LPS_48h,3 
16 sample_16.bam,alive_0h,4 
17 sample_17.bam,control_24h,4 
18 sample_18.bam,LPS_24h,4 
19 sample_19.bam,control_48h,4 
20 sample_20.bam,LPS_48h,4 
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21 sample_21.bam,alive_0h,5 
22 sample_22.bam,control_24h,5 
23 sample_23.bam,LPS_24h,5 
24 sample_24.bam,control_48h,5 
25 sample_25.bam,LPS_48h,5 
 
# DESeq2 - differential analysis  
# SummarizedExperiment 'se' created before will be used for DESeq2 
> dds <- DESeqDataSet(se, design = ~ horse + treatment) 
> dds <- DESeq(dds) 
> resultsNames(dds) 
 
#'contrast' argument to extract comparisons of different levels  
# contrast = c('factorName','numeratorLevel','denominatorLevel') 
> res_exp3_control24h_LPS24h <- results(dds_exp3, 
contrast=c("treatment", "control_24h", "LPS_24h")) 
> res_exp3_LPS24h_LPS48h <- results(dds_exp3, contrast=c("treatment", 
"LPS_24h", "LPS_48h")) 
 
#save and export  
> write.csv(res_exp3_control24h_LPS24h, 
"res_exp3_control24h_LPS24h.csv") 
> write.csv(res_exp3_LPS24h_LPS48h, "res_exp3_LPS24h_LPS48h.csv") 
 
# normalize data to produce PCA plot 
> rld <- rlog(dds, blind=FALSE) 
> pcaData <- plotPCA(rld, intgroup = c("treatment", "horse_id"), 
returnData = TRUE) 
> percentVar <- round(100 * attr(pcaData, "percentVar")) 
> library("ggplot2") 
> ggplot(pcaData, aes(x = PC1, y = PC2, color = treatment, shape = 
horse_id)) + geom_point(size =3) + xlab(paste0("PC1: ", percentVar[1], 
"% variance")) + ylab(paste0("PC2: ", percentVar[2], "%variance")) + 
coord_fixed() + scale_shape_manual(values=seq(0, 8)) 
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Appendix 7.1 
Kenney classification of mares providing biopsies in Chapter 7 
Mares Histology report
a
 
Kenney 
classification 
1  Medium epithelium. Stratum compactum examined, but no pathologic findings noted. Stratum spongiosum showed diffuse fibrosis grade 
1. 
I 
2  Medium epithelium. Stratum compactum showed focal lymphocyte infiltration grade 1. Stratum spongiosum examined, but no pathologic 
findings noted.  
I 
3  Tall epithelium. Stratum compactum showed focal infiltration of lymphocytes grade 1. Stratum spongiosum showed focal cystic glands 
grade 1 and focal lymphocyte infiltrate grade 1. 
I 
4 Medium epithelium. Stratum compactum showed diffuse gland atrophy grade 2 and focal lymphocyte infiltration grade 1. Stratum 
spongiosum showed diffuse gland atrophy grade 2, multifocal cystic glands with inspissated contents grade 3, epithelial hyperplasia of 
cystic glands grade 1, periglandular fibrosis grade 2 and focal haemorrhage grade 2.   
III 
5 Medium epithelium. Stratum compactum showed diffuse gland atrophy grade 4. Stratum spongiosum showed diffuse gland atrophy grade 
4 and lymphocyte infiltration grade 1. 
I 
6  Tall epithelium. Stratum compactum showed diffuse gland atrophy grade 3, cystic glands grade 2 and focal haemorrhage grade 1. 
Stratum spongiosum showed diffuse gland atrophy grade 3, multifocal cystic glands grade 3 with inspissated contents and epithelial 
hyperplasia grade 3.  
III 
a
 Grade 1 = minimal/very few/very small. Grade 2 = slight/few/small. Grade 3 =  moderate/moderate number/moderate size. Grade 4 = marked/many/large.
279 
 
Appendix 7.2  
Computer Code used in Chapter 7 
 
# load package to summarize bam files 
> library(GenomicAlignments) 
 
# put bam files together in a list 
bamfilelist <-c("sample1.bam", "sample2.bam", "sample3.bam”, 
“sample4.bam", "sample5.bam", "sample6.bam”,  )  
 
#BamFileList from Rsamtools provides an R interface to BAM files 
> library(Rsamtools) 
> bamfiles <- BamFileList(bamfilelist)  
 
# use annotation file with the function makeTxDbFromGFF from 
GenomicFeatures  
# list of exons grouped by gene for couting read/fragments 
> library(GenomicFeatures) 
> txdb <- makeTxDbFromGFF("annotationfile.gtf", format="gtf")  
 
 
# produce a GRangesList of all the exons grouped by gene  
> ebg <- exonsBy(txdb, by="gene") 
 
# summarizeOverlaps from GenomicAlignment counts the fragments/reads 
and produces a SummarizedExperiment object`'se' 
> se <- summarizeOverlaps(features=ebg, reads=bamfiles, 
                        mode="Union", 
                        singleEnd=FALSE, 
                        ignore.strand=TRUE, 
                        fragments=TRUE )  
# metadata file created in excel (info about the experiment) 
> sampleTable <- read.csv("exp4_metadata.csv") 
 
# assign the sampleTable as the colData of the summarized experiment by 
converting it into a DataFrame 
> colData(se) <- DataFrame(sampleTable) 
> colData(se)  
DataFrame with 6 rows and 3 columns 
         sample   tissue      mare      
       <factor> <factor> <integer>  
1  sample_1.bam  ex_vivo         1        
2  sample_2.bam  ex_vivo         2        
3  sample_3.bam  ex_vivo         3        
4  sample_4.bam  in_vivo         4    
5  sample_5.bam  in_vivo         5   
6  sample_6.bam  in_vivo         6  
 
# DESeq2 - differential analysis  
# SummarizedExperiment 'se' created before will be used for DESeq2 
> library(DESeq2) 
> dds <- DESeqDataSet(se, design = ~ tissue) 
> dds <- DESeq(dds) 
> resultsNames(dds) 
 
# dispersion-mean plot 
> plotDispEsts(dds, main="Estimation of dispersion", sub="For DESeq2 
object") 
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#'contrast' argument to extract comparisons of different levels  
# contrast = c('factorName','numeratorLevel','denominatorLevel') 
> res <- results(dds_exp4_1A1B7B, contrast=c("tissue", "ex_vivo", 
"in_vivo")) 
 
#save and export  
> write.csv(res,"res_exp4.csv") 
 
# normalize data to produce PCA plot 
> rld<- rlog(dds, blind=FALSE)  
> pcaData <- plotPCA(rld_, intgroup = c("tissue", "mare"), returnData = 
TRUE) 
percentVar <- round(100 * attr(pcaData, "percentVar")) 
> library("ggplot2") 
> ggplot(pcaData, aes(x = PC1, y = PC2, colour = tissue, shape = mare)) 
+ geom_point(size =3) + xlab(paste0("PC1: ", percentVar[1], "% 
variance")) + ylab(paste0("PC2: ", percentVar[2], "%variance")) + 
coord_fixed() 
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Appendix 7.3 
List of all significantly enriched GO terms in Chapter 7 when comparing the 
transcriptome of resistant mares relative to the transcriptome of susceptible 
mares at an FDR of 0.05 sorted by p-value  
 
GO Category
a
 
Term 
name
b
 
Description
c
 Count
e
 
FDR p-
value
f
 
Cellular component GO.0005737 Cytoplasm 10 8.86 x 10
-6
 
Cellular component GO.0044464 Cell part 11 8.86 x 10
-6
 
Cellular component GO.0005623 Cell 11 9.38 x 10
-6
 
Cellular component GO.0005622 Intracellular 10 1.08 x 10
-5
 
Cellular component GO.0005575 Cellular component 11 3.48 x 10
-5
 
Cellular component GO.0016020 Membrane 8 6.80 x 10
-5
 
Cellular component GO.0043226 Organelle 8 1.35 x 10
-4 
 
Molecular function GO.0003674 Molecular function 11 1.37 x 10
-4
 
Cellular component GO.0044444 Cytoplasmic part 7 3.27 x 10
-4
 
Cellular component GO.0043227 Membrane-bounded organelle 7 4.83 x 10
-4
 
Cellular component GO.0043229 Intracellular organelle 7 7.54 x 10
-4
 
Cellular component GO.0098796 Membrane protein complex 4 7.54 x 10
-4
 
Cellular component GO.0044429 Mitochondrial part 4 0.002 
Molecular function GO.0003824 Catalytic activity 7 0.002 
Cellular component GO.0043231 Intracellular membrane-bounded 
organelle 
6 0.002 
Cellular component GO.0044446 Intracellular organelle part 5 0.002 
Cellular component GO.0031090 Organelle membrane 4 0.003 
Cellular component GO.0005739 Mitochondrion  4 0.003 
celullar componet GO.0016021 Integral component of membrane 5 0.003 
Cellular component GO.0070469 Respiratory chain 3 0.004 
Molecular function GO.0008137 NADH dehydrogenase 
(ubiquinone) activity 
3 0.005 
Molecular function GO.0098772 Molecular function regulator 4 0.005 
Cellular component GO.0031966 Mitochondrial membrane 3 0.007 
Molecular function GO.0016491 Oxidoreductase activity 4 0.008 
Cellular component GO.0005740 Mitochondrial envelope 3 0.009 
Cellular component GO.0005886 Plasma membrane 4 0.010 
Cellular component GO.0071944 Cell periphery 4 0.011 
Cellular component GO.0005747 Mitochondrial respiratory chain 
complex I 
2 0.017 
Cellular component GO.0005746 Mitochondrial respiratory chain 2 0.023 
Cellular component GO.0005743 Mitochondrial inner membrane 2 0.032 
Molecular function GO.0030234 Enzyme regulator activity 3 0.037 
 
 
